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Summary 
The prevalence of obesity is a growing problem worldwide. Such scenario urges for 
additional efforts in both investment on prevention and research relating to the identification of 
risk factors that may aid early intervention. It is widely accepted that obesity is a complex 
multifactorial and heterogeneous condition with an important genetic component in the 
susceptibility risk. Therefore, the identification of associated gene variants could be essential in 
the design of prevention strategies and management of individuals genetically predisposed to 
obesity. In 2007, it was identified the first single nucleotide polymorphism (SNP) located in the 
FTO gene (rs9939609) associated with obesity by genome-wide association studies (GWAS). 
Until now, more than 52 genetic loci have been unequivocally associated with obesity related-
traits in several European populations. However, none of these studies was performed before in 
a sample of Portuguese population.  
The main aims of this study were i) to estimate the prevalence of obesity in 6-12 years old 
children from the central region of Portugal; ii) to investigate whether 14 previously described 
SNPs in obesity-related genes are associated with the risk of obesity in Portuguese children; iii) 
to identify MC4R gene mutations in children with morbid obesity (BMI ≥99th) that could justify 
this phenotype. 
Anthropometric parameters such as weight, height and waist circumference were 
measured in a random representative sample of 1433 children (747 girls and 686 boys) between 
6-12 years old from several public schools in 2011. The International Obesity Task Force (IOTF) 
cut-offs were used to define obesity. Children classified with overweight (320) and obesity (154), 
and 256 randomly selected lean subjects with 18.5<BMI<25 kg/m2, were selected for 
genotyping. Polymorphisms were examined in DNA samples by TaqMan® assay. Sequencing of 
the MC4R gene was carried out in all individuals with BMI ≥99th. 
The prevalence of overweight/obesity found in the total sample was 33.0%; 10.7% were 
obese children. Overweight was significantly higher in boys than in girls (25.9% and 19.0% 
respectively,p=0.04), whereas no gender differences was found for obesity (10.6 % and 10.7% 
respectively, p=0.57). Comparison with previous studies showed a slightly increase in 
overweight/obesity in children of central Portugal in the last 10 years, reaching values of 40.0% 
prevalence in the 7-9 years old children. 
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For three study polymorphisms located in the FTO gene, we found significant associations 
for SNPs rs9939609 and rs1421085 with weight, BMI, BMI Z-score and waist circumference 
(p<0.05 in all traits). For rs1861868, marginally significant associations were obtained with 
weight (p=0.08) and BMI (p=0.09). Logistic regression analysis, in the additive model, revealed 
both rs9939609 and rs1421085 SNPs significantly associated with obesity (OR=1.41; p=0.02 and 
OR=1.45, p=0.01, respectively). Haplotype analyses (rs1861868-rs1421085-rs9939609) identified 
two combinations (ACA and GCA) associated with a higher risk of obesity (OR=1.53; p=0.02 and 
OR=1.73; p=0.03, respectively). 
We tested the association between the -13910C>T polymorphism, located in the lactase 
(LCT) gene, and obesity-related traits, and found indication for an association between the -
13910*T allele and abdominal obesity (OR=1.41; p=0.03). Under the dominant model, significant 
association was observed between the LCT-13910 CT/TT genotypes and abdominal obesity 
(OR=1.65; p=0.02). No association was detected with the risk of obesity (p=0.35) or 
anthropometrics traits (p>0.05). 
Finally, we tested for the association of obesity-related quantitative traits in Portuguese 
children with ten polymorphisms in the obesity related genes MSRA, TFAP2B, MC4R, NRXN3, 
PPARGC1A, TMEM18, SEC16B, HOXB5 and OLFM4. The MC4R rs12970134 polymorphism was 
nominally associated with BMI (p=0.03), BMI Z-score (p=0.04) and waist circumference (p=0.02), 
and borderline associated with weight (p=0.05). Near nominal associations were also found for 
the PPARGC1A rs8192678 polymorphism with weight (p=0.06), and for the MSRA rs545854 
polymorphism with BMI (p=0.05) and BMI Z-score (p=0.05). Furthermore, logistic regression 
under the additive model showed that MC4R rs12970134 and TFAP2B rs987237 were nominally, 
respectively, associated (OR=1.47; p=0.02) and borderline associated (OR=1.47; p=0.05) with the 
obese phenotype. 
Additionally, 32 children who present a BMI ≥99th were screened for MC4R gene mutations. 
We found two previously described polymorphisms at heterozygous state in two children: the -
174A>C (rs34114122) polymorphism in the 5´UTR region in a girl with BMI Z-score=2.51; and the 
common missense mutation 307G>A (Val103Ile) in the MC4R gene coding region identified in a 
boy with a BMI Z-score=2.60. No other pathogenic MC4R gene mutations were detected. 
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 In conclusion, this study shows a high prevalence of overweight/obesity among Portuguese 
children, following the trend of other European countries. We highlighted for the first time the 
possible association of FTO, MC4R, PPARGC1A, MSRA and TFAP2B SNPs with several obesity-
related traits in a sample of Portuguese children. FTO SNPs showed the strong association with 
the risk of obesity in line with previous studies performed in European populations. Our study is 
a significant contribution to the knowledge of the genetic basis of obesity in the Portuguese 
population, but further studies are needed to a better understanding of the genetic factors 
linked to the obesity risk. Such information could be used in the future for the development of 
new obesity preventive strategies. 
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Resumo 
A prevalência da obesidade tem vindo a aumentar em todo o mundo. Tal cenário implica 
esforços adicionais no investimento tanto em matéria de prevenção como de investigação 
relacionados com a identificação de fatores de risco que podem ajudar a intervenção precoce. É 
amplamente aceite que a obesidade é uma condição multifatorial e heterogênea complexa com 
uma importante componente genética. Portanto, a identificação de variantes genéticas 
associadas poderão ser essenciais em estratégias de prevenção em indivíduos geneticamente 
predispostos à obesidade. Em 2007, foi identificado o primeiro polimorfismo de nucleótido 
simples (SNP) localizado no gene FTO (rs9939609) associado à obesidade em estudos de 
associação do genoma (GWAS). Mais de 52 loci genéticos foram já associados à obesidade em 
várias populações Europeias. No entanto, nenhum estudo do género foi até agora realizado 
numa amostra da população Portuguesa.  
Os principais objetivos deste estudo foram i) estimar a prevalência de obesidade em 
crianças dos 6-12 anos da região centro de Portugal; ii) investigar se 14 SNPs previamente 
descritos em genes relacionados com a obesidade, estão associados com o risco de obesidade 
em crianças portuguesas; iii) identificar mutações no gene MC4R em crianças com obesidade 
mórbida (IMC ≥99th) que poderão justificar o fenótipo. 
Os parâmetros antropométricos, tais como, peso, altura e circunferência da cintura (CC) 
foram medidos numa amostra aleatória de 1433 crianças (747 raparigas e 686 rapazes) entre os 
6-12 anos, de várias escolas públicas em 2011. Os limites do International Obesity Task Force 
(IOTF) foram usados para definir obesidade. Crianças classificadas com excesso de peso (320) e 
obesidade (154), e 256 indivíduos normais escolhidos aleatoriamente com 18,5<IMC<25 kg/m2, 
foram selecionados para a genotipagem. Os polimorfismos foram examinados em amostras de 
DNA por ensaios com sondas TaqMan®. A sequenciação do gene MC4R foi realizada nos 
indivíduos com IMC ≥99th. 
A prevalência de excesso de peso/obesidade obtida na amostra total foi de 33,0%; 10,7% 
das crianças eram obesas. O excesso de peso foi significativamente maior nos rapazes do que 
nas raparigas (25,9% e 19,0%, respetivamente, p=0,04), não tendo sido encontradas diferenças 
entre os sexos para a obesidade (10,6% e 10,7%, respetivamente, p=0,57). A comparação com 
estudos anteriores mostrou um ligeiro aumento no excesso de peso/obesidade em crianças do 
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centro de Portugal nos últimos 10 anos, atingindo valores de prevalência de 40,0% nos 7-9 anos 
de idade. 
Dos três polimorfismos estudados localizados no gene FTO, foram encontradas associações 
significativas dos SNPs rs9939609 e rs1421085 com peso, IMC, IMC Z-score e CC (p<0,05 em 
todos os parâmetros). Para o SNP rs1861868, foram obtidas associações marginalmente 
significativas com peso (p=0,08) e IMC (p=0,09). A análise de regressão logística, no modelo 
aditivo, revelou os SNPs rs9939609 e rs1421085 significativamente associados com a obesidade 
(OR=1,41; p=0,02, e OR=1,45, p=0,01, respetivamente). A análise de haplótipos (rs1861868-
rs1421085-rs9939609) identificou duas combinações (ACA e GCA) associadas a um maior risco 
de obesidade (OR=1,53; p=0,02, e OR=1,73; p=0,03, respetivamente). 
Foi testada a associação entre o polimorfismo -13910C>T, localizado no gene da lactase 
(LCT), e a obesidade, tendo sido encontrada indicação para uma associação entre o alelo -
13910*T e a obesidade abdominal (OR=1,41; p=0,03). Sob o modelo dominante, foi observada 
uma associação significativa entre os genótipos CT/TT e obesidade abdominal (OR=1,65; p=0,02). 
Nenhuma associação foi observada com o risco de obesidade (p=0,35) ou características 
antropométricas (p>0,05). 
Finalmente, foi testada a associação de características quantitativas relacionadas com a 
obesidade em crianças portuguesas com dez SNPs nos genes relacionados com a obesidade 
MSRA, TFAP2B, MC4R, NRXN3, PPARGC1A, TMEM18, SEC16B, HOXB5 e OLFM4. O SNP MC4R 
rs12970134 foi encontrado nominalmente associado com IMC (p=0,03), IMC Z-score (p=0,04) e 
CC (p=0,02), e no limite de significância com peso (p=0,05). Foram também encontradas 
associações nominais para o polimorfismo PPARGC1A rs8192678 com peso (p=0,06), e para o 
polimorfismo MSRA rs545854 com IMC (p=0,05) e IMC Z-score (p=0,05). A regressão logística 
sob o modelo aditivo mostrou que os SNPs MC4R rs12970134 e TFAP2B rs987237 se encontram, 
nominalmente, respetivamente, associado (OR=1,47; p=0,02) e no limite de significância 
associado (OR=1,45; p=0,05) com o fenótipo obeso. 
Adicionalmente, 32 crianças que apresentavam um IMC ≥99th foram rastreadas para 
mutações no gene MC4R. Foram encontrados dois SNPs, previamente descritos, em 
heterozigotia em duas crianças: o SNP -174A>C (rs34114122) na região 5'UTR numa rapariga 
com IMC Z-score=2,51; e a mutação missense comum 307G>A (Val103Ile) na região codificante 
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do gene num rapaz com um IMC Z-score=2.60. Não foram detetadas outras mutações no gene 
MC4R.  
Em conclusão, este estudo mostrou uma alta prevalência de excesso de peso/obesidade nas 
crianças portuguesas, seguindo a tendência de outros países europeus. Foi encontrada pela 
primeira vez numa amostra de crianças portuguesas, uma possível associação dos SNPs nos 
genes FTO, MC4R, PPARGC1A, MSRA e TFAP2B com várias medidas de obesidade. Os 
polimorfismos no gene FTO mostraram a associação mais forte com o risco de obesidade em 
linha com estudos previamente realizados em populações europeias. O nosso trabalho é uma 
importante contribuição para o conhecimento da base genética da obesidade na população 
portuguesa, mas são necessários mais estudos para melhor compreender estes fatores genéticos 
associados ao risco da obesidade. Esta informação poderá vir a ser usada no futuro para o 
desenvolvimento de novas estratégias de prevenção para a obesidade. 
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Resumen 
La prevalencia de la obesidad es un problema creciente en todo el mundo. Tal escenario 
exige esfuerzos adicionales e inversión, tanto en materia de prevención como en investigación 
enfocada a la identificación de factores de riesgo que puedan ayudar a la intervención precoz. 
Está ampliamente aceptado que la obesidad es un complejo trastorno multifactorial y 
heterogéneo cuyo componente genético supone un importante factor de riesgo. Por lo tanto, la 
identificación de variantes genéticas asociadas podría ser esencial en el diseño de estrategias de 
prevención y de manejo de individuos genéticamente predispuestos a la obesidad. En 2007 se 
identificó el primer polimorfismo de nucleótido simple (SNP) asociado a la obesidad, localizado 
en el gen FTO (rs9939609), por un estudio de asociación del genoma completo (GWAS). Hasta 
ahora más de 52 loci genéticos han sido asociados inequívocamente a rasgos relacionados con la 
obesidad en varias poblaciones europeas. Sin embargo, ninguno de estos estudios se realizó 
antes en una muestra de población portuguesa. 
Los principales objetivos de este estudio fueron (i) estimar la prevalencia de la obesidad en 
niños de 6-12 años de edad de la región central de Portugal; (ii) investigar si 14 SNPs 
previamente descritos en los genes relacionados con la obesidad están asociados con el riesgo 
de obesidad en niños portugueses; (iii) identificar en niños con obesidad mórbida (IMC ≥ 
percentil 99) mutaciones en el gen MC4R que podrían justificar el fenotipo. 
Se midieron parámetros antropométricos tales como peso, altura y circunferencia de la 
cintura en una muestra aleatoria representativa de 1433 niños (747 niñas y 686 niños) de 6-12 
años de varias escuelas públicas en 2011. Para definir la obesidad se utilizaron los puntos de 
cortes de la International Obesity Task Force (IOTF), y con ellos se seleccionaron para el 
genotipado 320 niños con sobrepeso, 154 con obesidad, y 256 de peso normal escogidos al azar 
para el grupo control de un total de 928 (18.5<IMC<25 kg/m2). Los SNPs se estudiaron en 
muestras de ADN mediante ensayos TaqMan®. La secuenciación del gen MC4R se realizó en 
individuos con IMC ≥ percentil 99. 
La prevalencia de sobrepeso/obesidad en la muestra total fue de 33,0%; 10,7% eran obesos. 
El sobrepeso fue significativamente mayor en niños que en niñas (25,9% y 19,0% 
respectivamente, p=0,04), mientras que no se encontraron diferencias de sexo en los obesos 
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(10,6% y 10,7% respectivamente, p=0,57). La comparación con estudios anteriores mostró un 
ligero aumento del sobrepeso/obesidad en los niños del centro de Portugal en los últimos 10 
años, alcanzando una prevalencia del 40,0% en los 7-9 años de edad. 
De los SNPs localizados en el gen FTO se encontró una asociación significativa de rs9939609 
y rs1421085 con el peso, IMC, IMC Z-score y circunferencia de la cintura (p<0,05 en todas las 
asociaciones), mientras que el SNP rs1861868 presentó una asociación marginalmente 
significativa con el peso (p=0,08) y el IMC (p=0,09). El análisis de regresión logística, con el 
modelo aditivo, reveló una asociación significativa entre los SNPs rs9939609 y rs1421085 y la 
obesidad (OR=1.41 p=0.02; y OR=1.45 p=0.01; respectivamente). Los análisis de haplotipos 
(rs1861868, rs1421085, rs9939609) identificaron dos combinaciones (ACA y GCA) asociadas a un 
mayor riesgo de obesidad (OR=1,53 p=0,02; y OR=1,73 p=0,03; respectivamente). 
En el SNP -13910C>T, situado en el gen de la lactasa (LCT), se encontraron indicios de 
asociación entre el alelo -13910*T y la obesidad abdominal (OR=1,41 p=0,03). Bajo el modelo 
dominante, se observó una asociación significativa entre los genotipos CT/TT y la obesidad 
abdominal (OR=1,65 p=0,02), pero no se detectó asociación con el riesgo de obesidad (p=0,35) o 
con rasgos antropométricos (p>0,05). 
Por último, se estudiaron otros diez SNPs de genes relacionados con la obesidad (MSRA, 
TFAP2B, MC4R, NRXN3, PPARGC1A, TMEM18, SEC16B, HOXB5 y OLFM4). El SNP rs12970134 
MC4R mostró una asociación nominal con el IMC (p=0,03), el valor Z-score (p=0,04) y la 
circunferencia de la cintura (p=0,02), y en el límite de significancia con el peso (p=0,05). En el 
límite se encuentran también las asociaciones nominales obtenidas para el SNP rs8192678 
PPARGC1A con el peso (p=0,06), y para el SNP rs545854 MSRA con el IMC (p=0,05) y el IMC Z-
score (p=0,05). Por otra parte, la regresión logística bajo el modelo aditivo mostró que los SNPs 
MC4R rs12970134 y TFAP2B rs987237, en relación con el fenotipo obeso, estaban nominalmente 
asociados (OR=1.47; p=0.02) y nominalmente en el límite de la asociación (OR=1.47; p=0.05), 
respectivamente. 
Además, se realizó el cribado de mutaciones del gen MC4R en los 32 niños que presentaban 
un IMC ≥ percentil 99. Se encontraron dos SNPs descritos anteriormente en estado heterocigoto: 
el polimorfismo -174A>C (rs34114122) en la región 5'UTR en una niña con IMC Z-score=2,51; y la 
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mutación común missense 307G>A (Val103Ile) en la región codificante del gen MC4R de un niño 
con IMC Z-score=2,60. No se detectaron otras mutaciones patogénicas en el gen MC4R. 
En conclusión, este estudio muestra una alta prevalencia de sobrepeso/obesidad entre los 
niños portugueses, siguiendo la tendencia de otros países europeos. Además, se destaca por 
primera vez la posible asociación de SNPs  en los genes FTO, MC4R, PPARGC1A, MSRA y TFAP2B 
con varios rasgos relacionados con la obesidad en una muestra de niños portugueses. Los SNPs 
del gen FTO mostraron una fuerte asociación con el riesgo de obesidad, en línea con estudios 
previos realizados en poblaciones europeas. Este trabajo es una contribución significativa al 
conocimiento de las bases genéticas de la obesidad en la población portuguesa, pero se 
necesitan más estudios para una mejor comprensión de este componente genético, lo que 
podría ser utilizado en el futuro para el desarrollo de nuevas estrategias preventivas frente a la 
obesidad. 
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Introduction 
 
For a considerable period of prehistory, hominins were primarily hunter-gatherers. In that 
period food was severely limited and this resulted in a natural selection for humans who had the 
capability of storing energy as fat. Today, food is easily available in modern societies, and this 
environment change could act in an ancient genetic background selected to store energy. On the 
other hand, the changes in our environment occurred more rapidly than the modifications in our 
genetic background. In fact, our genetic background is not very different from 12,000 years ago, 
which correspond to the beginning of the agriculture development [1]. This means that there 
might be a delay in the adjustment of the genetic profile to environment, and that our genetic 
background is similar to the one from the time our forefathers were foragers. Therefore, when 
considering the imbalance in our modern lifestyle and our “ancient” genetic profile, it is 
understandable that many people gain weight so easily. When human morphology is considered, 
there are profound individual differences, such as body size, hair color/form, eyes color/form, 
etc. These human variations were due, in part, to evolutionary forces, genetic drift, 
environmental conditions, among others. However, in all societies and subpopulations, there are 
both obese and non-obese individuals. The difference arises primarily as a consequence of 
genetic factors, as is revealed by the high heritability for body mass index (BMI) (40-70%)  [2–5]. 
A trait can reflect the activity of a single-gene (Mendelian or monogenic) or more than one gene 
(polygenic); both cases could be influenced by environmental factors. The polygenic 
multifactorial condition reflects the additive contribution of many genes conferring different 
degrees of susceptibility. Accordingly, we may understand a polygenic trait as the combined 
action of several genes producing a “continuously varying” phenotype. With the advent of the 
Human Genome Project (1990-2003), millions of DNA sequence variants were discovered in the 
human genome. This large and diverse database of polymorphism markers provided a novel 
opportunity to study the human genetic basis of several complex diseases through population 
approaches. In the study design of population approaches, a significant amount of individuals 
must be screened for a large number of polymorphisms. If a polymorphism increases 
susceptibility to a specific disease of interest, we should note that it is more common among 
C h a p t e r  I  
 
 
4 
individuals affected by this condition than among non-affected individuals. Thus, through the 
genotyping of significant number of individuals, the population genetics tools are able to 
highlight the genetic basis of polygenic diseases, such as obesity. 
 
1. What is Obesity? 
Human obesity is a global public health concern and results from an excessive accumulation 
of body fat that can adversely affect health [6]. The global rise of obesity has serious effects, and 
may contribute for a significant number of diseases including type 2 diabetes mellitus, 
cardiovascular diseases, metabolic syndrome, and some cancers [6, 7]. Beyond co-morbidities, 
obesity has an important social impact with direct and indirect costs in healthcare services [7]. 
Excessive fat accumulation results from a persistent positive energy balance, that is, the amount 
of energy consumed exceeds the amount of energy expended [5]. So, obesity could be a 
consequence of an imbalance between energy intake and energy expenditure [8]. The energy 
balance represents a conglomerate of traits, each one influenced by numerous variables such as 
behavior, diet, environment, social structures, metabolic factors and genetics [9]. The result of 
this complex interaction among all of these variables contributes to individual differences in the 
development of obesity.  
Interestingly, at the early 2000s emerged in the literature a considerable number of studies 
with a controversy surrounding the idea of the “obesity paradox”. According to it, some 
individuals with overweight or obesity can be considered healthy regarding to their metabolic 
and cardio-respiratory fitness. Concretely, this paradox suggests that individuals with a high BMI 
have a better prognosis than individuals with normal BMI concerning the risk association with 
cardio-vascular diseases and many other chronic diseases [10]. For example, and to cite only one 
study, Romero-Corral et al. [11] showed that overweight individuals had a significantly lower risk 
of all-cause mortality, and a trend towards decreased cardiovascular mortality, comparing to 
individuals with normal BMI. Some hypotheses were proposed trying to explain this obesity 
paradox. For example, this could be a result of a possible selection bias and inability to control 
non-measurable confounding factors [12]. In fact, BMI cannot distinguish between an elevated 
body weight due to high levels of lean vs. fat body mass. Therefore, an excess of body fat is more 
frequently associated with metabolic abnormalities than a high level of lean body mass [13]. The 
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genetically inherited leptin or other adipokines deficiency was also investigated and could have 
an important role in obesity paradox, in which increased levels of leptin could be 
cardioprotective [14]. However, until now the underlying mechanisms for obesity paradox 
remain unclear, and the idea controversial. A more detailed discussion about this topic could be 
found in detail in other studies [10, 12, 15]. 
 
1.1. How obesity is defined? 
Currently, the BMI, which is a simple index of weight-for-height, is the most commonly 
measure used to classify overweight and obesity [16]. It is defined as a person’s weight in 
kilograms divided by the square of his height in meters (kg/m2). 
 The BMI is a measure that was devised in the 19th century by Adolphe Quetelet, although 
only in 1972 it became a world reference for measuring body fat in adults. Decades of research 
have shown that BMI provides a good estimate for body fat, although more sophisticated and 
accurate measures are also being used nowadays. Currently, it is widely accepted that BMI is a 
reliable and easy way to access to body fat, which make an important advantages of its use as an 
obesity measure. Also importantly several studies related the risk of developing health problems 
and risk of death with BMI. According to the world health organization (WHO) for a healthy adult 
the BMI should range from 18.5 to 24.9 kg/m2. Overweight is defined as a BMI of 25 to 29.9 
kg/m2, whereas obesity is defined as a BMI above 30 kg/m2 [16]. If for adults these cutoffs are 
more or less consensual, the definition of children obesity based in BMI was more controversial. 
Depending of the age and gender it is normal for children and adolescents to have different 
amounts of body fat, thus several scales based in age and gender are currently used (WHO, 
United States the Centers for Disease Control and Prevention (CDC), and International Obesity 
Task Force (IOTF)). Despite the great advantages and the broad use, BMI have also some 
limitations. For example, being an indirect measure of body fat it does not distinguish between 
body fat and lean body mass. Also, it is not so accurate in younger ages compared to adults and 
it does not take into account normal differences between gender or ethnic groups. Thus, other 
indirect methods were developed to measure body fat (for example waist circumference or 
waist-to-hip-ratio) and currently more sophisticated direct methods such as magnetic resonance 
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imaging or dual energy X-ray absorptiometry are being used. However, despite all these 
methods and techniques, BMI remains the simple, cheap and most used measure of obesity. 
 
1.2. Prevalence of Obesity 
Epidemiological studies indicate that adiposity, as reflected by BMI, has increased 
worldwide over the past decades [17]. Moreover, obesity is more common in some countries 
than in others, though precise cross-country comparisons can be difficult because not all 
samples are representative of the relevant populations. Nonetheless, available data suggest that 
the increase in the prevalence of obesity began to emerge during the 1980s and ever since more 
countries have joined the global obesity pandemic [17, 18]. Between 1980 and 2008, the global 
change per decade for age-standardized mean BMI was increased ~0.4 kg/m2 and ~0.5 kg/m2 in 
men and women, respectively [17]. By 2013, the global estimated prevalence of 
overweight/obesity in men and women was 36.9% and 38.0%, respectively, comparing with 
28.8% and 29.8%, respectively, in 1980. In children and adolescents the prevalence of 
overweight and obesity has increased from 1980 to 2013 in developed countries (23.8% and 
22.6%, in boys and girls, respectively), but also in developing countries with an increase around 
5% of both boys and girls. In some countries like Kiribati, Federated States of Micronesia, Libya, 
Qatar, Samoa among others the estimated prevalence of obesity in adults exceeded 50% of the 
population [18]. In 1989, worldwide estimates for the prevalence of overweight and obesity 
among adults (>20 years) was around 857 million individuals, comparing to the 2.1 billion in 
2013 [18]. These values represent an increase of ~41% in 33 years. 
Concerning the Portuguese population, the prevalence of overweight in adults (>18 year-
old) were 46.7% and 38.1% in men and women, respectively, and obesity prevalence was 
reached the 20.0% in both sex [19]. In children aged 3-10 years 28.0% were overweight or obese 
(19.7% overweight; 8.2% obese) [20]. Among adolescents (11-17 years-old) the prevalence of 
overweight/obesity was around 20% for boys and 17% for girls between 2002 and 2010 [21]. 
In modern societies, despite obesity awareness campaigns and efforts to decrease in energy 
intake and increase in energy expenditure, obesity prevalence is increasing. However, we don’t 
yet understand why not everyone in our societies becomes obese. Obesity has a multi-factorial 
etiology, involving various non-genetic and genetic factors [6, 22]. Probably most cases of 
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obesity results of a cluster towards the middle of this spectrum, which can be best described as 
the outcome of an adverse obesogenic environment, working on a susceptibility genotype. 
Effectively, the genetic susceptibility can potentially be mediated through defects in several 
different homeostatic mechanisms. Certainly, the exposure to an obesogenic and other 
environmental factors should be the main cause of the increase in the prevalence of high BMI 
over the last 30 years [6, 7, 17].  
The field of genetic epidemiology aims to use systematic methods to investigate the 
influence of human genetic variation on health and disease, and also the relationship between 
environmental factors and disease.  
  
2. Genetics of obesity 
The increase in the obesity prevalence around the world has been broadly attributed to the 
change in environment, which is more obesogenic, against an evolutionary background, that 
could be maladaptive in this new obesogenic context. On the other hand, specific features of the 
energy balance mechanisms can effectively protect against obesity, possibly explaining why one 
third or more of the population remains lean [23]. The obesity phenotype only emerges if food 
consumption exceeds the energy expenditure on a lasting basis, resulting in a prolonged positive 
energy balance. However, there are many risk factors that predict the development of obesity 
and generally all involve the interaction of biological and social factors. Numerous studies are 
consistent with the hypothesis that the personal genetic profile could be a cause for individual 
differences in the predisposition to weight gain. It is, therefore, interesting that most of the 
genes involved in the susceptibility of obesity are also related to food intake and regulation of 
energy balance [23]. Based on genetic and phenotypic characteristics, three types of obesity 
forms can be considered: monogenic syndromic obesity, monogenic non-syndromic obesity and 
polygenic (common) obesity. 
 
2.1. Evidence for a genetic component to obesity 
Over the last 30 years, the increase in the prevalence of obesity could be attributed 
primarily to environmental changes, or to high-calorie food intake together with the sedentary 
lifestyle of modern societies [22]. The fact that the prevalence of obesity in many countries has 
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increased 3-fold over the last 3 decades seems difficult to conjugate with the notion that 
genetics are the primary cause of obesity, as revealed by twin and adoption studies [2–5]. 
Nevertheless it is now believed that environmental factors can influence the genetic background 
contributing to the increase in obesity prevalence. Moreover, epigenetic mechanisms, in which 
environmental factors cause changes in the expression of genes, could also help explaining the 
observed increase in obesity prevalence. 
Heritability represents the proportion of phenotypic variation among individuals due to 
genetic contribution. Hence, it is not surprising that one important risk factor for childhood and 
adolescent obesity is parental obesity. Whitaker et al. [24] found that when both parents are 
obese there is an increase of more than double of the risk for childhood obesity. However, most 
of the studies found a small to medium effect of parental obesity as risk factor for childhood 
obesity [25]. Other studies have found a stronger effect for maternal obesity compared to 
paternal obesity, which may reflect pre- and postnatal environmental factors [26]. Moreover, 
maternal weight gain in pregnancy has been positively associated with BMI of the children into 
adulthood [27]. Several studies found that environmental conditions experienced in utero are an 
important factor in programming obesity. 
Twin studies have been used to model the genetic component of a given trait, due to the 
fact that monozygotic (MZ) twins are genetically identical, while non-identical dizygotic (DZ) 
twins share only 50% of their genetic material [22]. In 1977, Feinleib et al. [2] studied the 
correlations for weight in 250 MZ and 264 DZ male veteran twin pairs, and established for the 
first time that familial aggregation for obesity results mainly from genetic influence. In 1986, 
Stunkard et al. [4] confirmed these results in a 25-year follow-up study using more than 4000 MZ 
and DZ twin pairs. High heritability values for BMI were observed for the same subjects at 20 
years (h2=0.77) and at 45 years (h2=0.84). The heritability of fat mass among MZ twins has been 
reported to range from 70-90%, while in DZ twins it is 35-45%. Adoption studies have 
strengthened the evidence of a strong genetic influence on human body weight. Body 
corpulence of adopted children correlates more strongly with BMI of their biologic parents 
versus the BMI of their adoptive parents [3]. Recently, Silventoinen et al. [5] conduct a review of 
studies in twins and adopted children, suggesting that genetic factors could have a much 
stronger effect than environmental factors on the BMI trends in children up to the age of 18 
G e n e r a l  I n t r o d u c t i o n  
 
 
9 
years.  
Another genetic component for obesity is highlighted through the different prevalence 
between racial groups. For example, it was found that obesity prevalence in Caucasian and Asian 
populations is of about 35% or less compared to 50% or more found among Pima Indians living 
in New Mexico [28]. However, the search for underlying genotypes that cause of obesity has 
been challenging due to the complex interactions involved in the regulation of adiposity. Indeed, 
many of individual genotypes (especially those obtained with a lower odds ratio) that have been 
associated with elevated body mass have not been replicated in a reliable fashion. Moreover, 
environmental factors and cultural diversity also account for the different obesity prevalence 
found across ethnicities. 
 Studies have shown that genetic population substructure, economic disadvantages, 
psychosocial stress, or access to medical care could have an important impact in obesity 
development and prevalence. The cultural context could also influence obesity, by defining for 
example the type and quality of food intake. Also, in some cultural contexts the obesity 
phenotype could represent a signal of wealth and high social status. Another important factor is 
the genetic architecture, which is different across population (population substructure) and 
might be differentiated in ethnic clusters. This could presuppose that disease-causing alleles are 
more likely to be present in some groups or even be specific to other groups. This point could be 
considered as the population genetic predisposition to develop the disease. For example, it is 
well demonstrated that in the US black-white population occur disparities in the risk of 
developing cardiovascular disease [29]. Also, social factors such as economics disadvantage or 
psychosocial stress between groups could have a real impact in causes of ill health. For example, 
disparities originated by the limited access of quality medical care between different ethnics 
groups living in the same population might influence health, causing different disease rates.  
The role of maternal nutrition and stress suffered during pregnancy, mostly due to social 
disparities or cultural differences could also influence biological processes and responses across 
the life cycle that will be discussed later. All these factors affect the intrauterine environment 
reflecting differences in birth weight. However, nowadays is still evident that genetic factors play 
a considerable role in obesity. Three distinct forms of obesity could be found: monogenic, 
syndromic and polygenic obesity. 
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2.2. Mendelian forms of obesity 
Monogenic forms of obesity result from an alteration of a single gene and are rare, affecting 
about 5% of the population, and severe [30, 31]. There are more than 200 described cases of 
human obesity associated with homozygous forms of a single gene mutation [32, 33]. Two forms 
of Mendelian inheritance of obesity could be found: syndromic and non-syndromic. Most of 
these monogenic forms of obesity are characterized by an early-onset of the disease and an 
extreme phenotype [30]. In the search for homologous mutations in mice, several human forms 
of obesity have been identified [34]. Thus, murine models appear useful to understand the 
molecular pathogenesis of human obesity [35]. Family studies based on individuals with extreme 
obesity, also proved to be very successful in the detection of obesity-related mutations [36]. 
Below is presented a brief and general review about the two syndromic forms of obesity. 
 
2.2.1. Non-syndromic form of obesity 
Over the past 15-20 years, several gene mutations have been shown to cause autosomal 
recessive or co-dominant forms of obesity. More than 200 single-gene mutations have been 
found to cause human obesity [37]. Interestingly, all these mutations can be found in only ten 
genes [33]. However, these mutations are rare and lead to extreme obesity with an early-onset 
obesity and other endocrine disorders [31]. There are eight well-known genes in monogenic 
non-syndromic form of obesity explaining up to 10% of cases with early-onset extreme obesity, 
affecting LEP, LEPR, POMC, PCSK1, MC4R, BDNF, NTRK2 and SIM1 (Table 1.1) [30, 31, 38]. All 
these genes code for proteins with a central role in the leptin-melanocortin signaling pathway 
present in the hypothalamus, and therefore affect regulation of food intake and energy 
expenditure [31]. This pathway is activated when LEP is secreted by the adipose tissue, binds to 
its receptor, localized in the surface neurons in the arcuate nucleus of the hypothalamus [39]. 
The signal that regulates satiety and energy homeostasis  is  then  propagated  through  the  
POMC/cocain  and  amphetamine  related  transcript (CART) and melanocortin system [31]. 
While POMC/CART neurons synthesize anorexigenic peptide alpha-melanocyte-stimulating 
hormone (α-MSH), a distinct group of neurons synthesizes the orexigenic peptide neuropeptide 
Y (NPY) and agouti related protein (AGRP), which act as inhibitors of MC3 and MC4 receptors 
[40].  
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Table 1.1. Monogenic forms (syndromic and non-syndromic) of obesity. 
 
Non-syndromic forms 
Gene name 
Gene 
symbol 
Chromosome 
location 
Mutations Obesity Phenotype 
Leptin  
 
LEP 7q32.1 ΔG133, Arg105Trp 
Extreme, early-onset 
obesity, hyperphagia. 
Leptin receptor  
 
LEPR 1p31.3 
Exon 16 splice donor 
GA 
Extreme, early-onset 
obesity, hyperphagia. 
Pro-opiomelanocortin 
 
POMC 2p23.3 
G7013T, 7133delC, 
C3804A, A6851T, 
6906delC, 6996del, 
7100insGG, 7134delG 
Early onset obesity. 
Proconvertase 1  PCSK1 
5q15 
 
Gly483Arg, AC+4 
intron 5 donor splice site, 
Glu250Stop, Del213Ala 
Childhood onset obesity,  
elevated proinsulin,  
hypocortisolemia,  
depressed POMC,  
reactive hypoglycemia. 
Melanocortin-4 receptor  
 
MC4R 18q21.32 >150 
Early onset obesity,  
hyperphagia, increased  
fat mass, increased lean  
mass. 
Brain-derived 
neurotrophic factor  
 
BDNF 11p13 46, XX, inv(11)(p13p15.3) 
Severe obesity, 
Hyperphagia, body weight. 
Neurotrophic tyrosine 
kynase receptor type 2 
 
NTRK2 9q22.1 Y722C 
Severe early onset obesity, 
hyperphagia. 
Single-minded homolog 1  SIM1 6q16.3 
de novo balanced 
translocation 1p22.1 and 
6q16.2.  
Early-onset obesity, 
hypotonia, developmental 
delay. 
Syndromic forms 
Syndrome Gene Chromosome location Obesity Phenotype 
Prader Willi syndrome (PWS) 
Contiguous 
gene disorder 
15q11-13 
Neonatal hypotonia, poor feeding, 
evolving into extreme hyperphagia,  
central obesity. 
Bardet-Biedl syndrome (BBS)  BBS1-BBS12 11q13.2 progressive late childhood obesity 
Alstrom syndrome ALMS1 2p13.1 Mild truncal obesity 
WAGR syndrome BDNF 11p14.1 Obesity 
16p11.2 deletion 
 
16p11.2 Progressive obesity 
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The derived peptide nature of POMC depends of the endoproteolytic type enzyme present, 
specific in brain region. In the anterior pituitary, the PCSK1 enzyme produces 
adrenocorticotropic hormone (ACTH) and β-lipotropin (β-LPH), while the combined presence of 
PCSK1 and PCSK2 in the hypothalamus control the production of α-, β-, γ- MSH and β-endorphins 
[31]. Individuals carrying mutations in the MC4R, LEP and LEPR genes represents the most 
extreme phenotype and become obese at a very young age. 
The protein encoded by the MC4R gene, is a membrane-bound receptor and a member of 
the melanocortin receptor family [41]. The protein interacts with adrenocorticotropic and MSH 
hormones and is mediated by G proteins. The MC4R gene is composed by a single exon, and is 
located in the chromosome 18q21.3, encoding for the 332-amino acid seven-transmembrane G-
protein-linked receptor, critically involved in regulating energy balance [42]. It is expressed 
mainly in the central nervous system, including in the hypothalamus, contributing to food intake 
and energy expenditure regulation [42, 43]. In 1998, two independent groups reported a 
mutation in the MC4R gene, which result in a non-functional receptor causing severe early-onset 
obesity [44, 45]. In morbidly obese individuals, deficiency in the MC4R gene activity represents 
the most common cause (1 to 6%) for the obese phenotype [45–47]. More than 150 variants of 
this gene have been described, usually classified into five classes depending of their molecular 
effects [41]. 
The LEP gene (chromosome 7q31.2) encodes a protein that is secreted by white adipocytes, 
which plays a central role in body weight regulation [39]. This protein, acts as part of a signaling 
pathway that can inhibit food intake and/or regulate energy expenditure to maintain constancy 
of adipose mass. In 1997, in a screening for serum level concentrations in severely obese 
subjects, two children of the same family were found with undetectable levels of leptin [48]. 
Subsequently research revealed that leptin deficiency is inherited and produces extreme early 
onset obesity [49]. This deficiency can be caused by a frameshift mutation (del G133), which 
produces a truncated protein that is not secreted [49] or a missense mutation Arg105Trp, which 
is associated with low levels of circulating leptin [50]. 
The protein encoded by the LEPR gene (chromosome 1p31.3) belongs to the gp130 family 
of cytokine receptors, which stimulate gene transcription via activation of cytosolic STAT 
proteins, predominantly in the hypothalamic neurons [51]. This protein is a receptor for leptin 
G e n e r a l  I n t r o d u c t i o n  
 
 
13 
and is involved in regulation of fat metabolism. A splice site mutation in the exon 16 is 
associated with leptin receptor deficiency, producing extreme obesity [52]. 
 
2.2.2. Syndromic form of obesity  
Syndromic forms refer to obesity cases that occur in a distinct set of associated clinical 
phenotypes, such as mental retardation or organ-specific developmental abnormalities [53]. 
There are more than 30 Mendelian disorders that result in obesity [37]. Research is beginning to 
determine the genetic basis of some of these syndromes, thus elucidating the pathogenesis of 
the chronic positive energy balance. The genetic basis of these disorders is extremely 
heterogeneous. Table 1.1 presents the most common forms of early-onset syndromic obesity for 
which the genetic basis is, at least, partially understood, including WAGR (Wilm´s tumor, 
aniridia, genitourinary anomalies and mental retardation), Prader-Willi, Bardet-Bield, Altröm and 
Cohen syndromes. 
WAGR syndrome is a rare genetic disorder characterized by a deletion at chromosome 
11p13 in a region containing the Wilm´s tumor 1 (WT1) and paired box 6 (PAX6) genes [30]. A 
specific type of WAGR has been associated with a deletion in the brain-derived neurotrophic 
factor (BDNF) gene, which results in an obese phenotype. 
Prader-Willi syndrome (PWS) can have several etiologies, characterized by central obesity, 
neonatal hypotonia, hyperphagia, hypothalamic hypogonadism and mild mental retardation, 
with such abnormalities as short stature and peculiar facial features [30]. Most of the cases were 
associated with loss of expression from paternal deletions of the 15q11.2-q12 chromosomal 
region [31]. 
Bardet-Biedl syndrome (BBS) is characterized by early-onset obesity, which is associated 
with progressive cone-rod dystrophy, morphological finger abnormalities, dyslexia, learning 
disabilities, and progressive renal disease [30]. BBS has extensive genetic heterogeneity with at 
least 14 loci, (often called BBS gene) and several mutations identified within these loci [31].  
Alström (ALMS) and Cohen syndromes are associated with childhood mild truncal obesity 
and small stature [30, 31]. Both of them are autosomal recessive and genetically homogenous. 
ALMS is caused by a balanced translocation of chromosome 2p13 that disrupts ALMS1 gene or 
by a small number of mutations in this gene. Cohen syndrome results from mutations in the 
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COH1 gene, located at chromosome 8q22, which encodes a transmembrane protein of unknown 
function [30]. 
Finally, we can also found ciliary dysfunction, collectively termed “ciliopathies”. These 
comprise a group of several disorders associated with genetic mutations encoding defective 
proteins, affecting normal function or formation of cilia [54]. Ciliary dysfunction can manifest as 
a set of heterogeneous features including retinal degeneration, renal disease, cerebral 
anomalies, congenital fibrocystic diseases of the liver and pancreas, diabetes, obesity and 
skeletal dysplasias [55]. Due to the heterogeneous phenotype, ciliopathies have been associated 
with mutations in more than 40 genes including the genes involved in BBS and ALMS syndromes.  
 
2.3. Polygenic or common obesity 
In most modern societies, the environment favors weight gain rather than loss, due to food 
abundance and lack of physical activity. Furthermore, the increase of common obesity in both 
adults and children has increased in the last decade worldwide. However, the genetic and 
molecular mechanisms involved in body weight regulation are complex. The genetic profile of 
polygenic obesity results from the effects of several altered genes. In theory, the genetic basis of 
polygenic obesity implies that the specific set of variants relevant for obesity vary considerably 
from one obese person to the next [36]. For this reason, the study of common obesity is far 
more complex. However, the advent of new techniques facilitated this study by allowing the 
analysis of several loci at the same time.  
 
2.3.1. Genetic approach for common obesity  
The study of common obesity is based in the analysis of gene variation in genomic DNA 
(single nucleotide polymorphism, or microsatellites) situated within or near candidate genes. In 
contrast with monogenic obesity, in polygenic obesity each variant confers susceptibility, 
requiring additionally the presence of other variants and an obesogenic environment to 
determine the obese phenotype [56]. There are some approaches used in the detection and 
analysis of a candidate gene in body weight regulation: linkage studies, candidate gene 
association studies and GWA studies. Their objective is to determine whether an association 
between a genetic variation and an obesity-related trait do exist. Until now, GWAS had 
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identified more than 52 loci associated with obesity-related traits [57].  
Recently, with the advent of automated DNA sequencing instruments, involving advances in 
engineering, chemistry, molecular biology, and software, open a number of new opportunities 
[58]. Currently, molecular diagnosis based on Sanger’s sequencing is restricted to only a few 
genes as this technology is expensive, time consuming, and labor intensive. The advent of next-
generation sequencing (NGS) technology provides a new method for molecular diagnosis, 
allowing the sequencing of whole genomes or exomes, or several genes at the same time [59]. 
NGS promises to change the landscape of genetic testing with innovative cost-efficient methods 
for sensitive obesity multi-gene screening.  
Only a few studies have used NGS technology to study obesity. Saeed et al. [60] analyzed 26 
susceptible genes for obesity in a sample of 39 Pakistani children with early-onset obesity. They 
found two new LEPR mutations at the homozygous state: a splice site mutation in exon 15 
(c.2396-1 G>T), and a nonsense mutation in exon 10 (c.1675 G>A).  Sällman et al. [61] amplified 
the entire region of the fat mass and obesity-associated (FTO) gene (412 kilo base pairs), from 
524 severely obese and 527 lean Swedish children. They detected 705 single nucleotide 
polymorphisms, from which 19 were novel obesity-associated polymorphisms within the first 
intron of the FTO gene. An interesting finding was the fact that 10 of them have a stronger 
association with obesity (p<0.007) when comparing with the commonly studied rs9939609 
polymorphism (p<0.012). This study concluded that within the entire region of the FTO gene the 
first intron was the only one associated with obesity. Bonnefond et al. [62] searched for 
mutations with NGS in 40 patients, with a monogenic form of diabetes (n=19) or obesity (n=21), 
in which the causing mutation was already known. The study found the same mutations 
described as the phenotype cause, except for one variant (mean of 98.6%). On the other hand 
novel mutations were found in 3 patients with a putative deleterious effect.  
The NGS approach could be used as an efficient tool with highly sensitive screening for 
mutations in genes associated with obesity or other diseases. Further, sequencing the human 
genome can now be accomplished in the data-generation phase within two weeks at a cost of 
approximately US $5,000 [58]. However, the price for genome sequencing continues to 
decrease; in 2014 Illumina announced that would produce a new system called HiSeq X Ten that 
can deliver full coverage of human genomes for less than US $1,000. However, until now the 
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majority of loci associated with obesity susceptibility were found by GWAS. For this reason we 
described the loci found by this technique
 
2.4. Common loci associated with obesity
The GWAS approach is the most commonly methodology used, allowing geneticists to scan 
numerous polymorphisms (~0.1
powerful statistical methods to identify 
start of the GWAS era in 2005, there have been five waves of GWAS’ discoveries for BMI. The 
first loci identified through GWAS was the 
have been identified as being associated with at least one obesity
1.1).  
 
 
 
 
Figure 1.1. Loci associated with obesity
chromosome it was found a locus linked to predisposition to obesity
abdominal fat, fat percentage or extreme obesity).
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2.4.1. First discoveries by GWAS: the FTO gene 
The first locus associated with obesity was the insulin-induced gene 2 (INSIG2) [64]. 
However, replication studies demonstrated very inconsistent results. So, the first locus 
unequivocally associated with obesity by a GWA study was the FTO gene [65]. Initially, Frayling 
et al. [65] conducted a GWA study to test the correlation between polymorphisms across the 
entire human genome and type II diabetes (T2D). They found that the rs9939609 polymorphism, 
located in the first intron of the FTO gene was strongly associated with T2D and increased BMI. 
However, after adjustment for BMI, the apparent association of the polymorphism with T2D was 
not maintained. The effect size of FTO polymorphism on BMI is modest, with homozygous 
individuals for the risk allele (in this case the “A-allele”) weighing on average 3 kg more than 
those homozygous for the protective allele (in this case the “T-allele”), with the difference 
representing approximately 0.36 kg/m2 [22].  
These findings have been independently replicated and have consistently confirmed the 
association of rs9939609 polymorphism with the etiology of common obesity in several 
populations: European [65–68], Asian [69–72] and African [73–75], both in children and adults. 
Two following studies reported other polymorphisms in the intronic FTO region also consistently 
associated with severe early-onset childhood and adult obesity (rs1421085 and rs17817449) 
[76], and have extended the association to other obesity-related traits including body weight 
and waist-to-hip circumference ratio (WHR) (rs9930506) [67]. The FTO polymorphisms were also 
associated with abdominal obesity, waist circumference and waist-to-hip ratio (WHR) [77, 78], 
and also with body fat percentage [79]. Although these posterior reports replicate well the initial 
findings, the FTO polymorphisms explain only 1-3% of the variance in BMI [65, 67]. 
To date, over 500 studies have been performed concerning the association of FTO 
polymorphisms with obesity in several populations worldwide, and more than 60 
polymorphisms in this gene were significantly associated with obesity [61]. All these 
polymorphisms were found within a 47 kb linkage disequilibrium (LD) block encompassing parts 
of the first two introns as well as exon 2 of the FTO gene [80]. This is a region where the 
sequence is strongly conserved across species, with polymorphisms highly correlated (LD r2 > 
0.80 in CEU of the HapMap) in Caucasian populations [81].  
The functional mechanism underlying FTO role in obesity remains unknown, as well as the 
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pathway underlying that role. The FTO is a very large gene with 9 exons spanning more than 400 
kilobase (kb) in the chromosome 16q12.2 [82]. It was originally identified in 1999 in the Fused 
toes (Ft) homologue mutants, in a deletion of 1.6 megabase (Mb) on chromosome 8 [83]. 
Homozygosity of Ft mutants is embryonically lethal. To investigate the biological function of FTO 
gene, two mouse models were used. Homozygous FTO-/- mice introduced by Fischer et al. [84] 
show postnatal growth retardation, significant reduction in fat and lean body mass compared to 
the wild-type animals [85]. In other mice model, Church et al. [86] observed a lean phenotype in 
mice carrying a missense mutation in exon 6 of FTO (FTOI367F mice). These results seem to 
indicate that FTO could play a role in food intake control, energy expenditure and homeostasis. 
The predicted human protein consists of 505 amino acids, characterized as a 2-
oxoglutarate-dependent enzyme that is localized in the cell nucleus, belonging to the (2OG) 
oxygenases AlkB family of proteins [87]. The AlkB is a DNA repair enzyme, which catalyzes Fe(II)- 
and 2OG-dependent demethylation of damaged DNA substrates [88]. Recently, Jia et al. [89] 
indicated that FTO also demethylates N6-methyladenosine (m6A) residue in nuclear RNA. FTO 
variation appears to lead to an increase in energy intake [90] by modifying hypothalamic control 
of appetite [81]. The crystal structure of FTO has recently been published and reveals the basis 
for its substrate specificity [91]. 
Moreover, it was found that the FTO gene is also a transcriptional co-activator [92] and a 
possible regulator of telomere length [93]. A recent study found that BMI-associated FTO 
variants interact with the promoter region of iroquois homeobox 3 (IRX3) gene in the human, 
mouse and zebrafish genomes [94]. They also found that in Irx3-deficient mice, there is a 
reduction in body weight of 25 to 30%. This study suggests that IRX3 gene is a functional long-
range target of obesity-associated polymorphisms within FTO. On the other hand, the FTO 
deficiency remains still poorly understood in the context of obesity development and confirm 
the complexity of the genetics underlying common obesity.  
 
2.4.2. Five waves of GWAS 
Following the discovery of the FTO locus, investigators enhanced GWA studies by increasing 
the sample size improving statistical power to uncover additional obesity-susceptibility loci 
(Table 1.2). Subsequently, a large-scale international consortium, called the Genetic 
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Investigation of Anthropometric Traits (GIANT) emerged. The association data of 16,876 
Caucasians from seven GWAS for BMI were combined in a meta-analysis [95]. This study 
confirmed the strong association of obesity with polymorphisms in the FTO gene, and identified 
one new locus near the MC4R gene which mutations are known to be the common cause of 
extreme childhood obesity [30]. The MC4R was the second gene significantly associated with 
common obesity [95, 96]. The rs17782313 polymorphism near the MC4R gene was associated 
with obesity among both adults and children [95]. Another polymorphism (rs12970134) near the 
MC4R gene also appears to increase the risk of obesity among Europeans [97]. Several 
polymorphisms near the MC4R gene have subsequently been found and replicated in various 
European populations, as well as in Asians [98], African-American [98], both in children and 
adolescents [73, 75]. 
In the third wave of discoveries, a meta-analysis was performed using 15 GWAS for BMI in 
Caucasians (n > 32,000) and replicated in another 14 studies for a second-stage sample of 59,082 
individuals [99]. They confirmed the association of the FTO and MC4R genes, and found six new 
genes positively associated with obesity: MTCH2, GNPDA2, KCTD15, SH2B1, NEGR1 and 
TMEM18. At the same time, a GWAS of 31,392 individuals, predominantly from Iceland 
population, found seven new genetic loci near or in BDNF, SEC16B, ETV5 and FAIM2, as well as 
FTO and MC4R genes associated with BMI [97]. Four of the seven newly identified loci were 
common with the results from Willer et al. [99].   
In 2010, the fourth wave, the GIANT consortium expanded its GWAS stage to comprise 
249,796 individuals of European origin, and reveal 18 new loci associated with BMI near or in: 
PRKD1, SLC39A8, GPRC5B, MAP2K5, QPCTL, RBJ, LRRN6C, FLJ35779, CADM2, TMEM160, FANCL, 
LRP1B, TNNI3K, MTIF3, TFAP2B, ZNF608, NRXN3, RPL27A, PTBP2 and NUDT3 [100]. By 2011, 
GWAS had identified 32 genetic loci unequivocally associated with BMI. 
The most recent and fifth wave expanded the GIANT meta-analysis, to comprise 263,407 
individuals of European ancestry [57]. Besides confirming all 32 BMI-associated loci previously 
identified by the fourth wave, they found seven new loci, ZZZ3, RPTOR, ADCY9, GNAT2, 
MRPS33P4, HS6ST3 and HNF4G, explaining an additional 0.09% of the variability in BMI [57]. 
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Table 1.2. Currently established loci associated with BMI in GWAS. 
Wave Gene symbol Gene name SNP ID 
Effect size BMI (OR 
95%CI)* 
Discovery study 
First  FTO Fat mass and obesity associated rs9939609 1.31 (1.23-1.39) [65, 67] 
      
Second Near MC4R Melanocortin-4 receptor rs17782313 1.12 (1.08-1.16) [95] 
      
Third Near TMEM18 Transmembrane protein 18 rs7561317 1.20 (1.13-1.27) 
[97, 99] 
   rs6548238 1.19 (1.10-1.26) 
 FAIM2 Fas apoptotic inhibitory molecule 2 rs7138803 1.14 (1.09-1.19) 
 Near GNPDA2 Glucosamine-6-phosphate deaminase 2 rs10938397 1.12 (1.07-1.17) 
 SEC16B S. cerevisiae Sec16 rs10913469 1.11 (1.05-1.18) 
 BDNF Homolog of brain-derived neurotrophic 
factor 
rs925946 1.11 (1.05-1.16) 
 Near ETV5 Ets variant 5 rs7647305 1.11 (1.05-1.17) 
 SH2B1 SH2B adaptor protein 1 rs7498665 1.11 (1.06-1.17) 
 Near NEGR1 Neuronal growth regulator 1 rs2568958 1.07 (1.02-1.12) 
 Near KCTD15 Potassium channel tetramerization domain 
containing 15 
rs29941 1.10 (1.04-1.15) 
   rs11084753 1.04 (0.98-1.10) 
 MTCH2 Mitochondrial carrier 2 rs10838738 1.03 (0.98-1.08) 
      
      
Fourth Near PRKD1 Protein kinase D1 rs11847697 1.10 (1.03-1.17)  
SLC39A8 Solute carrier family 39, member 8 rs13107325 1.10 (1.05-1.15)  
     
TFAP2B Transcription factor AP-2 beta rs987237 1.09 (1.05-1.12)  
QPCTL Glutaminyl-peptide cyclotransferase-like rs2287019 1.09 (1.05-1.12) 
[100] 
 NRXN3 neurexin 3 rs10150332 1.09 (1.05-1.12) 
 Near GPRC5B G protein-coupled receptor, family C, group 
5, member B 
rs12444979 1.08 (1.04-1.11) 
 Near RBJ-
DNAJC27 
DnaJ (Hsp40) homolog, subfamily C, 
member 27 
rs713586 1.07 (1.05-1.09) 
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 MAP2K5 Mitogen-activated protein kinase 5 rs2241423 1.07 (1.04-1.10) 
 Near TMEM160 Transmembrane protein 160 rs3810291 1.06 (1.03-1.08) 
 Near FANCL fanconi anemia, complementation group L rs887912 1.06 (1.03-1.08) 
 Near FLJ35779-
POC5 
centriolar protein 
rs2112347 1.05 (1.03-1.08) 
 NearLRP1B low density lipoprotein receptor-related 
protein 1B 
rs2890652 1.05 (1.02-1.08) 
 MTIF3 mitochondrial translational initiation factor 
3 
rs4771122 1.05 (1.01-1.08) 
 LRRN6C leucine rich repeat neuronal 6C rs10968576 1.04 (1.02-1.06) 
 TNNI3K interacting kinase rs1514175 1.04 (1.02-1.07) 
 CADM2 cell adhesion molecule 2 rs13078807 1.03 (1.00-1.06) 
 NUDT3 nucleoside diphosphate linked moiety X 
type motif 3 
rs206936 1.03 (1.01-1.06) 
 Near RPL27A ribosomal protein L27a rs4929949 1.03 (1.01-1.05) 
 Near ZNF608 izinc finger protein 608 rs4836133 1.03 (1.01-1.05) 
 Near PTBP2 polypyrimidine tract binding protein 2 rs1555543 1.02 (0.99-1.04) 
      
Fifth GNAT2 guanine nucleotide binding protein (G 
protein) alpha transducing activity 
rs17024258 1.27 (p=0.02) 
[57]
#
 
HS6ST3 heparin sulphate 6-O-sulfotransferase 3 rs7989336 1.09 ( p=0.0001) 
HNF4G hepatocyte nuclear factor 4, gamma rs4735692 1.09 ( p=1.97x10-5) 
 RPTOR regulatory associated protein of MTOR, 
complex 1 
rs7503807 1.08 ( p=7.07x10-5) 
 MRPS33P4 mitochondrial ribosomal protein S33 
pseudogene 4 
rs13041126 1.08 (p=0.001) 
 ZZZ3 zinc finger, ZZ-type containing 3 rs17381664 1.08 (p=0.001) 
 ADCY9 adenylate cyclise 9 rs2531995 1.06 (p=0.01) 
 
 
Abbreviations: BMI, body mass index; OR, odd ratio; 95%CI, confidence interval; SNP ID, polymorphism identification. 
*Effect size from first discovery study. 
# This study not reported confidence intervals, but rather p-values. 
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To date, more than 35 loci have been found associated with the increase of BMI (explaining ~1-
4% of the variance in BMI), while other loci correlate with abdominal obesity, establishing 13 loci 
associated with it, assessed by the WHR [101]. Other loci, such as the Lactase gene (LCT) have been 
associated with BMI and abdominal obesity, but more studies are required to confirm associations 
[102–104]. A study identified two new loci with body fat percentage: IRS1 and the other near SPRY2 
[105]. There is a gap between the explained variance of BMI due to known common polymorphisms 
(1-4%), and the estimated heritability (40-70%). One of the main problems pointed out in GWAS is 
the failure to detect loci that are associated with traits whose effect sizes are too small to reach 
genome-wide statistical significance (false negative rate). To circumvent this “missing heritability” 
the genome-wide complex trait analysis (GCTA) method appears to show a multitude of low 
penetrance common polymorphisms, each with causal effects but too small to allow detection by 
GWA studies. Using this approach, Yang et al. [106] estimated in 17% the BMI variance due to 
common genetic variation and a recent analysis of twin studies revealed that additive effects of 
multiple common polymorphisms could explain 37% of BMI [107]. Most GWAS were performed in 
population samples of Caucasians adults, and only a few in children. However, it seems important to 
determine the genetic predisposition in children, as obesity tends to develop from childhood into 
adult life. 
 
2.5. Testing adult-discovered loci in children  
Childhood obesity is a major health problem in developing countries throughout the world. 
Most of obesity susceptible genes were found in studies with adults, which prompted an effort to 
replicate findings in studies with children [75, 108]. Knowledge of the genetic risk factors of obesity 
in children could be used as a first step to develop possible prevention measures. The FTO locus 
remains the most replicated gene and the strongest gene associated with obesity susceptibility, both 
in adults and children [75, 109]. Results from longitudinal studies suggested a possible age-related 
change in the association between the FTO rs9939609 polymorphism and higher BMI. Sovio et al. 
[110] studied subjects of European ancestry aged from early infancy to 13 years-old. In that sample, 
individuals’ carriers of the minor A-alleles of this polymorphism showed lower BMI in infancy and 
higher BMI later in childhood. In another study, Hallman et al. [111] analyzed a sample of non-
Hispanic white children and adolescents (8-18 years). It was found a significant age-by-genotype 
G e n e r a l  I n t r o d u c t i o n  
 
 
23 
interaction predicting that in individuals with AA genotype the BMI would be ~0.7 kg/m2 higher at 
age 8, and ~1.6 kg/m2 higher at age 17, comparing to those with AT or TT genotypes. The results 
reported in these studies might help to reveal mechanisms regulating body mass in humans during a 
critical period of development. Genes TMEM18 and GNPDA2 were also associated with obesity 
susceptibility, with a similar effect of the FTO gene [112]. Remaining loci with evidence for 
association with obesity in children were INSIG2, MC4R, NEGR1, BDNF and KCTD15 [112, 113]. 
In a GIANT meta-analysis, Zhao et al. [108] examined 32 genetic loci in 1,097 obese cases and 
2,760 lean controls, aged between 2 and 18 years old, in a pediatric European American sample. 
They found evidence of associations with nine of these loci, namely FTO, TMEM18, NRXN3, MC4R, 
SEC16B, GNPDA2, TNNI3K, QPCTL, and BDNF. Overall, 28 of the 32 loci showed directionally 
consistent effects to that of the adult BMI meta-analysis. 
Another similar report by the Early Growth Genetics (EGG) consortium investigated the effect of 
established adult BMI with two recently associated loci with childhood obesity (HOXB5 and OLFM4 
genes) [114] in a Greek adolescents cohort [115]. The genetic risk score of the 34 (GRS-34) variants 
was calculated and found that variants at the FTO, TMEM18, FAIM2, RBJ, ZNF608 and QPCTL loci 
produced nominal evidence for association with BMI and/or obesity risk. Overall, 27 out 34 variants 
showed consistent effects with those reported by large-scale meta-analyses adult BMI. 
These results showed clearly that these obesity-conferring variants operate early in life, 
suggesting that individual preventative lifestyle intervention in childhood could be important to 
obesity development. 
 
2.6. GWAS-related investigations in other ethnicities 
There are remarkable disparities in the prevalence of obesity between ethnic groups. To date 
most of GWAS published reports have been performed in populations of European origin. Only one 
study identified, at the first discovery stage, a locus near MC4R gene associated with waist 
circumference and insulin resistance in a cohort of South Asian population [96]. This could be partly 
due to the fact that some susceptible loci only affect a specific ethnic group, while others might 
affect any ethnic group. Indeed, the human genetic architecture differs across ethnicities, which is 
well illustrated by differences in linkage disequilibrium (LD), whereas haplotype blocks vary only 
somewhat among human populations [116]. 
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As a case in point, FTO locus also have consistently correlated with BMI and risk of obesity in 
populations of African [73–75, 117], Asian [69–72] and Pacific-Islander [118] ancestry. Despite the 
fact that effect sizes were similar to those observed in white European populations, the risk allele 
frequency varies substantially:  around 45% in white Europeans, 25% in Asian, and range of 7 to 18% 
in African origin [119]. In the case of FTO gene, Peters et al. [120] genotyped 3,756 polymorphisms 
across a 646 kb region, encompassing the large FTO gene (16q12.2) and the flanking gene RPGRIP1L 
in 20,488 African Americans. Authors reported the rs56137030 polymorphism as the most 
significantly associated with BMI. Interestingly, they found that in individuals of European ancestry, 
this polymorphism represents a cluster of 103 polymorphisms (r2>0.50), whereas in African 
Americans this cluster includes only 29 polymorphisms (at r2>0.50). 
Two recent independent meta-analysis were performed in both East Asian and African 
populations [121, 122]. Wen et al. [121] performed a meta-analysis using 27,715 individuals, 
followed by in silico and de novo replication studies in a further 37,691 and 17,642 individuals of East 
Asian origins, respectively. Seven previously identified loci were detected (FTO, SEC16B, MC4R, GIPR-
QPCTL, ADCY3-RBJ, BDNF and MAP2K5) and three new loci were uncovered, near or in CDKAL1, 
PCSK1 and GP2 genes. Data also implicated three loci, GNPDA2, TFAP2B (previously identified) and 
PAX6, which all reached the genome-wide significance threshold. A recent meta-analysis was 
conducted to examine the association of >3.2 million polymorphisms with BMI in 39,144 adults of 
African ancestry [122]. It identified one new locus at 5q33 (GALNT10, rs7708584 polymorphism) and 
another at 7p15, when data from the GIANT consortium was included (MIR148A-NFE2L3, rs10261878 
polymorphism). They also found evidence of an association at 6q16 (KLHL32, rs974417 
polymorphism) in African-ancestry sample. Overall, 32 of the 36 previously established BMI variants 
showed consistent effect in this GWAS. The 36 known BMI loci explain in average 1.30% of the 
variance in BMI of African ancestry compared with 1.67% and 1.25% in European and Asian ancestry 
populations, respectively [122]. More recently, Tan et al. [123] replicated six confirmed obesity genes 
(FTO, CTNNBL1, ADRB2, LEPR, PPARG and UCP2 genes) in eight different population samples from 
different ancestries (five Caucasian, one Chinese, one African-American and one Hispanic 
population). The main goal of this study was to explore whether the same genes contribute 
differentially to obesity susceptibility in populations of different ancestries. Regarding the FTO gene 
they found 35 polymorphisms significantly associated with obesity in Caucasian populations. 
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However, none of them showed evidence of associations with obesity in another ethnic group.  
Association studies across different populations can help us to define more precisely which loci 
or variants could play a role in the obesity etiology, and help to understand the genetic and 
environmental factors contributing to obesity. As we can see, polymorphisms in the FTO gene are 
associated with obesity in several ethnicities. However, the allele frequencies of the BMI-associated 
FTO polymorphisms vary substantially across the different ethnicities. The highest prevalence of 
minor risk allele is observed in Europeans and the smaller frequency in Asian and African 
populations. The LD cluster of FTO polymorphisms was clearly demonstrated by Loos and Yeo [82], in 
which Europeans present the larger cluster, followed by Asian populations that do not overlap with 
the African cluster (probably without association with obesity-related traits). The discovery of new 
loci in replication studies at established loci found in other populations reflect differences in allele 
frequency and effect size. Further studies will be needed to test the biological function at the 
associated loci and take into account difference observed regarding LD.  
 
2.7. Obesity risk-allele scores 
As noted, several GWAS have identified a large number of obesity susceptibility loci. Nevertheless, 
the major part of these studies only identified single genetic loci associated with obesity. It has 
indeed been demonstrated that combining information from all these obesity loci into genetic risk-
allele scores (GRS) could be a convenient way to summarize risk-associated variations across the 
genome [124] and more useful when individual genetic effects are moderate [125]. The simplest way 
to calculate a GRS is by summing the number of accumulated risk alleles associated with the disease. 
Using this approach, Zhu et al. [126] analyzed 28 BMI-associated polymorphisms in a sample of Han 
Chinese and found 26 nominally associated with BMI. To assess the combined effect of all 
polymorphisms studied with BMI, they create a GRS which was associated with increased risk of 
obesity (OR= 1.06; CI95%: 1.03-1.10), and each additional BMI-increasing allele in the GRS was 
associated with 0.11 kg/m2 higher BMI (p=1.54x10-7). Willer et al. [99] found effect sizes between 
0.06 kg/m2 to 0.33 kg/m2 per allele in BMI changes and that account for 0.40% of the variance of BMI 
analyzing six loci together (TMEM18, KCTD15, GNPDA2, SH2B1, MTCH2 and NEGR1). When they 
included the FTO and MC4R genes in the combined effect the variance increases to 0.84%. Similar 
results have also been found in other studies trying to explain the variance of BMI. Combining 12 
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polymorphisms in a sample of 20,431 of European descent, the GRS obtained by Li et al. [127] 
explained 0.9% of BMI variation. Apart the nominally association between 15 polymorphisms located 
in or near the INSIG2, FTO, MC4R, TMEM18, GNPDA2, NEGR1, BDNF, KCTD15, and 1q25 with BMI, 
Zhao et al. [128] explained 1.12% of the total variation for BMI z-score in a sample of children of 
European ancestry. In other sample of European descent González et al. [129] create a GRS including 
six polymorphisms located in the FTO, TFAP2B, SEC16B, ETV5 and SH2B1 genes and found that 
individuals carrying ≥7 risk-alleles had 3.1 (OR=3.11; CI95%: 1.58-6.61) times increase in the odds of 
developing the obese phenotype. Individually, each risk allele conferred an estimated increased risk 
of 1.69 (OR= 1.69; CI95%: 1.46-1.97) times to develop obesity.  
This is particularly more evident when the allele score consists either of many common 
polymorphisms with small effects, or of rare polymorphisms [125]. Generally, when several 
polymorphisms are combined, the estimated genetic score may explain a considerable proportion of 
variation in the risk factor, even if none of the polymorphisms individually does. This is partially due 
to the fact that the “signal” obtained from a GRS is more robust to imperfect linkage than each 
polymorphism individually [125]. In complex diseases it is likely that the effects of different genetic 
loci related to obesity operate in an interactive fashion. Future research should investigate this 
possibility using classification or regression tree analyses, which are well suited to detecting complex 
non-linear interactions.  
The identification of the complex interplay among all genes in the genome-wide context is 
essential to unravel the molecular mechanisms in the obesity etiology. However, as previously 
demonstrated there are differences between populations regarding to allele frequencies. Belsky et 
al. [125] developed a GRS for obesity using results obtained in 16 previously published GWAS in 
European descent samples. Analyzing 32 locus they found a significantly predictor of BMI and obesity 
among Europeans. However, the predictive effects for this GRS did not replicate among African 
Americans due particularly to the differences in risk-allele distributions.  
In less than 10 years we assisted to the discovery of several genes associated with obesity-related 
traits. Despite the discoveries, all these genes only explain a small percentage of obesity 
susceptibility. Of course, several genes remain to be found and certainly in the next year’s novel 
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candidate loci will appear. However, and more recently, new fields called epigenetic emerge as a new 
potential factor influencing the obese phenotype and helping to found differences in obesity risk 
based in the environment that surrounds us. 
 
2.8. Epigenetics 
Epigenetic regulation of gene expression emerged in the last few years as a potential factor that 
might explain individual differences in obesity risk [130]. Epigenetics can be defined as heritable 
changes that are mitotically stable (and potentially meiotically) and affect gene function but do not 
involve changes in the DNA sequence [131]. At the molecular level, epigenetic markers include 
genomic DNA methylation, changes in chromatic organization by histone modifications, the non-
coding microRNAs (miRNA), genomic imprinting, non-covalent mechanisms, and other nuclear 
proteins that are critical for epigenetic gene regulation [132]. Currently, there is a growing interest in 
the study of the relations between genetic variation, epigenetic variation, and disease 
simultaneously. 
Emerging studies have characterized the potential mechanisms by which epigenetic factors 
could increase the risk for obesity (Table 1.3). 
Moreover, unlike DNA genotypes, epigenetic markers can change during lifetime, and have a 
heterogeneous distribution in tissues. DNA methylation is the most well know epigenetic marker, 
which has been proposed as a new generation of biomarkers. It is a biologic process that consists of 
the addition of a methyl group at the carbon-5 position of cytosine, in the context of the CpG 
dinucleotides, and usually associated with gene silencing in the promoter regions [131, 133]. The 
universal methyl donor is DNA methyltransferases (Dnmts) that maintain the cellular DNA 
methylation patterns [130]. Despite the high number of DNA methylation candidate genes and some 
epigenome-wide association studies (EWAS), most of the associations have not yet been replicated in 
other samples to further confirm and establish whether those loci are reliably associated with 
obesity. 
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Table 1.3. Some human genes related to obesity through epigenetic mechanisms. 
Gene 
symbol/EWAS 
Associated 
genes 
Epigenetic 
mechanisms 
Tissue Study sample Role in obesity References 
EWAS UBASH3A, TRIM3 DNA methylation Peripheral blood 
leukocytes 
14 African-American men 
(14-18) 
Replication: 46 Obese (14-
18) and 46 lean (14-30) 
African-American men  
Obesity [134] 
EWAS in individuals 
carriers FTO risk allele 
(rs9939609) 
KARS, TERF2IP, DEXI, 
MSI1, STON1, BCAS3 
DNA methylation Whole blood 33 obese and 24 normal-
weight preadolescent girls 
Caucasian (Greek) (9-13 
years) 
Obesity [135] 
SLC6A4 SLC6A4 DNA methylation Peripheral blood 
leukocytes  
84 MZ twin pairs Caucasian 
(~55.1 year)   
BMI, body weight, 
waist circumference 
[136] 
PPARGC1A, PPARG, 
Tfam 
PPARGC1A DNA methylation Umbilical cord tissue 
and white blood cells  
88 healthy pregnant women 
(~29.7 year) and their 
babies 
Maternal BMI [137] 
 
 
MC4R MC4R DNA methylation Brain tissues Berlin fat mouse (Mus 
musculus) 
Fat diet [138] 
 
 
EWAS HSP90B3P, NAV1, 
NR5A2, CCDC48, 
GPR125, SNCA, 
EHMT2, IER3, 
DNA methylation, 
mRNA expression 
Adipose tissue 31 healthy Caucasian men 
(Sweden) (~37.4) 
Adipocyte metabolism [139] 
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SERPINB1, STX1A, 
PVT1, LHX6, ENKUR, 
CTTN, HCCA2, 
PKNOX2, ANO2, 
ITPR2, RB1, PACS2, 
CRTC3, KIFC3, 
MIR1910, ZFHX3, 
MSI2, RPTOR, TRPM4, 
C20orf160, 
LOC647979, MLC1, 
CDX4, KCND1 
EWAS Diferences between 
number of 
differentially 
methylated CpG sites 
and number of 
differentially variable 
CpG sites 
DNA methylation Peripheral blood 
leukocytes 
48 obese and 48 lean 
African-American (14-20) 
Obesity [140] 
LEP LEP DNA methylation Troncal blood and 
retroperitoneal 
adipose tissue 
Male Wistar rats diet [141] 
RXRA, eNOS, SOD1, 
IL8, PI3KCD 
RXRA, eNOS DNA methylation Umbilical cord tissue 78 Caucasian women (≥16) 
Replication: 239 children  
Fat mass and %fat 
mass 
[142] 
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Using a genome wide approach, obesity has been related to changes in DNA methylation status 
in peripheral blood leukocytes of lean and obese adolescents for two genes. In the ubiquitin-
associated and SH3 domain-containing protein A (UBASH3A) gene, a CpG site showed higher 
methylation levels in obese cases, and one CpG site in the promoter region of Tripartite motif-
containing 3 (TRIM3) gene, showed lower methylation levels in the obese cases [134]. In a recent 
work, Godfrey et al. [142] measured the methylation status of 68 CpGs 5' from five candidate genes 
in umbilical cord tissue DNA from healthy neonates, and found that methylation higher levels within 
promoter region of retinoid X receptor-a (RXRA) gene, measured at birth, was strongly correlated 
with greater adiposity in later childhood [142]. A positive correlation between maternal BMI and 
promoter methylation in peroxisome proliferator-activated receptor-gamma co-activator 1alpha 
(PPARGC1A), a gene encoding a transcriptional coactivator of the peroxisome proliferator-activated 
receptor (PPAR) α and У, playing an essential role in energy homeostasis, was observed when 
analyzing promoter genomic DNA from umbilical cord newborns [137].  
The obesity risk allele of FTO has been associated with higher methylation of sites within the 
first intron of the FTO gene, suggesting an interaction between genetic and epigenetic factors [137]. 
Moreover, Almén et al. [135] determined the methylation profile on a genome-wide scale by 
sampling DNA from peripheral whole blood in female preadolescents. The sample included obese 
and a normal weight groups, both of which contains homozygous carriers of both the FTO normal 
and risk alleles (rs9939609). They analyzed how the risk allele for rs9939609 polymorphism affects 
the methylation status of sites related to other genes (KARS, TERF2IP, DEXI, MSI1, STON1 and BCAS3), 
showing that the FTO gene may influence the methylation level of other genes [135]. 
 A study examined the MC4R gene, which is associated with common and morbid obesity and 
encodes for a protein that is a membrane-bound receptor and member of the melanocortin receptor 
family controlling food intake and energy expenditure. Mouse genomic DNA of brain tissue was 
examined to determine the methylation status of the MC4R exon. Results indicated that methylation 
of the CpGs was decreased in response to high-fat diet [138]. A study examining whether a high-
energy diet may affect promoter methylation of LEP gene, encoding an adipokine involved in body 
weight and food intake regulation, showed in DNA isolated from retroperitoneal adipocytes in rats 
that leptin methylation pattern can be influenced by diet-induced obesity [141]. Zhao et al. [136] 
demonstrated that promoter hypermethylation in the serotonin transporter gene (SLC6A4) was 
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associated with an increase in BMI, body weight and waist circumference. Xu et al. [140] studied 
470,000 CpG sites from 48 obese and lean youth African-American (14-20 years-old); they found a 
differential variability in CpG sites which was more variable in obese than lean subjects, constituting 
an important feature of obesity related with methylation changes. In another recent EWA study, 
Rönn et al. [139] analyzed 476,753 CpG sites to evaluate the possible alteration of DNA methylation 
patterns after a six-month exercise intervention. A global DNA methylation changes were found in 
17,975 individual CpG sites altering the levels of DNA methylation in response to physical activity 
[139]. 
Thus, most of these DNA methylation sites need to be confirmed as being associated with 
obesity, taking into account the tissue sampled, obesity history, and eating behaviors. However, the 
high number of new studies concerning obesity epigenetics will undoubtedly permit the confirmation 
some of these associations, thereby establishing an epigenetic basis for human obesity. Interestingly, 
one recent work of genome wide analysis revealed that carriers of the FTO risk allele (rs9939609) had 
a significant differential methylation level in 6 loci (KARS, TERF2IP, DEXI, MSI1, STON1 and BCAS3) 
compared to non-carriers controls [138]. This work could elucidate the mechanisms underlying the 
association of obesity with genetic variants, possibly due to epigenetic factors. 
Studies based on pre-conceptual, in utero, and postnatal developmental environment showed 
an impact on long-term risk for adult-onset obesity by a set point of adaptive changes. It could be 
understood as a “critical period” where environmental conditions experienced in utero may have a 
life-long effect on the propensity to develop the obese phenotype. The Agouti mouse viable yellow 
(Avy) model is one of the best examples on how early environmental exposures interact with 
epigenetic gene regulation influencing the phenotype [143]. Briefly, the murine agouti gene 
influences DNA methylation in early development, affecting coat color, which correlates with adult 
body weight. Varying the mother´s diet tends to produce offspring with a wide variation in individual 
coat color and obese phenotype as epigenetic modifications of agouti gene were established in early 
development [144]. These variations in phenotypes are caused by DNA methylation patterns, which 
were acquired during early embryonic development and passed through the female germline that 
results in stable intergenerational transmission [145].  
In a recent report, Relton et al. [146] evidenced that DNA methylation patterns in 9 of 24 
(37.5%) genes at birth, show association with at least one index of body composition (BMI, fat mass, 
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lean mass, height) at age of 9 years. This observation suggests that variation in DNA methylation 
patterns at birth in multiple target genes may influence body size in childhood. Moreover, maternal 
diet can alter later child´s adiposity, accompanied by epigenetic changes in genes controlling the 
energy homeostasis. Parental pre-conceptional environmental exposures could also have an effect in 
the health status of the offspring in later life. In two recent studies regarding parental obesity 
conducted by Soubry et al. [147, 148] it has been observed an association between DNA methylation 
profiles at human imprinted genes, such as MEST, PEG3, and NNAT, in children born from obese 
parents, when compared with children born from non-obese parents. Changes related to maternal 
obesity were also detected at loci PLAGL1, MEG3 and H19 [147, 148]. Hypomethylation at the IGF2 
gene was associated with paternal obesity [148]. These results points to a pre-conceptional influence 
of parental life-style or over-nutrition on the reprogramming of imprint marks during gametogenesis 
and early development [147, 148]. The trans-generational effects of parental obesity can influence 
the offspring’s future health status. These reports evidenced that peri-natal events are important in 
defining the epigenetic marks that will persist until the adult age. In the future it might be used as 
early prognostic markers to identify those individuals with more risk to develop obesity. However, 
the knowledge of mechanisms by which maternal nutritional environment induces such changes 
remains largely unknown.  
 
microRNAs 
Another type of epigenetic mechanisms is microRNAs (miRNAs). The gene expression in humans 
is precisely controlled in cellular, temporal, and condition specific manner. Because miRNAs have 
been shown to be important in gene regulation, it is not surprising that they have been implicated in 
the development of obesity [149]. Therefore, the understanding of the regulatory mechanisms of 
gene expression can shed some light on the underlying mechanisms causing obesity. miRNAs are 
endogenous short single-stranded non-protein-coding RNAs with about 21/25 nucleotides in length 
which are involved in post-transcriptional regulation of gene expression by partially complementary 
binding to the 3’ untranslated region (3’ UTR) of target mRNAs [150, 151]. 
Several miRNAs expression patterns have been profiled during adipocyte differentiation [152–
154], others have been linked to adipocyte phenotype, and other obesity parameters [152–160] 
(Figure 1.2). For example, miR-21 was strongly expressed in human adipose tissue and positively 
 correlated with BMI [158]. These studies revealed that miRNAs may represent biomarkers for 
obesity, and could also be implicated in the molecular mechanisms leading to this disease. However, 
further studies are needed to elucidate the effect of miRNAs and other epigenetic mechanisms in the 
etiology of obesity. 
Continuous advances in research show promising results about the implication of epigenetics 
mechanisms in the etiology of obesity. Epigenetics has shown 
to determine our phenotype and that our behaviors can alter the expression of our genotypes. 
However, additional research is needed, particularly with regard to which cell types should be 
explored in EWAS. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. Gene expression profile in obesity
altered in obesity, and others were found significantly correlated with BMI and morbid obesity.
 
 
3. Evolutionary explanations for obesity
The evidence for a genetic component of obesity has been well established in recent years 
The question about the evolution of obesity is: how has natural selection favored the spread of genes 
that increase risk for an obese phenotype and how has this predisposition to obesity evolved? 
Answers to these questions should advance the understandin
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our knowledge about the evolution of body-weight regulation mechanisms in humans remains 
incomplete. Nevertheless, four different types of evolutionary perspective have been proposed in an 
attempt to address these questions [161, 162]. 
The first hypothesis, called “thrifty gene”, is that the modern genetic predisposition to obesity 
was adaptive in the past, when storing large amounts of fat could have been selectively 
advantageous [163]. It explain the prevalence of obesity and diabetes in modern societies due to a 
change in lifestyle from that of Paleolithic hunters-gatherers to a subsistence based on agriculture, a 
pattern characterized by more sedentary occupations. The basis of this hypothesis states that during 
evolution of the modern humans, genes that promoted efficient fat accumulation would be 
extremely advantageous for primitive humans, because they allow their holders to survive famine 
periods [164]. In modern societies, where food supply is always available, such genes are 
disadvantageous and the result is the widespread obesity [162, 164]. 
Studies were conducted to try and identify genes under positive selection that have a role on 
obesity. A study lead by Myles et al. [165], suggested that the high frequency of the risk allele of the 
Gly482Ser variant in the PPARGC1A gene in Polynesians populations remains a thrifty allele in the 
Pacific populations. Another variant, the PC-1 Gln121, was also considered as a possible thrifty gene 
supported by studies in African and other groups [166]. A recent study provides evidence for a 
positive selection of TRIB2 gene, which influences visceral fat accumulation in East Asians [167]. In 
addition to these few examples showing a possibly positive selection in our evolutionary history with 
metabolic traits, other loci have been extensively studied, one of them being the lactase (LCT) gene, 
at ~7,000 years bp, which is considered a prototypic example of selective advantage leading to rapid 
human evolution compatible with the agricultural innovations [168]. In European populations, the -
13910C>T polymorphism, located ~14 kb upstream of the LCT gene, has been associated with the 
persistence of the lactase enzyme in adulthood: individuals carrying the CC genotype possess 
insufficient enzyme activity in intestinal cells and are classified as lactase non-persistence (i.e., show 
lactose intolerance), which is considered the ancestral condition in humans, whereas individuals 
carrying at least one T allele are considered lactase persistent [169]. Nevertheless, this adaptive 
hypothesis reveals some problems: if accumulating extra adipose tissue was advantageous in the 
past populations, many people with these thrifty genotypes in modern society do not develop the 
obese phenotype, despite the environmental change favoring fat storage. On the other hand, 
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population genetic models predict that thrifty genes would not have sufficient advantage or even 
time to spread in the human population [170]. 
A second explanation, for the evolutionary perspective favoring obesity is that most mutations 
in the obesity susceptibility genes are neutral and have been drifting over evolutionary time [162, 
171]. The neutral theory of molecular evolution, postulates that most evolutionary changes at the 
molecular level is not caused by natural selection, but by genetic drift [172]. According to this theory, 
the majority of genetic variation observed within and between species is selectively neutral, i.e. does 
not affect the fitness of individuals, in contrast to the theory of natural selection for which most of 
the genetic variation observed in populations affect the fitness of individuals and thus is subject to 
selection [173]. This new “drifty genes” hypothesis is a non-adaptive scenario providing an 
explanation for why some individuals get obese while others remain obesity resistant [162, 171]. 
The maladaptive viewpoint is another hypothesis that suggests that obesity is not adaptive and 
may never even have existed in human evolution history, except in some individuals with unusual 
genetic modifications such as the monogenic forms of obesity [162]. Nevertheless, genes that 
actually predispose to obesity could be favored as a maladaptive by-product of positive selection on 
some other advantageous trait. One example of this maladaptive interpretation is a work suggesting 
that obesity could result from individual differences in brown adipose tissue (BAT) [161]. This recent 
point of view emerged highlighting the differences in genetic susceptibility to develop an obese 
phenotype based on BAT.  
Sellayah et al. [161] proposed the thermogenesis hypothesis, in which climatic selection 
pressures in the evolutionary history could exert a strong influence on genes. Effectively, climate 
changes played a key role in our evolution, representing the principal engine of evolutionary change 
(climate is an important factor in determining anatomical differences among different geographical 
populations). In fact, we can see around the world several differences among warm-adapted and 
cold-adapted species. Regarding human populations there is a significant variation in their body 
form, by an adaptation to different climates, suggesting a link between body shape and climate, 
probably related to thermoregulation. In warm climates, individuals have a large surface area relative 
to body mass (e.g. slim, long trunk) that facilitate heat loss, whereas in cold climates individuals have 
a small surface area relative to body mass (e.g. bulky, short trunk) allowing heat retention. In most 
eutherian mammals, BAT is an essential factor in thermogenesis helping to maintain their body 
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temperature regardless of the ambient temperatures. The uncoupling protein 1 (UCP1) gene was 
found with a key role to maintain body temperature in cold climates, which is highly expressed in 
BAT [174]. Some polymorphisms were found in the UCP1 gene associated with body fat 
accumulation, body weight gain and BMI in response to a high-fat diet [175]. Feldmann et al. [176] 
demonstrated in mice exempt from thermal stress that UCP1 ablation induced itself obesity, even in 
mice fed with control diet. They conclude that ambient temperature has an important role in UCP1 in 
mediating diet-induced adrenergic thermogenesis. They suggest that, UCP1 activity could be 
determinative for obesity in mice, and possibly in humans. As it was stated by Sellayah et al. [161], 
epidemiological studies found different rates of obesity (including other metabolic disorders) across 
certain ethnic groups. These studies demonstrated that in United States there are ethnically 
differences; with blacks, Hispanics, and people of Native American ancestry being more prone to 
develop an obese phenotype than European Caucasians and people of East Asian ancestry (Chinese, 
Japanese, and Koreans). When we look to these ethnic population distributions it could be observed 
that people living in warm climates have a higher obesity prevalence compared to people living in 
cold temperatures. In evolution history, genes with an essential role to survival, especially in 
newborn and young children, were positively selected.  
So, Sellayah et al. [161] proposed in the thermogenesis hypothesis that migration to colder 
climates could result in a more efficient BAT and UCP1 gene function. This fact, would endow the 
capacity of higher energy expenditure and energy-burning capacity, providing a higher metabolic 
rate, which then could reduce body fat. At the opposite side, Africans and South Asians whose 
ancestors had no need to evolve efficient BAT and UCP1 function due to the warm climate, show an 
increased propensity for obesity when subjected to sedentary and hypercaloric lifestyle. 
Regarding the thrifty and drifty genotype hypotheses that attempt to explain how human 
obesity evolved, at least one fact remains unclear. Obesity emerged in industrialized countries, which 
then exported their sedentary and hypercaloric lifestyle. One of the principal drawbacks in these two 
hypotheses is that it cannot explain the clear evidence for ethnic differences in susceptibility to 
develop obesity. On the opposite side, the thermogenesis point of view it will be interesting; as 
during the out of Africa migration, genes involved in the BAT thermogenic function could be 
positively selected to a better cold adaptation, although it has also some drawbacks. So, further 
investigation in the UCP1 gene and other in genes involved in metabolic regulation could help 
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unraveling the causes of obesity susceptibility, and to explain the differences among populations and 
why not all people in the same environment seem to have the same predisposition for obesity. 
However, it should be mentioned that these hypotheses are not mutually exclusive and it is possible 
that all have some valid arguments explaining the evolutionary origin of obesity. Thus, understanding 
human evolution could help us to understand modern human behavior and traits.  
 
 
4. Prevention and treatment based on genotyping 
4.1.          Nutrigenetics  
Nutrition is one of the lifestyle factors contributing to the development and progression of 
obesity. An appropriate intake of energy and nutrients has been commonly accepted to prevent 
weight gain. Furthermore, epigenetics studies have demonstrated that several nutrients and 
bioactive food could play a role in the complex machinery involving the interaction between genome 
and the epigenome, which regulate gene expression [177]. The ingestion of these nutrients 
introduces some bioactive components that have signal molecules that carry information from the 
external environment [178]. Many dietary components can modulate epigenetic phenomena by 
inhibiting enzymes such as DNA methyltransferases and histone deacetylases [177], with the most 
well know vitamin B-12 and folate providing methyl groups for DNA methylation reaction [179, 180]. 
New research has attempted to understand the variability in metabolic responses to diet and food 
components, which could affect health. Nutrigenetics and nutrigenomics are defined of the effect of 
genetic variation on dietary response and the role of nutrients and bioactive food compounds in 
gene expression, respectively [181]. These areas aim to develop diagnostic tools that can “read” 
genetic susceptible loci in order to offer a personalized diet, taking into account the individual needs. 
Interactions among genetic loci and diet were found for obesity in IL-6, with daily food intake, PPAR-
gama2 and FTO with fat intake [182]. The Mediterranean diet is known to be rich in folates, which is 
crucial for the DNA methylation status. Ortega-Azorín et al. [183] found a significant gene-diet 
interaction of the FTO rs9939609 and MC4R rs17782313 polymorphisms with type 2 diabetes 
depending on diet, in which the Mediterranean diet counteracts the genetic predisposition. A cross-
sectional study found that individuals carrying both AA risk allele of the rs9939609 polymorphism 
were positively associated with a high intake of total fat (>34% energy) and low fiber consumption 
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(<16 g/day), independently of BMI [184]. It has also been reported in a recent study that obesity 
susceptibility genes (FAIM2, FLJ35779, FTO, LRRN6C, RBJ, and SEC16B) were found to interact with 
dietary carbohydrates (sugar-sweetened beverages) to increase BMI when one or more servings are 
consumed per day [185]. Other two genes, β-adrenergic receptor 2 (ADRB2) and MC4R, were also 
suggested being related with carbohydrate intake [182]. 
During pregnancy and early postnatal life, an individual can be programmed for nutritional thrift 
to adapt and survive in an environment scarce in resources. In 2008, Heijmans et al. [186] studied the 
degree of methylation at five DNA sites in the insulin-like growth factor 2 (IGF2) gene on the 
population exposed to the Dutch famine of 1944-1945. Prenatal exposure to the Dutch famine was 
associated with the risk of obesity. Kucharski et al. [187], provided evidence that epigenetic 
information could be differentially altered by the nutritional input in honeybee (Apis mellifera). 
Moreover, they found that epigenetic modifications could provoke profound changes in 
developmental fates with implications in reproductive and behavioral status. When bee larvae are 
fed royal jelly, it turns off the expression of DNA Dnmt3 and other genes are expressed, turning some 
of them into a queen, whereas bee larvae that are not fed royal jelly, Dnmt3 remains active and the 
larval development produces the worker variety of bees. 
In the past few years, a new window of research opened concerning the possible influence of 
the diversity of human gut microbiota (microorganisms that populate the adult intestines) in obesity 
[188]. Some studies found that the gut microbiota of nonobese individuals is more diverse than that 
of obese individuals [189]. Furthermore, several studies found an increase or decrease of different 
phyla between diet modification (e.g. reduced-carbohydrate, fiber, high-fat, etc.) and weight 
gain/loos [188, 189]. However, the mechanisms underlying gut microbiota affecting obesity in 
humans remain largely unknown. Thus, new studies and discoveries about how the gut microbiota 
affects the host metabolism could provide a more comprehensive understanding on how it affects 
obesity. A dietary intervention could be helpful in prevention as a potential instrument that can 
complement dietary advice. However, there are some limitations concerning nutrigenetics 
applications, such as, the lack of studies analyzing the evidence of common polymorphisms, 
polymorphisms differ on ethnic background, and the high cost of the genetic analyses. More 
generally, compliance with nutrient based recommendations, such as reducing intake of fat and 
sugar, has been very poor. 
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4.2.          Physical activity–genotype interactions in obesity 
Physical activity is another important component involved in the heterogeneous set of factors 
influencing obesity. Regular exercise is one of the most promising behavioral candidates for 
preventing and reducing weight gain, with other health and psychological benefits [190]. The most 
extensively studied example of a gene interaction with physical activity in obesity is the FTO locus; 
evidencing that physical activity attenuates the association of FTO variants with obesity-related traits 
[190–195]. A meta-analysis by Kilpeläinen et al. [79] observed that the estimated effect of the A risk 
allele of rs9939609 increased the odds ratio of obesity by 1.23-fold/allele, but this effect is 
attenuated by 27% in physical active adults (pinteraction =0.001). Similarly, the meta-analysis conducted 
by Ahmad et al. [196] showed a statistical significant GRS and physical activity interaction effect in 
obesity (pinteraction =0.015). In this analysis of 111,421 adults of European ancestry, data support the 
interaction effect between physical activity and a genetic risk score (combining 12 polymorphisms) in 
obesity disposition (pinteraction =0.015). So, higher levels of physical activity may attenuate the 
influence of obesity susceptibility polymorphisms on BMI during adolescence. 
However, several studies have provided evidence that the propensity to be physically active has 
also a strong genetic component in both animals and humans [197]. In humans, physical activity has 
been shown to aggregate in families; more active parents have more active children relative to 
inactive parents [198]. The physical activity heritability ranges from 9% in Mexican-American families, 
to almost 80% in European twins [197]. Common polymorphisms in the MC4R gene were also found 
associated with self-reported physical inactivity in French-Canadian families and Mexican-Americans 
[199, 200]. Another variant, the Gln223Arg polymorphism located in LEPR gene, was found to be 
associated with lower 24h energy expenditure and physical activity levels in individual homozygotes 
for the Arg223 allele compared to Gln homozygotes in Pima Indians population [201]. Summarizing, it 
appears that some variation in our DNA could contribute to the variation in the physical activity level. 
Thus, new studies and the identification of new loci implicated in this interaction could better enligth 
and help to understand the causes contributing to the development of obesity. 
 
4.3.          Drug genotype interaction 
The use of drugs as a treatment option for obesity could be indicated for individuals with a BMI 
>30 kg/m2 with existing co-morbidities such as diabetes, dyslipidemia or hypertension [202]. In the 
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last decade, with the discovery that some drugs were affected by hereditarily variation, the concept 
of “pharmacogenetics” emerged [203]. This new field focuses on the study of polymorphisms within 
one or more candidate genes for associations with pharmacologic phenotypes. So, common 
polymorphisms may alter the response to pharmacotherapy affecting drug metabolism, drug 
transport or drug targets [202, 203]. Relating to obesity, at least 35 loci were validated as being 
associated with BMI and the advent of GWAS and next generation sequencing will likely lead to the 
identification of additional genetic biomarkers. Until now, only three obesity-related drugs were 
approved for continuous use in the United States of America (USA): orlistat (Xenical®, Alli®), 
lorcaserin HCL (Belviq®), and phentermine and topiramate extended release (Qsymia™) [202]. 
Orlistat is a drug that alters metabolism by inhibiting the gastro-intestinal absorption of triglycerides 
[204]. Lorcaserin HCL and Phentermine are drugs that act centrally as an appetite suppressant [202, 
205]. At the end of 2014, the US Food and Drug Administration (FDA) approved a new drug the 
Saxenda® (Novo Nordisk), an agonist of a glucagon-like peptide 1 (GLP-1). 
In the future, it may be possible to determine which sub-populations will respond optimally to 
particular doses of drugs, allowing more effective personalized pharmacologic intervention. To 
achieve this end, it would be ideal if pharmacogenetic studies could identify differences in drug 
response and tolerability, and investigate gene regulation, epigenetic modifications, and DNA-protein 
interactions that could explain individual differences in responses to drugs beyond genetic variation. 
Ultimately, it will also be necessary for clinical trials to evaluate pharmacologic interventions that are 
guided by genetic tests. 
 
4.4.         Surgical intervention 
 For patients with morbid obesity (BMI ≥40 kg/m2) and overweight (BMI ≥35 kg/m2), suffering also 
of obesity-related comorbidities, which failed diet, exercise, and drug therapy, a surgical intervention 
could be the only option for the resolution of obesity problem. This approach could be a definitive 
way in many situations to reduce loss weight. However, some patients present a significant weight 
gain after chirurgical intervention. There are several guidelines and procedures that 
surgeons/gastroenterologists need to follow [206]. In this section we will not detail about surgical 
intervention strategies, which have been reviewed elsewhere [207], but about a possible relation 
between some genetic variants and the success to maintain weight loss after surgical intervention.  
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 Throughout this introduction we discuss the importance that genetics factors play in the etiology 
of obesity, and for that it should be a factor taking into account in patients undergoing surgery. 
Effectively, there is a high degree of inter-subject variability for surgical outcomes [208]. Generally, 
patients submitted at a surgical intervention have a durable weight loss [209]. However, despite its 
effectiveness not all people lose the same amount of weight or obtain the same clinical benefits after 
the intervention. Some studies emerged associating specific polymorphisms with the response to 
bariatric surgery. Still et al. [210] used a summative allele risk score to found the presence of an 
association between several polymorphisms (including the FTO, and MC4R genes) with postoperative 
weight loss. De Luis et al. [211] investigated the role of rs6923761 polymorphism at GLP-1R gene on 
outcomes after biliopancreatic diversion. They found that homozygous individuals for the rs6923761 
G allele showed higher weight loss 12 and 18 months after bariatric surgery than individuals A allele 
carriers. In another study, Hatoum et al. [209] found that a 15q26.1 locus was significantly associated 
with weight loss after Roux-en-Y gastric bypass surgery. Using the same surgery intervention, in 
2013, a GWAS identified 17 polymorphisms whose frequencies were significantly different between 
two phenotypic extremes of weight loss at two years after surgery [212].            
 There are some evidences for the use of genomics to identify response to surgical procedures 
[209, 213]. Thus, the identification of genetic contributors could be useful to select those individuals 
who will obtain a better benefit from a weight-loss surgery. However, these results need to be 
interpreted with some caution due to the few number of replication studies.  
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5. Objectives  
The main goal of this study was to investigate for the first time the genetics of common obesity 
in Portuguese children, which could allow in the future the identification of a genetic predisposition 
to obesity, and help developing possible approaches to treat this condition. 
 
From this general goal, we pointed out more detailed objectives, specifically: 
 
• To assess prevalence of overweight and obesity in a sample of 6-12 years old children 
with Portuguese origin. 
• To assess the association between three FTO polymorphisms with obesity-related 
traits in the sample previously established. 
• To test the association in the sample of Portuguese children, the -13910C>T (LCT) 
polymorphism with obesity-related traits. 
• To investigate the nominal association of ten obesity-related polymorphisms within 
or near genes MSRA, TFAP2B, MC4R, NRXN3, PPARGC1A, TMEM18, SEC16B, HOXB5 
and OLFM4 in the previously established sample. 
• To search in children with morbid obesity (BMI ≥99th) for possible mutations in MC4R 
gene. 
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1. Selection of polymorphisms  
In the beginning of this PhD project, in 2009, eleven single nucleotide polymorphisms, identified 
from the literature as being related to obesity or obesity-related traits in populations of European 
origin, were selected for this study. Throughout the development of the study, three new 
polymorphisms were included in the analysis, totaling fourteen polymorphisms.  
 
FTO gene 
Three polymorphisms located within the first intron of the FTO gene were selected: two that 
have been closely associated with obesity and prominent in the literature, rs9939609 (position: 
chr16:53820527), described by Frayling et al. [65], rs1421085 (position: chr16:53800954), reported in 
the work of Dina et al. [76], and the yet poorly studied rs1861868 polymorphism (position: 
chr16:53790402), described in only two studies [66, 192]. 
 
MC4R gene 
Two polymorphisms located in the MC4R gene, prominent in the literature, rs17782313 
(position: chr18:57851097) and rs12970134 (position: chr18:57884750), were chosen. 
 
NRXN3, PPARGC1A, TMEM18, SEC16B genes 
Four poorly studied polymorphisms comprising rs10146997 (position: chr14:79945162) in 
NRXN3, rs8192678 (position: chr4:23815662) in PPARGC1A, rs7561317 (position: chr2:644953) in 
TMEM18 and rs10913469 (position: chr1:177913519) in SEC16B, were chosen. 
 
MSRA and TFAP2B genes 
Two polymorphisms associated in adult´s populations but never replicated in sample children, 
rs545854 (position: chr8:9860080) in MSRA and rs987237 (position: chr6:50803050) in TFAP2B [214], 
were chosen. 
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LCT gene 
The rs4988235 (-13910C>T) (position: chr2:136608646) polymorphism located ~14 kb upstream 
from the LCT gene coding region, reported in 2010 as a new candidate related with obesity in adults 
of European origin [102–104], was chosen. 
 
HOXB5 and OLFM4 genes 
The two remaining polymorphisms were chosen due to their recent (2012) association with 
childhood obesity, but never replicated in an independent study: rs9299 (position: chr17:46669430) 
in HOXB5 and rs9568856 (position: chr13:54064981) in OLFM4 [114]. 
 
2. Ethical procedures 
The study protocol was approved by Direcção-Geral de Inovação e de Desenvolvimento 
Curricular, the ethical committee of the Ministério da Educação e Ciência (Portugal). The 
authorization can be found at the http://mime.gepe.min-edu.pt homepage, using the identification 
number process nº: 0151100001. The study protocol was also conducted in accordance with the 
institutional guidelines of the University of Coimbra (Portugal).  
After having obtained the written informed consent of children´s parents/guardians, children 
with positive consent were included in this study. 
 
3. Study subjects 
Subjects were selected in 2011 (April-June) from several public schools in the central region of 
Portugal. The study subjects were derived from five grouping of schools: Agrupamento de escolas Dr. 
Manuel Fernandes (Abrantes), Agrupamento de escolas Pêro da Covilhã (Covilhã), Agrupamento de 
escolas da Pedrulha (Coimbra), Agrupamento de escolas Carolina Beatriz Ângelo (Guarda) and 
Agrupamento de escolas das Dairas (Vale de Cambra). All children from these groups of schools, aged 
between 6 to 12 years old, were chosen to integrate this study. From a total of 4028 initially selected 
children, 1468 parents gave their written informed consent. Thirty-five children were excluded from 
the study due to non-Portuguese origin: African (n=8), Asian (n=2), or other European origins (n=15). 
After this exclusion, the final sample was composed by 1433 children with Portuguese ancestry, 
comprising 747 girls and 686 boys.  
G e n e r a l  l a b o r a t o r y  m e t h o d s : …  
 
47 
4. Anthropometric measures  
Some anthropometric measures are used by anthropologists to assess variation in physical size 
and shape of the body in humans. These analyses can provide data and clues about the cause of 
human variation. A trait can be described and reflect the activity of a single-gene (Mendelian or 
monogenic) or more than one gene (polygenic). Both of them can be multifactorial influenced in the 
same time by environment factors. A polygenic multifactorial condition reflects additive contribution 
of several genes conferring different degrees of susceptibility.  
 
4.1. Anthropometry 
Anthropometry arises as a branch of biological science that aims the study of body size. The 
principal study object is the different character measurable in human morphology, such as height, 
weight, waist circumference, and subcutaneous fold. It has the particularity to be a universally 
applicable, inexpensive and non-invasive method to assess the size and composition of human body. 
This field was developed mostly in the early nineteenth century and in other phase in the early of the 
twentieth century. Initially constituted an attempt, through the physical dimensions of man, to 
subdivide and classify human in "race". In the last decade, its focus was mainly devoted to human 
growth and physical classification. 
 
 
4.2. Body mass index (BMI) in adults 
To define and classify the body weight in adults, we used the Body Mass Index (BMI) [215]. The 
BMI is a weight parameter corrected for height. This is calculated by dividing body weight (in kg) by 
height (in square meters) [215]. Table 2.1 presents the values for BMI for adults, according to the 
classification of the World Health Organization (WHO). BMI between 18.6 and 24.9 kg/m2 are 
considered with normal weight. However, values above 25kg/m2 mean excess of weight [16]. 
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Table 2.1. World Health Organization classification for BMI in adults. 
Classification Body Mass Index (BMI), kg/m
2
 
Underweight <18.5 
Normal range 18.5 – 24.9 
Overweight 25 – 29.9 
Obese 30.0 - 34.9 
Severely obese (Class I) 35.0 – 39.9 
Morbidly obese (Class II) 40.0 – 49.9 
Super obese (Class III) >50.0 
 
One of the main advantages of the BMI is to be relatively inexpensive, easy to use, non-invasive, 
and does not cause any discomfort to people. This has numerous advantages in the clinical setting, 
making BMI generally used as a measure of total body fat. Despite this advantage, there are some 
limitations to its use as BMI does not measure the amount of body fat directly, therefore can lead to 
an inaccurate assessment of adiposity. Nevertheless, it has clinical validity and acceptable, but must 
be used with caution [216, 217]. 
A major problem of fat deposits in the body that can lead to metabolic risk, especially with regard 
to the central abdominal fat, is measured by waist circumference and can be associated with the 
development of metabolic risk factors, diabetes, cholesterol and cardiovascular diseases 
(hypertension) [218]. Thus, the waist circumference has become a good indicator of central obesity, 
since it quantifies the accumulated body fat in the abdomen. Understanding pathogenic central fat 
distribution may help in understanding the relationship between adiposity and cardiovascular 
disease risk. It is through the ratio of the circumference of waist / hip ratio that the indicator of 
abdominal obesity and associated risk is obtained. According to the National Institute of Health 
(USA), men and women with a waist circumference greater than 100 cm and 80 cm, respectively, are 
more likely to become obese [219]. 
 
4.3. Body mass index in children and adolescents 
Body mass index Z-scores, also called BMI standard deviation (s.d.) scores (BMI Z-score), are 
measures of relative weight adjusted for child age and sex [220]. Given a child's age, sex, BMI, and an 
appropriate reference standard, a BMI Z-score (or its equivalent BMI-for-age percentile) can be 
determined. It should be noted that BMI Z-scores are calculated relative to a national or international 
reference.  
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Body mass index Z-scores correspond to growth chart percentiles, and can be converted into 
their equivalent BMI-for-age percentiles by comparison to a normal distribution table [221] (Figure 
2.1). For example, using the US BMI-for-age reference, a 5-year-old boy with a BMI of 20 kg/m2 has a 
BMI Z-score of approximately 2.5 (BMI >99th percentile) and a 15-year-old boy with a BMI of 20 
kg/m2 has a BMI Z-score of approximately 0.0 (BMI= 50th percentile). In the United States, BMI-for-
age percentiles above the 95th percentile in children and adolescents are labeled “obese” and BMI-
for-age percentiles between the 85th and 95th percentiles are labeled “overweight” [222]. Therefore, 
although both the 5- and 15-year-old boys described above have a BMI equal to 20 kg/m2, only the 5-
year-old would be considered obese.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Percentile ranks and standard scores in relation to the normal curve (SD, standard 
deviation). Adapted from [223]. 
 
 
4.4. Anthropometric measurements  
All children participants in this study underwent anthropometric measurements of height (cm), 
weight (kg), waist and hip circumference (cm) using a standardized protocol by the same operator. 
The equipments used were a compact digital weighing scale (Seca, model 872, Germany), a portable 
stadiometer (Seca, model 213, Germany) and a flexible measurement tape (Seca, model 201, 
Germany). 
Body weight (kg) and height (cm) were taken with participants dressed in lightweight clothing 
without shoes. Waist circumference (WC) was measured midway between the lowest rib and the iliac 
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crest to the nearest 0.1 cm after inhalation and exhalation. Hip circumference (cm) was measured at 
the point over the buttocks yielding the maximum circumference. 
The BMI was calculated as the weight in kilograms (kg) divided by the square of height in meters 
(kg/m2). Overweight and obesity were defined according to the International Obesity Task Force 
(IOTF) reference data, making a correspondence between the traditional adult cutoff (BMI in adult’s 
cut-points of 25 kg/m2 and 30 kg/m2 respectively for overweight and obesity) and specific values for 
children according to gender and age [221]. A Z-score was calculated for each child using the LMS 
(lambda-mu-sigma) method and the calculation was determined using the LMS growth add-in for 
Microsoft Excel [224].  
 
5. Genotyping 
5.1. Collecting buccal samples 
For each child, individuals packaged containing a sterile brush was used (Sarstedt, Nümbrecht, 
Germany) to collect buccal cells. After 1-2 minutes rubbing into mouth, buccal swab sample were 
released in an eppendorf tubes containing 1ml of ethanol (absolute) for conservation, for subsequent 
DNA extraction, and PCR analysis. All tubes were properly blindly numbered for a posteriori 
identification with the child phenotype. 
 
5.2. DNA extraction 
From the original sample of 1433 subjects, a total of 730 children were selected for genotyping 
including 154 subjects as obese, 320 subjects as overweight, and 256 for the control group random 
chosen from the total of 928 children with a normal BMI (18.5>BMI<25.0 kg/m2).  
The genomic DNA was extracted from buccal cells using the PureLink Pro 96 Genomic DNA Kit 
(Invitrogen Corporation, Carlsbad, CA, USA), according to the instructions of the manufacturer. 
 
5.3. DNA quantification 
After the DNA extraction we performed the quantification of the sample to determine the 
average concentration of DNA present, as well as the purity. For this purpose we used the 
NanoDrop™ 2000C spectrophotometer (Thermo Scientific, Wilmington, DE, USA) according to the 
instructions of the manufacturer. This technology is based on the absorption of ultraviolet light at 
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12 ng/µl    A260/280nm = 1.88    A260/230 nm = 1.80 
260 nm by nucleic acids, and a photo-detector measures the light passes through the sample. When 
more light is absorbed by the sample, higher is the nucleic acid concentration in the sample. In 
molecular biology is common for nucleic acid samples to be contaminated with other molecules (i.e. 
proteins, organic compounds, other). To assess the purity of the sample, the ratio of absorptions at 
260 nm vs. 280 nm is used. Generally, pure nucleic acids yield a 260/280 ratio of ~1.8 for DNA. If the 
sample present values out of range it will probably require further optimization before the isolation 
technique used. 
Due to the higher number of quantified samples we only present the mean values obtained in 
our sample collection: 
 
 
 
 
5.4. Allelic discrimination using TaqMan® probes approach 
The detection of polymorphisms in the genome is a growing approach due to the development 
of new technologies. The real-time polymerase chain reaction urged as a more promising PCR 
method for high through put assays. The real time PCR also called quantitative polymerase chain 
reaction (qPCR) method is a technique that involves simultaneously amplification, detection and 
quantification of a specific nucleic acid target in a biological sample. The introduction of a fluorescent 
reporter molecule in the PCR reaction allows a quicker detection of polymorphisms in large scale. 
TaqMan® (Applied Biosystems, Foster City, USA) probes are oligonucleotide fragments labeled 
with two fluorophores at the 5´and 3´ends. The 5′ nuclease activity of Taq polymerase is used to 
cleave a non-extendable oligonucleotide hybridization probe during the extension phase of PCR. This 
methodology use dual-labeled fluorogenic hybridization probes for two alleles, including a reporter 
(R) dye FAM™ (6-carboxyfluorescein) for one allele and a reporter dye VIC® for the second allele  
covalently linked to the 5′ end, whose emission spectra is quenched (Q) by a second dye TAMRA (6-
arboxytetramethylrhodamine), covalently linked to the 3′ end. During a PCR cycle, the probe 
specifically hybridizes to the corresponding template, cleaves via the 5′ to 3′ exonuclease activity of 
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Taq DNA polymerase and subsequently increases the FAM
2.2). 
Except for the rs4988235 (-13910C>T at the 
were amplified for allelic discrimination assays, using TaqMan® probes (Applied Biosystems, Foster 
City, USA). For the rs4988235 polymorphism we used previously reported primers and labeled 
probes for genotyping [225]. The TaqMan® probes used are described in 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2. Representation of the TaqMan® PCR based on the 5
polymerase. This method uses a probe (additional primer), which also binds specifically to the target 
DNA sequence. Probes have a fluorescent ‘reporter’ dye (R) at
which inhibits fluorescence at the other. During the extension stage (phase 3) the probe is broken 
apart by the DNA-polymerase and begins to fluoresce more strongly. The fluorescence can be 
measured at each cycle and increases in proportion to the number of target sequence copies 
produced.  
 
™ and VIC® fluorescent emission (Figure 
LCT gene) polymorphism all the polymorphisms 
Table 2.2. 
 
′-3′-exonuclease activity of 
 one end and a ‘quencher’ dye (Q), 
Taq 
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Table 2.2. Description of TaqMan® probes (20X) used for amplification of DNA target.  
Chromosome Gene Polymorphism TaqMan® probes* 
1q25 SEC16B rs10913469 C__3193319_10 
2q21 LCT rs4988235 [225]# 
2p25 TMEM18 rs7561317 C__11804554_10 
4p15 PPARGC1A rs8192678 C__1643192_20 
6p12 TFAP2B rs987237 C__9489781_10 
8p23 MSRA rs545854 C__27120820_10 
13q14 OLFM4 rs9568856 C__30191235_20 
14q31 NRXN3 rs10146997 C__30288512_10 
16q12.2 FTO rs9939609 C__30090620_10 
16q12.2 FTO rs1421085 C__8917103_10 
16q12.2 FTO rs1861868 C__11717119_10 
17q21 HOXB5 rs9299 C__2906037_20 
18q21 MC4R rs12970134 C__3058722_10 
18q22 MC4R rs17782313 C__32667060_10 
 
*Applied Biosystems, Foster City, USA 
#
Regarding the LCT gene the previously described probes in [225] were used, VIC®-labelled probe 
ATAATGTAGTCCCTGGCCT to detect the T-allele and the 6-FAM™-labelled probe ATAATGTAGCCCCTGGC to 
detect the C-allele. 
 
 
All polymerase chain reactions (except for the rs4988235 polymorphism) were carried out in a 
total volume reaction of 20 µl containing 1x of SsoFast™ Probes Supermix (Bio-Rad, Hercules, CA, 
USA), 0.5 μl of specific TaqMan® polymorphism Genotyping Assays (20x) (Applied Biosystems, Foster 
City, USA) and 2 μl (~12 ng/μl) of genomic DNA, according to the manufacturer΄s instrucons.  
 
For the rs4988235 polymorphism of the LCT gene, the reaction was carried out in a total volume 
of 20 µl containing 1x of SsoFast™ Probes Supermix (Bio-Rad, Hercules, CA, USA), 0.4 μM of each 
primers, 0.2 μM of each probe, and 2 μl (~12 ng/μl) of genomic DNA (Table 2.3). 
 
Thermal cycling conditions for all polymorphisms were 10 minutes at 95°C, and 35 cycles of 95°C 
for 15 seconds and 60°C for 1 minute. The fluorescence was observed through a MiniOpticon real 
time PCR system (Bio-Rad, Hercules, CA, USA). 
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6. Genotyping reproducibility 
6.1. Amplification of DNA target by Polymerase Chain Reaction (PCR) 
To assess genotyping reproducibility, about 10% random samples were re-genotyped for all 
polymorphisms by the Single Strand Conformation Polymorphism (SSCP) method or sequencing by 
the Sanger’s dideoxy chain termination reaction, using oligonucleotides detailed in Table 2.3. 
The PCR technique allows obtaining a large number of copies of a specific segment of DNA, 
called DNA target. The principle of this technique consists in using two primers (small sequences of 
DNA with about 18-24 nucleotides) that will bind to the complementary DNA strands of the two sites 
bounding the region to be amplified. The elongation of complementary strands from the primers is 
ensured by a polymerase enzyme. This technical concept was developed by Kary Mullis in 1983 [226], 
which earned him the Nobel Prize for Chemistry in 1993. Although the principle of PCR have been 
described in 1986, it was in 1988 that the better PCR performance was obtained using Taq 
polymerase derived from Thermus aquaticus bacteria isolated from the hot springs of Yellowstone 
Park, which has the property of being stable at heat temperatures (~100°C) [227]. This revolutionary 
method becomes one of the most universal techniques used in the field of molecular biology. 
In this study, the PCR conditions were performed in a final reaction volume of 25 μl, 
containing 50 ng of PCR primers, 0.2 mM of each dNTPs, 3 mM of MgCl2, 1x Taq buffer [750 mM Tris-
HCl (pH 8.8 at 25°C), 200 mM (NH4)2SO4, 0.1% (v/v) Tween 20], 0.5 U Taq DNA Polymerase (Thermo 
Scientific, Fermentas) and about 20 ng of genomic DNA. Amplification conditions consisted in 35 
cycles of 45 seconds denaturation at 94°C, 45 seconds annealing at 56-62°C and 45 seconds 
extension at 72°C. A 5 minutes initial denaturation at 95°C and a 5 minutes final extension at 72°C 
were performed (Table 2.3). 
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Table 2.3. Description of primers and PCR conditions used for amplification of DNA target. 
 
Gene Poly. ID Pr. Primers sequences (5´- 3´) 
Amplification conditions (x35 cycles) Size 
(pb) Denaturation Annealing Elongation 
SEC16B rs10913469 
F AGGACGTTCAAACATCAGCA 
94°C – 45´´ 57°C – 45´´ 72°C – 45´´ 154 
R TCTACTGAACTTTTCCTCATTAGCTT 
LCT* rs4988235 
F AAATGCAACCTAAGGAGGAGAGTTC 
94°C – 45´´ 58°C – 45´´ 72°C – 45´´ 71 
R CTGCGCTGGCAATACAGATAAG 
TMEM18 rs7561317 
F CCTTCCCAGAGGTGAGGTCT 
94°C – 45´´ 58°C – 45´´ 72°C – 45´´ 153 
R CAGGGCTCATTCACGCTTAT 
PPARGC1A rs8192678 
F CCTTGCAGCACAAGAAAACA 
94°C – 45´´ 58°C – 45´´ 72°C – 45´´ 211 
R CTTCGCTGTCATCAAACAGG 
TFAP2B rs987237 
F ACCGCCGCTCATATGAATTA 
94°C – 45´´ 58°C – 45´´ 72°C – 45´´ 206 
R AAGTGTGCCCCATTCTTCC 
MSRA rs545854 
F CCCCATCACATGGTTTAAGG 
94°C – 45´´ 56°C – 45´´ 72°C – 45´´ 196 
R CGGTTGCCTTTCGTAGAGAC 
OLFM4 rs9568856 
F TGTGCATATTGTGTTTGGGATT 
94°C – 45´´ 58°C – 45´´ 72°C – 45´´ 169 
R TTTGCTTGTGTGATTAGGCATC 
NRXN3 rs10146997 
F ATGCCGTGTCATCATTGAAA 
94°C – 45´´ 58°C – 45´´ 72°C – 45´´ 242 
R CAACAGCTTACAGGGTCCAG 
FTO rs9939609 
F CATCAGTTATGCATTTAGAATGTCTG 
94°C – 45´´ 58°C – 45´´ 72°C – 45´´ 132 
R TCCCACTCCATTTCTGACTGT 
FTO rs1421085 
F AATCTCATTGTTCCTCCTGCT 
94°C – 45´´ 58°C – 45´´ 72°C – 45´´ 179 
R ACAGTGGAGGTCAGCACAGA 
FTO rs1861868 
F CGCATCTCTGCAACTCTTTT 
94°C – 45´´ 58°C – 45´´ 72°C – 45´´ 171 
R CCCCTTGCATCAGAGTGTTT 
HOXB5 rs9299 
F GGGAGCATGGAAGGAAAATA 
94°C – 45´´ 62°C – 45´´ 72°C – 45´´ 187 
R CTGGCCCCTCCAATCCTC 
MC4R rs17782313 
F AAGGGCATAAGCAAGTTCTACC 
94°C – 45´´ 58°C – 45´´ 72°C – 45´´ 211 
R GCTACCTCAATCCCAGATGC 
MC4R rs12970134 
F CAGATTATTTCGGTTCTAAGCAA 
94°C – 45´´ 56°C – 45´´ 72°C – 45´´ 99 
R CAGGTACTAACAAGCACCCTTC 
 
*Primers previously described in [225]. 
All primers described (except for the LCT gene) were designed for this study based on the Primer3 program, 
version 0.4.0 [228] (freely available in http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). 
 
 
 
All amplifications were performed in a Biometra TProfessional Thermocycler (Biomedizinische 
Analytik GmbH, Göttingen, Germany). 
 
The amplification efficiency was confirmed by and electrophoresis run with 5 μl of the amplified 
product in a gel of 1.5% agarose containing ethidium bromide (final concentration 4 μg/ml) and 
visualized under ultraviolet (UV) light. A negative control was also used in all amplifications to verify a 
possible contamination, as well as a molecular weight marker (pBR322/Hinf1) to compare the size of 
the amplified band. 
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6.2. Allelic discrimination by SSCP 
The Single-Stranded Conformation Polymorphism (SSCP) method was used to corroborate the 
results obtained by TaqMan® probes for rs1421085, rs1861868, rs7561317, rs8192678, rs987237, 
rs545854, rs10146997, rs12970134 polymorphisms. The SSCP technique developed by Orita et al. 
[229] allows the detection of polymorphisms based on the three-dimensional configuration of a 
single chain DNA. It relies on the fact that single stranded DNA acquires a particular structure 
depending on their nucleotide composition. A variation of one or more nucleotides directly translates 
into a modification of the 3D structure of the chain, which can be detected. 
The SSCP method involves denaturation of the two strands of DNA amplified by PCR at elevated 
temperatures (± 94°C) in the presence of formamide, followed by rapid cooling preventing that these 
single strands become annealed again. The two chains independently acquire a three-dimensional 
structure itself. The PCR products are separated by electrophoresis in non-denaturing gel. Depending 
on their structure, migration will also be different in the electrophoresis run. The polymorphism 
detection is made by comparison of the different electrophoretic profiles from different individuals. 
The amplification reaction was made using primers previously described in Table 2.3. Then, it 
was added a denaturing solution with 95% deionized formamide, 0.1% bromophenol blue, 0.1% 
xylene cyanol, 10 mM EDTA, 0.1% SDS 1:1 giving a final volume of 6 μl/tube. The mixture was 
denatured by heat (94°C for 5 min) in a thermocycler (40 Robocycler, Stratagene) and subsequently 
placed in a vertical polyacrylamide gel. After, 4 μl of the solution was applied to a mini-gel (7.2 x 10.2 
cm) constituted by: 12% acrylamide-bisacrylamide (C = 1.3%), 10% glycerol and 200 mM TBE buffer 
(89 mm Tris, 89 mm boric acid, 2 mM EDTA, pH 8.3).  
 
Electrophoresis was performed at 60 volts (V) for 16 hours. 
 
The DNA bands were visualized by staining with silver nitrate using the following solutions and 
steps [230]: 
1) 10% of acetic acid, for 20 minutes; 
2) Distilled water, twice, for 2 minutes; 
3) 0.1% silver nitrate (100ml) with 37% formaldehyde (150 μl), for 30 min; 
4) Distilled water, for 30 second; 
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5) 3% Sodium carbonate (100ml), with 37% formaldehyde (150 μl) and 10% sodium thiosulfate 
solution (20 μl), for 2 to 5 minutes; 
6) 10% acetic acid, for 30 seconds; 
7) Distilled water.  
 
6.3. Automated DNA sequencing  
Automated DNA direct sequencing was used to corroborate the results obtained by TaqMan® 
probes for rs9939609, rs10913469, rs17782313, rs9568856, rs9299, and rs4988235 polymorphisms, 
using an ABI Prism 310 sequencer (Applied Biosystems, Foster City, CA, USA). The BigDye® 
Terminator v1.1 Cycle Sequencing kit Ready Reaction Kit (Applied Biosystems, Foster City, CA, USA) 
was used to sequence DNA fragments. The amplified PCR products (4 µl) were purified with 1 µl of 
ExoSAP enzyme (Pharmacia Biotech) (conditions: 37°C for 15 minutes followed by 80°C for 15 
minutes) and used directly in reactions of cyclic dideoxynucleotide sequencing (Sanger et al, 1977): 2 
μl of the purified PCR product, 1 μl of reagent BigDye® Terminator v1.1 Cycle Sequencing Kit (Applied 
Biosystems, Foster City, CA, USA), 0.5 μl (100 ng/µl) of primer (Table 2.3) and 6.5 μl of bi-distilled 
water, for a total volume of 10 μl. The conditions used for the sequencing reaction were 25 
successive cycles of denaturation at 96°C for 20 seconds and annealing and extension at 60°C for 2 
minutes. The sequenced samples were then purified using Centri-Sep Columns (DyeEx 2.0 Spin 
Columns Qiagen, Hilden, Germany) according to the manufacturer instructions, and applied directly 
on the ABI PRISM 310 automated sequencer (Applied Biosystems, Foster City, CA, USA). Sequence 
analysis was performed using the Sequencing Analysis v5.2 software (Applied Biosystems, Foster City, 
CA, USA). 
Nevertheless, for all the studied polymorphisms the 3 different genotypes were confirmed by 
automatic sequencing of selected samples based on the allelic discrimination by TaqMan® assay, 
using primers described in Table 2.3. 
 
7. Direct sequencing of the MC4R gene  
In all children that present a morbid obese phenotype (BMI ≥99th), the entire sequence of MC4R 
gene was screened. 
C h a p t e r  I I  
 
58 
DNA was amplified by polymerase chain reaction (PCR), using primers and conditions previously 
published for the MC4R coding sequence [231]. For the promoter region, primers were designed with 
the Primer3 software, v0.4.0 [228] (freely available in http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi) (Table 2.4). 
 
 
Table 2.4. Description of primers and PCR conditions used for amplification of MC4R DNA fragments. 
 
Frag. Pr. Primers sequences (5´- 3´) 
Amplification conditions (x35 cycles) 
Denaturation Annealing Elongation 
MC4R-Prom# F CGCCTACAGCCCCTAACACT 94°C – 45´´ 57°C – 45´´ 72°C – 45´´ 
R CCTCCTGGGTCAGGGAGT 
MC4R-A* F ATCAATTCAGGGGGACACTG 94°C – 45´´ 57°C – 45´´ 72°C – 45´´ 
R CATGGGTGAATGCAGATTCT 
MC4R-B* F GTGATTGTGGCAATAGCCAA 94°C – 45´´ 58°C – 45´´ 72°C – 45´´ 
R TCCACTGCAATTGAAAGCAG 
MC4R-C* F TGTAGCTCCTTGCTTGCATC 94°C – 45´´ 60°C – 45´´ 72°C – 45´´ 
R GGCCATCAGGAACATGTGGA 
MC4R-D* F ACCATGTTCTTCACCATGCTG 94°C – 45´´ 55°C – 45´´ 72°C – 45´´ 
R GAGACATGAAGCACACACAA 
MC4R-E* F CCATTCTTCCTCCACTTAAT 94°C – 45´´ 55°C – 45´´ 72°C – 45´´ 
R TGCATGTTCCTATATTGCGTG 
 
Abbreviations: Frag., fragment; Pr., primer; F, forward; R, reverse; °C, Celsius degree; ´, minute; ´´, second.   
*Primers previously described in [231]. 
#Primers for the promoter region  were designed for this study based on the Primer3 program, version 0.4.0 
[228] (freely available in http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). 
 
The PCR conditions were performed in a final reaction volume of 25 μl, containing 50 ng of PCR 
primers, 0.2 mM of each dNTPs, 3 mM of MgCl2, 1x Taq buffer [750 mM Tris-HCl (pH 8.8 at 25°C), 200 
mM (NH4)2SO4, 0.1% (v/v) Tween 20], 0.5 U Taq DNA Polymerase (Thermo Scientific, Fermentas) and 
about 20 ng of genomic DNA. Amplification consisted in 35 cycles of 45 seconds denaturation at 
94°C, 45 seconds annealing at 55-60°C and 45 seconds extension at 72°C. A 5 minutes initial 
denaturation at 95°C and a 5 minutes final extension at 72°C were performed 
All amplified fragments were purified with the enzyme ExoSAP-IT (GE Healthcare, New Jersey, 
USA). The conditions used for purification were one cycle at 37°C for 2 hours follow by one cycle at 
95°C for 5 minutes (21 μl of PCR product add with 1.0 μl of ExoSap-IT). 
For the sequencing reaction 5 μl of purified product with 1.0 μl BigDye® Terminator v3.1 Reagent 
Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA), 1.5 μl buffer and 1.0 μl (100 ng/µl) of 
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primer (F or R) was added to 1.5 μl of double distilled water to a total volume of 10 μl. This step was 
realized for both forward and reveres strands. The conditions used for the sequencing reaction were 
25 successive cycles of denaturation at 95°C for 30 seconds, annealing at 52°C for 15 seconds and 
extension at 60°C for 2 minutes. The sequenced samples were then purified using the conditions 
described above:  
1) Addition of 1 μl of 125 mM EDTA and 40 μl 1:25 3M NaOAc: 100% ethanol during 15 minutes 
at room temperature; 
2) Centrifugation at 4000 rpm  during 30 minutes at 4°C; 
3) Discard the flow; 
4) Washed with 60 μl of 70% ethanol; 
5) Centrifugation at 1000rpm during 2 minutes at 4°C (2 times); 
6) Discard the flow; 
7) Dry the pellet; 
8) Add 15 μl of formamide and wait 15 minutes (to re-suspend the pellet); 
9) Denaturation at 95°C for 5 minutes. 
 After this purified step, samples were applied directly on an automated sequencer ABI 3130 DNA 
Analyzer (Applied Biosystems, Foster City, CA, USA).  
Sequencing data were analyzed with the Staden Package software [232] and the SeqScape 
software v2.5 (Applied Biosystems, Foster City, CA, USA). The sequences obtained were compared 
with the standard MC4R gene sequence (ENSG00000166603). 
 
8. Statistical analysis 
The quantitative variables were expressed as means and standard deviation (SD), whereas 
qualitative variables were expressed as absolute numbers and frequencies. For the rs4988235 
polymorphism (LCT gene), a dominant model was used in all the statistical analyses: children with CT 
or TT genotypes were grouped and compared with CC children. This was performed because 
individuals of European populations carrying the T allele possess sufficient activity in intestinal cells 
and are classified as lactase persistence, whereas individuals carrying the CC genotype are classified 
as lactase non-persistence. 
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All SNP allele, genotype and haplotype frequencies were estimated by direct counting. The 
software package Arlequin, v3.11 [233] (freely available in 
http://cmpg.unibe.ch/software/arlequin3/), was used to: 
- Estimate allele, genotype and haplotype frequencies; 
- Estimate statistical significance levels (p-values) for the Hardy-Weinberg equilibrium and 
population differentiation; 
- Test of non-random association of alleles at different loci, D´and r2 values for linkage 
disequilibrium (LD); 
- Assess haplotype phase by statistical inference via the ELB algorithm; 
 
8.1. Association of quantitative traits 
Normality of the data was examined using the Kolmogorov–Smirnov test. Due to lack of the 
normal distribution, non-parametric tests have been used in the statistical analyses. For each 
obesity-related quantitative parameters (BMI, BMI Z-score, weight, height, and waist circumference), 
the nonparametric Kruskal-Wallis test was used to evaluate differences among the three genotypes 
in all polymorphisms (except for the LCT gene). Regarding the LCT gene the Mann-Whitney test was 
used to compare means of obesity-related traits between genotypes (CT/TT vs. CC).  
All these statistical analyses were performed using the Statistical Package for the Social Sciences 
(SPSS, for windows version 18.0; Chicago, IL, USA), as well as graphical analysis. A p-value below 0.05 
was considered as statistical significant.  
  
8.2. Case-control study 
A case-control study is used to determine if an exposure is associated with an outcome (i.e. 
disease). Is an analytical study, which compares individuals who have a specific disease, “cases”, with 
a group of individuals without the disease, “control”. Frequencies of each of the measured variables 
in each of the two groups were calculated. As a measure of the strength of the association between 
an exposure and the outcome, case-control studies yield an odd ratio (OR). An OR is the ratio of the 
odds of an exposure in the case group to the odds of an exposure in the control group. A 95% 
confidence interval (CI) is also calculated for each OR. A 95% CI that not includes 1.0 could be 
associated between the exposure and the disease at the 0.05 significance level. Logistic regression is 
G e n e r a l  l a b o r a t o r y  m e t h o d s : …  
 
61 
regularly used to analyze relationship between a dichotomous (or binary) dependent variable 
(phenotypes) and metric or dichotomous independent variables (genotypes), as in the case of most 
obesity genetic studies. It focuses instead upon the relative probability (odds) of obtaining a given 
category. 
In our study sample, children were classified into three groups based in their phenotype “obese”, 
“overweight”, and “normal-weight” (as control group). Logistic regression, under an additive genetic 
model (except for the LCT gene), was used to test the risk of being overweight (normal vs. 
overweight subjects) and the risk of being obese (normal vs. obese subjects) calculating OR, 95% CI 
and p-values. The association between polymorphisms and the risk of developing obesity was 
adjusted for age and sex. 
All these statistical analyses were done using the set-based tests implemented on PLINK software 
v1.07 [234] (freely available in http://pngu.mgh.harvard.edu/purcell/plink/). A significant p-value was 
considered below 0.05.  
 
8.3. Power calculation 
The power of a statistical test represents the chance that the study will be successful in 
detecting a true effect and is dependent on a number of factors, including sample size, study design, 
and the specified false-positive rate. In case-control study, performing a power calculation it is 
important because the association with a functional locus can vary due to the random sampling 
process (each replicated sample differs slightly in its estimated odd ratio) [235]. The chance of 
detecting true effects brings two types of inferential error: the type I error (or false-positive) that 
detect a nonexistent effects; and the type II error (or false-negative) that do not detect the true 
effects [236]. In many studies, investigators have adopted by convention the value of 80% power as 
representing a realistic and adequate trade-off. 
To estimate the power calculation for each polymorphisms studied, QUANTO version 1.1 power 
calculator (freely available in http://hydra.usc.edu/gxe/) for genetic association studies was used to 
estimate the power of association as a function of the frequency of the effect allele assuming an 
additive model [237]. 

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter III 
  
 
Assessment of obesity and 
abdominal obesity among 
Portuguese children 
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1. Abstract 
Background: Childhood obesity is a major public health issue in developed countries, and frequently 
proceeds into adulthood. The aim of this study was to estimate the prevalence of obesity and 
abdominal fat distribution in 6-12 years old children from the central region of Portugal, providing 
new data about trends on prevalence, epidemiology and evolution in obesity. 
 
Methods: Weight, height and waist circumference were measured in a random representative 
sample of 1433 children (747 girls and 686 boys) from public schools in 2011. International Obesity 
Task Force (IOTF) cut-offs were used to define overweight and obesity. Abdominal obesity was 
estimated using the sex and age-specific ≥90th waist circumference percentile and waist-to-height 
ratio cut-off. 
 
Results: The prevalence of overweight and obesity among children was 33.0%; 10.7% were obese. 
Overweight was significantly higher in boys than in girls (p=0.044), whereas no gender differences 
was found in obesity (10.6 % in boys and 10.7% in girls, p=0.571). The prevalence of abdominal 
obesity based on waist circumference was similar in girls and boys (3.8% vs. 3.9% respectively; 
p=0.924), but significantly higher in boys than in girls based on waist-to-height ratio (28.1% vs. 19.4%, 
respectively; p=0.009). Comparison with previous studies showed a slightly increase in 
overweight/obesity in children of central Portugal in the last 10 years, reaching values of 40.0% 
prevalence in the 7-9 years old. 
 
Conclusion: In conclusion, this study shows a very high prevalence of overweight/obesity and 
abdominal obesity among Portuguese children, following the trend of other southern European 
countries. Thus, it is of the utmost importance the development of preventive and treatment 
strategies. 
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2. Introduction 
The prevalence of overweight and obesity in childhood, according to the World Health 
Organization (WHO), is a growing problem worldwide, in many European countries as well as in 
developing countries [16, 238]. The health consequences of overweight and obesity during childhood 
are strongly associated with risk factors for cardiovascular diseases, diabetes, orthopedic problems 
and it is an important predictor of adult obesity [239]. In fact, it tends to develop from childhood into 
adult life, resulting in an elevated risk of illness and premature mortality [239]. In Portugal, the 
majority of obesity and overweight prevalence studies were carried in adults, although it is reported 
a tendency for weight increase in children along the last 30 years [240]. 
The definition of obesity during childhood and adolescence is controversial due to the gender 
differences, and the variability in growth rate. The standard measure of adult overweight and obesity 
is Body Mass Index (BMI): weight (kg) / height (m)2. It started being used for measuring children 
obesity after the development of a BMI for age and sex as an international standard for the 
assessment of childhood overweight and obesity [221]. However, this alone could be insufficient as 
an obesity indicator because it is limited to give an approximation of the total adiposity in the body 
[218]. The use of other complementary obesity measures can overcome this problem, as it gives a 
better approximation of overweight and obesity in children. 
Waist circumference (WC) can be defined as an excessive accumulation fat around the organs 
inside the abdominal cavity and it is calculated between the lowest rib and the superior border of the 
iliac crest [219]. It can also be a good indicator of abdominal fat reported in the development of 
cardiovascular risk factors [219]. Recently, waist-to-height ratio (WHtR) emerged as a good predictor 
for abdominal obesity and cardiovascular risk factors [241]. This measure is very simple to use, and it 
can be applied to both genders and ages with a cut-off of WHtR ≥0.50 defining those with excess 
abdominal fatness [241]. 
This study aimed to estimate the prevalence of overweight, obesity and abdominal fat 
distribution among 6-12 years old Portuguese children from the central region of Portugal, providing 
new data based on different obesity measures, from a recent sampling in 2011. 
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3. Material and Methods 
3.1 Study Subjects 
Subjects were selected in 2011 from several public schools in the central region of Portugal. 
Children derived from five grouping of schools; Agrupamento de escolas Dr. Manuel Fernandes 
(Abrantes), Agrupamento de escolas Pêro da Covilhã (Covilhã), Agrupamento de escolas da Pedrulha 
(Coimbra), Agrupamento de escolas Carolina Beatriz Ângelo (Guarda) and Agrupamento de escolas 
das Dairas (Vale de Cambra), and all children from these groups of schools, aged between 6 to 12 
years old, were chosen to integrate this study. From a total of 4028 initially selected children, only 
1468 parents gave their written informed consent. Thirty-five children were excluded from the 
purpose due to had African (n=8), Asian (n=2), or other European origins (n=15). After these 
exclusions, the final sample was composed by 1433 children with Portuguese ancestry, comprising 
747 girls and 686 boys. 
The study protocol was approved by Direção-Geral de Inovação e de Desenvolvimento Curricular, 
the ethical Committee of the Ministério da Educação (available at http://mime.gepe.min-edu.pt/ 
with the identification number process: 0151100001), and was conducted in accordance with the 
institutional guidelines of the University of Coimbra. 
 
3.2 Anthropometric measurements and analyses 
Height (cm) and weight (kg) were measured with participants dressed in lightweight clothing 
and without shoes. Waist circumference (cm) was measured midway between the lowest rib and the 
iliac crest to the nearest 0.1 cm after inhalation and exhalation. Hip circumference (cm) was 
measured at the point over the buttocks yielding the maximum circumference. The BMI was 
calculated as the weight in kilograms divided by the square of height in meters (kg/m2). The 
definition of overweight and obesity were defined using the International Obesity Task Force (IOTF) 
cut-offs [221], derived from the BMI in adults cut-points of 25 kg/m2 and 30 kg/m2 respectively. 
Abdominal obesity was defined using the sex and age-specific ≥90th waist circumference percentile 
[242] and waist-to-height ratio was calculated as the ratio of waist and height using the cut-off value 
of ≥0.5 [218]. Comparisons between groups for all the characteristics were made using the student t-
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test. All statistical analyses were performed using the Statistical Package for the Social Sciences 
(SPSS, for windows version 18.0; Chicago, IL). 
 
4. Results 
The children characteristics are shown in Table 3.1. 
Table 3.1. Characteristics of the sampled Portuguese children. 
Characteristics 
Overall 
(n=1433) 
Boys 
(n=686) 
Girls 
(n=747) 
p-value 
Age (years)  9.3 ± 1.77 9.2 ± 1.77 9.4 ± 1.76 0.952 
Height  (cm)  136.6 ± 11.90 136.3 ± 11.30 136.9 ± 12.43 0.002 
Weight (kg)  34.3 ± 10.00 34.1 ± 9.59 34.6 ± 10.38 0.033 
BMI (kg/m2)  18.1 ± 3.08 18.0 ± 3.04 18.1 ± 3.12 0.370 
BMI Z-score  0.40 ± 1.02 0.45 ± 1.05 0.35 ± 0.99 0.080 
WC (cm)  63.9 ± 7.20 64.7 ± 7.21 63.1 ± 7.11 0.619 
HC (cm)  76.0 ± 9.41 75.4 ± 8.86 76.5 ± 9.84 0.006 
WHR  0.84 ± 0.06 0.86 ± 0.05 0.83 ± 0.06 0.003 
WHtR 0.47 ± 0.05 0.48 ± 0.05 0.46 ± 0.05 0.953 
 
Data are presented as mean ± standard deviation. 
Abbreviations: BMI, body mass index; BMI Z-score, body mass index standard deviation score; WC, waist 
circumference; HC, hip circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio. 
p-value significant (p ≤0.05) in bold. 
 
Significant statistical differences were found between boys and girls regarding height (p=0.002), 
weight (p=0.033), hip circumference (p=0.006) and waist-to-hip ratio (p=0.003). The prevalence of 
overweight and obesity found in the sample ranged 33.0% (36.5% in boys and 29.7% in girls), with 
22.3% children classified as overweighed and 10.7% as obese (Table 3.2). 
 
 
 Table 3.2. Prevalence of overweight, obesity and abdomina
gender according to the International Obesity Task Force (IOTF) cut
  
 
 
Body mass index
 
n 
Overweight 
and obese
Overall 1433 33.0 (473)
Boys  686 36.5 (250)
Girls  747 29.7 (223)
p-value  0.002
 
* According to the International 
Abbreviations: WC, waist circumference; WHtR, waist
p-value significant (p ≤0.05) in bold.
 
Boys presented higher prevalence of overweight than girls (25.9% for boys and 19.0% for girls, 
≤ 0.05), but obesity prevalence was statistically similar between genders. Regarding the prevalence 
of abdominal obesity it was found that 7.8% of the children had a waist circumference 
23.6% had a waist-to-height ratio (WHtR) 
among boys (28.1%) than in girls (19.4%) (
increased with age until the 10 years
ages (Figure 3.1). From the 959 children with a BMI < 25
points), 928 were classified as normal weight (64.8%) and 31 (2.2%) were classified as underweight 
(BMI < 18.5 kg/m2, derived from the BMI in adults cut
 
 
 
 
 
 
Figure 3.1. Prevalence of overweight and obesity among Portuguese children by age and gender.
l obesity among Portuguese children by 
-offs of BMI.
*, % (n)  Abdominal obesity, % (
 
Overweight Obese 
 
WC ≥90th 
 22.3 (320) 10.7 (154)  7.8 (111) 
 25.9 (179) 10.6 (71)  3.9 (52) 
 19.0 (141) 10.7 (82)  3.8 (59) 
 0.044 0.571  0.924 
Obesity Task Force (IOTF) cut-offs of BMI. 
-to-height ratio. 
 
≥ 0.50 (Table 3.2). The WHtR was significantly higher 
p=0.009). The prevalence of overweight and obesity 
-old in boys, while in girls no trend was detected across different 
 kg/m2 (derived from the BMI in adults cut
-points). 
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n) 
WHtR ≥0.50 
23.6 (338) 
28.1 (193) 
19.4 (145) 
0.009 
p 
≥ 90th, and 
-
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5. Discussion 
We found that overweight and obesity are common among Portuguese children. Comparing our 
data with a study of 2004 (data collected from October 2002 to June 2003) [240], we observe a 
slightly higher prevalence (1.5%) in overweight and obesity, but a decrease in children classified as 
obese (10.7% in this study and 11.3% in the 2004 study). However, if we consider only the children 
with 7-9 years old (like in the 2004 study) the prevalence of overweight and obesity increased during 
the last 10 years (overweight and obesity was estimated 40.7%, and 12.6% were classified as obese), 
which represents an increase of 10% in overweight and obesity comparing to 2004 study. These 
values revealed a high prevalence of overweight and obesity in this Portuguese region, mainly in the 
7-9 years old age category, being these values similar to those reported for Spain, Greece and Italy 
[243, 244]. This data indicates that, in Europe, 31.8% of children are estimated to be overweight and 
of these 7-9% are obese [244]. Our recent data (collected in 2011) reveals an increase in prevalence 
for overweight and obesity in central region of Portugal during this last 10 years [245], with values 
particularly dramatic for 7-9 years old children, as observed in Greek children [243]. This study 
provides further evidence that there were strong increases in BMI among Portuguese children 
between 2002/2003 and 2011. 
The changes in the social and economic structures in Portugal in the last three decades led to a 
global improvement of the living conditions [240]. These changes also had some negative effects 
leading to higher percentages of sedentary lifestyle for adults [240]. Several studies shown that the 
prevalence of obesity is common in families with low socio-economic status [246, 247]. Different 
studies have proved that healthier diets are more expensive than low quality diets, and could affect 
the acquisition of healthy foods both for parents and schools with lower budgets [246]. 
The prevalence of overweight and obesity was particularly high in boys (36.5%) when compared 
to girls (29.7%) (p=0.002). These differences remain significant when comparing the prevalence of 
overweight (p=0.044). However the same cannot be said about obesity, where prevalence values are 
similar in both genders (p=0.571). This trend is also observed across different age children, with a 
higher prevalence of overweight and obesity in boys comparing with girls. This prevalence is reverse 
when compared to the 2004 study [240], where prevalence of overweight and obesity was higher in 
girls. This fact could be due to the lack of physical activities in detriment of spending more time 
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playing electronic games/computer, which is more typical in boys than in girls. It was previously 
shown a relation between Portuguese children who spend more time playing electronic 
games/computer with higher values of BMI [248]. It is possible that Portuguese children especially 
boys display also a highly sedentary behavior, contributing to their increase in overweight/obesity. If 
we compare this results to other southern European countries, Portugal follows the trend found in 
Spain and Greece [249, 250] and the frequency of obesity in the last decade has increased more in 
boys than in girls [250]. A trend study from 1997-2007 in 8-9 years old Greek children, showed an 
increase of overweight and obesity in boys (26.5% and 12.2%, respectively), and in girls (26.7% and 
11.2%, respectively) [243]. In that study, the prevalence obtained in 2007 for overweight/obesity was 
estimated in 38.3%, and from these 11.7% were obese [243]. In our study, the prevalence of obesity 
is similar in boys and in girls, but overweight is higher in boys than in girls. We also analyzed 
abdominal obesity in the children, as it could be a better predictor for cardiovascular disease risk in 
children than BMI [219], and also important in weigh management [251]. Furthermore according to 
our data, BMI seems a better tool than WC for discriminating obesity prevalence. We also looked to 
WHtR as it might be a useful index to identify metabolic risk in overweight children [252]. This index 
showed a similar trend to BMI in both gender, and these could indicate that WHtR is a good tool for 
discriminating the prevalence of abdominal obesity, and also a possible measure of total obesity 
prevalence. All these measures are useful in measuring overweight and obesity prevalence, but they 
all have limitations and the use of all depicts a more accurate picture of the prevalence in a sample. 
Traditionally, BMI has been used to predict body composition whereas WC is a measure of adipose 
tissue, but both are important in prediction of health risks in children [219, 241]. Recently, WHtR also 
emerged has a good tool for evaluating obesity prevalence and health risk in children [252]. Our data 
are in agreement with this, as we detected a higher prevalence (above ≥ 0.50) in boys and girls using 
this index, than using BMI or WC. The higher value for WHtR than for WC could be due to the fact 
that WHtR takes into account differences in body height. Curiously, the trend of adults in European 
countries such as Spain shows that abdominal obesity is more frequent in women than in men [253]. 
We found that abdominal obesity in Portuguese children has a similar frequency in boys and girls 
using waist circumference percentile, but it is more frequent in boys than in girls using waist-to-heigh 
ratio cut-off. Nevertheless, data on secular trends in WC and WHtR are scarce in Portuguese children, 
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thus it is impossible to compare these results with previous studies. Future studies concerning 
overweight and obesity trends in children should also consider WC and WHtR as screening tools.  
Children obesity and overweight is a major public health issue, not only in developed but also in 
emerging countries. Our data in central Portugal showed a prevalence of childhood overweight and 
obesity similar to other southern European countries. However, our data also shown an increase in 
overweight and obesity prevalence in the last decade in the Portuguese children, indicating that the 
rate of prevalence could be increasing. It seems important to reverse this scenario, making 
prevention since childhood, and by that helping to reduce the higher incidence of cardiovascular 
diseases, that are the major cause of death in Portugal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter IV 
  
 
Association of FTO polymorphisms 
with obesity and obesity-related 
outcomes in Portuguese children 
  
 This chapter was mainly based on the following 
original paper: Albuquerque D, Nóbrega C, Manco L. 
Association of FTO polymorphisms with obesity-
related outcomes in Portuguese children. PLoS one 
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1. Abstract 
Background: Several studies have reported an association between single nucleotide polymorphisms 
in the first intron of the FTO gene and body mass index (BMI) or obesity. However, this association 
has not yet been studied among the Portuguese population. This study aims to assess the association 
of three FTO polymorphisms (rs1861868, rs1421085 and rs9939609) with obesity-related outcomes 
in a sample of Portuguese children. 
 
Methods: We examined a total of 730 children, 256 normal-weight, 320 overweight and 154 obese, 
aging from 6 to 12-years-old, recruited randomly from public schools in the central region of 
Portugal. DNA samples were genotyped for the three polymorphisms by allelic discrimination 
TaqMan® assay. Association of the FTO polymorphisms with several anthropometric traits was 
investigated. Additionally, we tested association with the risk of obesity using overweight and obese 
vs. normal-weight children group. 
 
Results: We found significant associations of rs9939609 and rs1421085 polymorphisms with weight, 
BMI, BMI Z-score, and waist circumference (p<0.05 in all traits). For rs1861868 polymorphism, 
significant associations were obtained with weight (p=0.004), BMI (p=0.011), and waist 
circumference (p=0.024). In case-control studies, both rs9939609 and rs1421085 polymorphisms 
were significantly associated with obesity (OR=1.41; 95% CI, 1.05-1.89; p=0.023; OR=1.45; 95% CI, 
1.08-1.95; p=0.012, respectively) but not with overweight (p>0.05). Haplotype analyses (rs1861868-
rs1421085-rs9939609) identified two combinations (ACA and GCA) associated with a higher risk of 
obesity (OR=1.53; 95% CI, 1.06-2.22; p=0.023; OR=1.73; 95% CI, 1.06-2.87; p=0.030, respectively). 
 
Conclusions: This study provides the first evidence for the association of FTO polymorphisms with 
anthropometric traits and risk of obesity in Portuguese children. 
 
 
 
 
 
C h a p t e r  I V  
 
76 
2. Introduction 
Overweight and obesity are a major health issue associated with risk factors for the 
development of hypertension, type 2 diabetes and cardiovascular diseases [254]. This complex 
phenotype results from the interaction of environmental and multiple genetic factors influencing 
body mass index (BMI), with heritability estimated at 40-70% [255]. 
The advent of Genome Wide Association Studies (GWAS) emerged as a powerful approach to 
identify genetic variants associated with common diseases [256]. Until now, GWAS deliver the 
identification of at least 52 genetic loci robustly associated with obesity [63]. In 2007, a strong 
association was detected between common single nucleotide polymorphisms in the first intron of the 
fat mass and obesity-associated gene (FTO), on the chromosome 16q12.2, and risk of obesity [65, 
67]. Of those polymorphisms, the rs9939609 is one of the most extensively studied, explaining about 
1% of BMI heritability [65]. Each rs9939609-A allele in this gene increases body weight by 1.5 kg in 
adult, with similar effects observed in children and adolescents [65]. Subsequently, several other 
studies have consistently confirmed the association of a cluster of polymorphisms within the first 
intron of the FTO gene with obesity-related traits in several European [65–68, 76, 192], Asian [69–72, 
257] and African [73, 74] populations. 
Knowledge of the genetic risk factors associated with common childhood obesity, can be helpful 
to design prevention strategies. Although in the Portuguese population several studies were made 
concerning the prevalence of overweight and obesity [240, 258], until now, no studies reporting the 
association of genetic variants with the risk of common obesity have been generated. Thus, the aim 
of this study was to evaluate the association between three FTO polymorphisms, including rs9939609 
and rs1421085, prominent in the literature, and rs1861868, yet poorly studied, with the susceptibility 
to obesity in a sample of Portuguese children. 
 
 
3. Material and Methods 
 
3.1. Study subjects 
Children aging 6 to 12 years old were randomly selected from several public schools in the 
central region of Portugal. A total of 1433 Portuguese children of European descent comprising 747 
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girls and 686 boys were recruited [258], and were classified using age and sex specific BMI cut-offs 
provided by the International Obesity Task Force (IOTF) [221]. From the 1433 analyzed children, 
three BMI groups were formed: 320 subjects were classified as overweight (resulting from the BMI in 
adult’s cut-points between ≥25 kg/m2 and <30 kg/m2), 154 as obese (BMI ≥30 kg/m2), 928 as normal 
weight (18.5 ≥ BMI <25 kg/m2), [31 children were classified as underweight (BMI <18.5 kg/m2) and 
excluded of this study]. 
 
The study protocol was approved by Direção-Geral de Inovação e de Desenvolvimento Curricular, 
the ethical Committee of the Portuguese Ministry of Education (available at http://mime.gepe.min-
edu.pt/ with the identification number process: 0151100001), and was conducted in accordance with 
the institutional guidelines of the University of Coimbra. Written informed consent was previously 
obtained from the children´s parents. 
 
3.2. Anthropometric Measurements 
Height (cm) and weight (kg) were taken with participants dressed in lightweight clothing without 
shoes. Waist circumference (cm) was measured midway between the lowest rib and the iliac crest, to 
the nearest 0.1 cm after inhalation and exhalation. Hip circumference (cm) was measured at the 
point over the buttocks yielding the maximum circumference. The BMI was calculated with the 
weight in kilograms divided by the square of height in meters (kg/m2). Abdominal obesity was 
defined using the sex and age-specific ≥90th waist circumference percentile [259] 
 
3.3. Selected and genotyping of the FTO polymorphisms 
Samples were analyzed for three polymorphisms located within first intron of the FTO gene: two 
that have been closely associated with obesity and prominent in the literature, rs9939609 (position: 
chr16:53820527), described by Frayling et al. [65], and rs1421085 (position: chr16:53800954), 
reported in the work of Dina et al. [76], and the yet poorly studied rs1861868 polymorphism 
(position: chr16:53790402), described in two studies [66, 192]. 
A buccal swab sample was collected from each child for genetic studies. The genomic DNA was 
extracted from buccal cells using the PureLink Pro 96 Genomic DNA Kit (Invitrogen Corporation, 
C h a p t e r  I V  
 
78 
Carlsbad, CA, USA), according to the instructions of the manufacturer, and was only used for the 
polymorphisms genotyping. 
Samples were genotyped for the three FTO polymorphisms by allelic discrimination assays using 
TaqMan® probes (C_30090620_10, C_11717119_10 and C_8917103_10; Applied Biosystems, Foster 
City, CA, USA). The PCR amplification was carried out in 25 µl of a total reaction volume containing 2 
µl (~20 ng) of DNA, 0.5 µl TaqMan® probes (Applied Biosystems, Foster City, CA, USA) in 1x of 
SsoFast™ Probes Supermix™ (Bio-Rad, Hercules, CA, USA). The PCR conditions were an initial 
denature step for 10 minutes at 95°C, followed by 40 cycles consisting of 1minute at 60°C and 15 
seconds at 95°C. Fluorescence was visualized through a MiniOpticon real time PCR system (Bio-Rad, 
Hercules, CA, USA). 
To identify the allele associated with the FAM probes, the automatic sequencing by Sanger’s 
method was used. After the PCR product amplification, using oligonucleotides 5´-
CATCAGTTATGCATTTAGAATGTCTG-3´ (forward) and 5´-TCCCACTCCATTTCTGACTGT-3´ (reverse) for 
rs9939609, 5´-AATCTCATTGTTCCTCCTGCT-3´(forward) 5´-ACAGTGGAGGTCAGCACAGA-3´(reverse) for 
rs1421085, and 5´-CGCATCTCTGCAACTCTTTT-3´ (forward) and 5´-TGCTTTGTTAAGGCCATAGG-3´ 
(reverse) for rs1861868, PCR fragments were purified with the enzyme ExoSAP-IT (GE Healthcare, 
New Jersey, USA) and subsequently subjected to Sanger´s dideoxy chain termination sequencing 
reaction using BigDye® Terminator v1.1 Cycle Sequencing kit (Applied Biosystems, Foster City, CA, 
USA), according to protocols recommended by the manufacturer and analyzed in an ABI 310 
automatic sequencer (Applied Biosystems, Foster City, CA, USA). Base calling was performed with 
Sequencing Analysis software v5.2 (Applied Biosystems, Foster City, CA, USA). 
To assess genotyping reproducibility a selection of 10% random samples was re-genotyped for all 
SNPs with 100% concordance by the Single Strand Conformation Polymorphism (SSCP) method, using 
oligonucleotides previously described (see conditions in chapter II). 
 
3.4. Statistical analysis 
The allele and haplotype frequencies were estimated by direct gene counting. The software 
package Arlequin, v3.5. (http://cmpg.unibe.ch/software/arlequin35/) [233], was used to calculate 
allele frequencies, Hardy-Weinberg equilibrium probability values and D’ and r2 values for linkage 
disequilibrium (LD). Haplotype phase was determined by statistical inference via the ELB algorithm 
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implemented in Arlequin, v3.5. The quantitative variables were expressed as means and standard 
deviation, and qualitative variables were presented as absolute numbers and frequencies. Normality 
of data was assessed using the Kolmogorov-Smirnov test. For each obesity-related quantitative 
parameters (BMI, BMI Z-score, weight and waist circumference), the nonparametric Kruskal-Wallis 
test was used to evaluate differences among the three genotypes in all polymorphisms. These 
statistical analyses were performed using the SPSS software (Statistical Package for the Social 
Sciences for Windows, version 18.0, SPSS inc., Chicago, IL, USA). Logistic regression under an additive 
genetic model, allowing for analysis of a binary outcome (a case–control status), was used to test 
obesity and overweight phenotype polymorphism associations, adjusted for age and sex, by 
calculating odds ratios (OR) with 95% of confidence intervals (CI) and p-values. This statistical analysis 
was done by using the set-based tests implemented on PLINK software v.1.07. 
(http://pngu.mgh.harvard.edu/purcell/plink/) [234]. Statistical significance was taken at p-values 
<0.05 for all comparisons. QUANTO, v1.1. power calculator (http://biostats.usc.edu/software) was 
used to estimate the power of association as a function of the frequency of the effect allele assuming 
an additive model [237]. 
 
4. Results  
The analyzed children were divided into three groups according to the definition of BMI 
specified by IOTF cut-offs [221]. From a total of 1433 children measured for anthropometric traits, 
genotyping was performed in a total of 730 children comprising 320 subjects classified as overweight 
(≥25 kg/m2 BMI <30 kg/m2), 154 classified as obese (BMI ≥30 kg/m2) and a control group of 256 
subjects randomly selected from the total normal weight children (n=928, 18.5≤ BMI <25 kg/m2). A 
descriptive study of the total genotyped sample, stratified by phenotype distribution, is shown in 
Table 4.1. 
 
 
 
 
 
C h a p t e r  I V  
 
80 
Table 4.1. General characteristic of the sampled children by phenotype distribution. 
Characteristics Overall 
Phenotype distribution* 
Normal Overweight Obese 
N 730 256  320 154 
Girls (%) 50.7 55.9 45.3 53.2 
Age (years) 9.1 ± 1.7 8.6 ± 1.6 9.5 ± 1.6 9.0 ± 1.7 
Height (cm) 136.2 ± 11.7 131.1 ± 11.1 139.5 ± 11.1 137.9 ± 10.6 
Weight (kg) 37.2 ± 11.3 28.1 ± 6.6 40.2 ± 9.3 46.1 ± 11.0 
BMI (kg/m2) 19.6 ± 3.4 16.1 ± 1.5 20.3 ± 1.8 23.8 ± 2.5 
BMI Z-score 0.93 ± 0.97 -0.15 ± 0.78 1.3 ± 0.23 1.99 ± 0.23 
Waist circumference (cm) 67.2 ± 7.8 60.3 ± 4.5 68.9 ± 5.4 75.1 ± 6.6 
Hip circumference (cm) 79.0 ± 10.3 70.4 ± 6.5 81.9 ± 8.0 87.1 ± 9.4 
WHR 0.85 ± 0.06 0.86 ± 0.06 0.85 ± 0.06 0.87 ± 0.05 
 
Data are presented as mean ± standard deviation. 
*Phenotype distribution was determined using age and gender specific BMI cut-offs provided by the 
International Obesity Task Force (IOTF). 
Abbreviations: BMI, body mass index; BMI Z-score, body mass index standard deviation score; WHR, waist-to-
hip ratio. 
 
The genotyping success rate of the three selected polymorphisms varied between 93.3% and 
99.6%. Genotype frequencies for the total sampled population were in accordance with Hardy-
Weinberg equilibrium (p=1.000 for rs9939609, p=0.598 for rs1421085, and p=0.937 for rs1861868). 
The minor allele frequency observed for the three polymorphisms in the total sample was 44.8% for 
the rs9939609-A allele, 45.4% for the rs1421085-C allele, and 46.1% for the rs1861868-G allele. The 
estimated power of association observed was above 95% for the rs9939609 and rs1421085 
polymorphisms and, 56% for the rs1861868 polymorphism. 
We analyzed anthropometric traits among different genotypes of FTO polymorphisms and found 
statistical significant differences in the mean score for rs9939609 and rs1421085 polymorphisms for 
increasing weight, BMI, BMI Z-score, and waist circumference (WC) (p≤0.05 for all traits) (Table 4.2). 
The strongest associations were found with weight (p=0.002) and waist circumference (p=0.003) 
(Table 4.2). The rs9939609 per-A allele increases was ~0.6 kg/m2 in BMI, ~1.2 cm in waist 
circumference and ~1.7 kg in weight; similar values were obtained for each rs1421085-C allele: 0.55 
kg/m2, 1.25 cm and 1.55 kg, for BMI, waist circumference and weight, respectively. The rs1861868 
polymorphism also showed associations with weight, BMI, and waist circumference (Table 4.2). 
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Table 4.2. Minor allele frequencies and Hardy-Weinberg equilibrium test of the 3 studied FTO polymorphisms in the sampled Portuguese children and their 
associations with obesity-related quantitative traits. 
 
Polymorphism Chr. Gene Alleles* n MAF HWE 
No. 
11/12/22 
Genotype (mean ± SD) 
 
p-value 
11 12 22 
 
rs9939609 16q12.2 FTO T:A 721 0.45 1.000 220/357/144      
BMI (kg/m2)        19.0 ± 3.4  19.7 ± 3.4  20.2 ± 3.5   0.005 
BMI Z-score        0.78 ± 1.1  0.97 ± 0.9  1.1 ± 0.9   0.011 
Weight (kg)        35.5 ± 11.7  37.7 ± 11.1  38.9 ± 10.9   0.003 
Waist C (cm)        65.9 ± 7.9  67.7 ± 7.6  68.4 ± 7.6   0.002 
rs1421085 16q12.2 FTO T:C 727 0.45 0.598 213/368/146      
BMI (kg/m2)        19.1 ± 3.5 19.6 ± 3.4  20.2 ± 3.5  0.013 
BMI Z-score        0.76 ± 1.0  0.95 ± 0.9  1.1 ± 0.9   0.012 
Weight (kg)        35.6 ± 11.7  37.4 ± 11.2  38.7 ± 10.9   0.012 
Waist C (cm)        65.9 ± 7.8 67.5 ± 7.6  68.5 ± 7.8  0.006 
rs1861868 16q12.2 FTO A:G 668 0.47 0.937 195/342/144      
BMI (kg/m2)        18.8 ± 3.2 19.6 ± 3.5 20.0 ± 3.5  0.011 
BMI Z-score        0.75 ± 1.0 0.95 ± 0.9 1.0 ± 0.8  0.162 
Weight (kg)        34.5 ± 10.3 37.4 ± 11.6 38.6 ± 11.3  0.004 
Waist C (cm)        65.6 ± 7.5 67.4 ± 7.8 68.1 ± 7.6  0.024 
 
Abbreviations: Chr., chromosome; n, number of genotyped children; MAF, minor allele frequency; HWE, Hardy-Weinberg equilibrium; BMI, body mass  
Index; BMI Z-score, body mass index standard deviation; SD, standard deviation; Waist C, waist circumference. 
* Alleles: Major (1): Minor (2). 
p-values were obtained using the Kruskal-Wallis test.  
p-value significant (p<0.05) are in bold and italic. 
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We performed nominal association analysis under the additive model using BMI case-control 
groups (Table 4.3). When compared obese vs. normal-weight groups the rs9939609 minor A-allele 
showed significant association with risk of obesity (OR=1.41; 95% CI, 1.05-1.89; p=0.023). 
Accordingly, 23.4% of the obese individuals were AA homozygotes compared to 16.2% of the control 
subjects. Significant association was also observed with increased risk of being obese for the 
rs1421085 minor C-allele (OR=1.45; 95% CI, 1.08-1.95; p=0.012). For this polymorphism, 26.6% of the 
obese individuals had the CC genotype, against 17.7% with normal weight. For the rs1861868 
polymorphism, it was not found a significant association with obesity (OR=0.85; 95% CI, 0.63-1.15; 
p=0.318) (Table 4.3). Association analysis under an allelic model, comparing obese vs. normal-weight 
groups, showed similar significant results for the rs9939609 A-allele (OR=1.44; 95% CI, 1.08-1.91; 
p=0.012) and rs1421085 C-allele (OR=1.48; 95% CI, 1.12-1.98; p=0.007), but not for rs1861868 
(OR=1.20; 95% CI, 0.89-1.61; p=0.228). We detected no significant association when comparing 
overweight vs. normal-weight groups (p≥0.05) (Table 4.3). 
We further investigated the difference in the genotype distribution between cases and controls 
for abdominal obesity by logistic regression analysis. In the total of 730 children, 111 revealed 
abdominal obesity (using sex and age-specific ≥90th waist circumference percentile). From the three 
polymorphisms studied, none of them showed association with increased abdominal obesity. 
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Table 4.3. Allele frequencies of the 3 studied FTO polymorphisms in the Portuguese children, and their associations with risk of obesity among phenotypic 
groups. 
 
SNP ID/ 
Gene 
Allele 
  Obese vs. normal 
 
Overweight vs. normal 
Normal*  Obese* OR CI 95% p-value 
 
Overweight* OR CI 95% p-value 
rs9939609 
FTO T>A 
T 0.591  0.503 
1.41 (1.05-1.89) 0.023 
 0.546 
1.15 (0.89-1.47) 0.274 
A 0.409  0.497  0.454 
           
rs1421085 
FTO T>C 
T 0.572  0.474 
1.455 (1.08-1.95) 0.012 
 0.560 
1.00 (0.78-1.29) 0.944 
C 0.428  0.526  0.440 
           
rs1861868 
FTO A>G 
A 0.504  0.552 
0.859 (0.63-1.15) 0.318 
 0.557 
0.886 (0.68-1.14) 0.350 
G 0.496  0.448  0.443 
          
 
Abbreviations: SNP ID; single nucleotide polymorphism identification; OR, odds ratio; CI, confidence interval; vs., versus. 
*Phenotypic groups was determined using age and sex specific BMI cut-offs provided by the International Obesity Task Force (IOTF). 
Logistic regression was used to compare genotype distribution. p-values (asymptotic p-value for t-statistic) shown are for an additive model and are adjusted for age and 
sex. OR is shown for the minor allele.  
p-value significant (p<0.05) are in bold and italic.  
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Haplotype analysis associating the three studied FTO polymorphisms (rs1861868-rs1421085-
rs9939609), revealed all the eight possible haplotypes, being the most commons GTT (33%), ACA 
(32%), ATT (19%) and GCA (12%) (Table 4.4). Three haplotypes had an estimated frequency below 1% 
(GCT, ATA and GTA). Compared with the most common and non-risk haplotype (GTT), two 
haplotypes (ACA and GCA) were significantly associated with a higher risk of being obese (OR=1.534; 
95% CI, 1.06-2.22; p=0.023; OR=1.739; 95% CI, 1.06-2.87; p=0.030, respectively). 
Regarding allelic combinations, polymorphisms rs9939609 (position: chr16:53820527) and 
rs1421085 (position: chr16:53800954), distant from one another about 19.6 kb, were found in high 
LD (D’= 0.91; r2=0.82). The rs1861868 polymorphism (position: chr16:53790402) was found in low LD 
(D’= 0.39; r2=0.11) with rs9939609, distant about 30.1 kb, as well with rs1421085 (D’= 0.44; r2=0.13), 
distant about 10.6 kb. 
 
 
Table 4.4. Haplotype frequencies associating FTO rs1861868-rs1421085-rs9939609 polymorphisms in 
the sampled Portuguese children. 
 
 
 
 
 
 
 
 
Rare: haplotypes with a frequency under 1% (GCT, ATA and GTA).  
Abbreviations: OR, odd ratio; CI, confidence interval.  
p-value significant (p<0.05) in bold and italic form. 
 
 
 
 
 
Haplotype Frequency OR 95% CI p-value 
GTT 0.33 Reference   
ATT 0.19 1.133 0.73-1.75 0.572 
ACA 0.32 1.534 1.06-2.22 0.023 
GCA 0.12 1.739 1.06-2.87 0.030 
ACT 0.02 2.000 0.68-5.89 0.209 
Rare 0.02 1.200 0.42-3.42 0.733 
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5. Discussion 
 
Recently, the growth in studies regarding the association of obesity, or obesity-related traits, 
with SNPs in the FTO gene has been reported for several populations across the world [65–74, 76, 
192, 257]. Most studies confirmed that FTO polymorphisms are strongly associated with BMI and/or 
obesity [65–74, 76, 192, 257]. However, in Portugal there are no studies to confirm the association 
between genetic variants and common obesity, which could permit the comparison with data from 
other European populations. Despite the similar genetic background between European populations, 
it is known that for several polymorphisms, frequencies can vary within different Caucasian 
populations [168, 260]. Moreover, a few studies failed to associate some FTO polymorphisms and 
obesity [261, 262], highlighting the need of more studies in different populations to better 
understand the role of FTO gene in obesity. The present study is the first to test whether common 
FTO gene polymorphisms are associated with obesity or to related anthropometric traits in children 
of Portuguese origin. 
Our research showed a significant genetic association of rs9939609 and rs1421085 
polymorphisms, in strong linkage disequilibrium (r2=0.82), with the risk of obesity in Portuguese 
children. Consistently, we also observed significant association with several anthropometric 
measurements including weight, BMI, waist circumference and hip circumference. These results are 
similar to those found in previous studies performed in other European populations reporting the 
association of FTO polymorphisms with obesity [65, 67, 76, 263]. In our study, the effect obtained for 
each copy of rs9939609-A allele was ~0.6 kg/m2 in BMI, ~1.2 cm in waist circumference and ~1.7 kg 
in weight, similar to the effect stated by Frayling et al. [65]. 
Regarding rs1861868 polymorphism, association with BMI was first described in a sample of Old 
Order Amish with low physical activity [192] and replicated in a sample of Spanish children [66]. 
However, in this last study, it was not found a significant association with BMI or obesity. Our study 
showed an association with weight, BMI, waist circumference and hip circumference.  
Our results show that in Portuguese children the rs9939609 and rs1421085 polymorphisms are 
in association with obesity, with no differences between girls and boys, and in line with previously 
reported studies in other European populations [65–68, 76, 192]. We found an odd ratio of 1.41 for 
the rs9939609 polymorphism under the additive model. This result appears similar to the effects 
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reported by Frayling et al. [65] in UK children (OR=1.35; 95% CI, 1.14-1.61), and Hinney et al. [264] in 
German children/adolescents (OR=1.57; 95% CI, 1.30-1.90). We also found an odd ratio of 1.45 for 
the rs1421085 polymorphism similar to that reported by Dina et al. [76] in French children (OR=1.43; 
95% CI, 1.25-1.64), and Meyre et al. [265] in German children (OR=1.50; 95% CI, 1.25-1.79). The 
rs9939609 polymorphism was the most replicated polymorphism associated with obesity across the 
world, nevertheless, in our study the strongest association was obtained with the rs1421085 
polymorphism (OR=1.45; 95% CI, 1.08-1.95; p=0.012, additive model), similar to the result obtained 
by Price et al. [266] in a sample of Caucasian women when analyzing both polymorphisms. 
None of the three study polymorphisms showed evidence of association with overweight in the 
sample. This means that the FTO risk allele predominates in individuals with higher BMI; hence the 
association was detected in severe obesity rather than in overweight population, similarly to the 
results obtained by Liu et al. [257]. 
The FTO risk allele frequencies observed in our study are within range of reported values in 
European populations [65–68, 76, 192]. Both rs9939609 and rs1421085 polymorphisms were found 
in high LD (r2=0.82) in our study reflecting the high LD across the 19.6 kb region within the intron 1 of 
FTO gene. Polymorphisms rs9939609 and rs1421085 are both part of a set of BMI-associated 
polymorphisms within a 47 kb LD block encompassing parts of the first two introns as well as exon 2 
of the FTO gene [80] suggesting that they all tag a same genetic signal in that region. The low LD 
(r2=0.13) observed in our study between rs1861868 5’ apart 10.6 kb from rs1421085, complement 
the lower genetic predictive power of rs1861868 for the studied obesity related parameters, 
suggesting that LD block decline between these two polymorphisms. As we show (Table 4.4) the only 
two common haplotypes that seem to confer risk to obesity were ACA (p=0.023) and GCA (p=0.030), 
which include both risk alleles A and C for rs9939609 and rs1421085, respectively. For the haplotype 
ACT, presenting only one risk allele, no association (p=0.209) with obesity was found. This seems to 
reflect that haplotypes combining the risk alleles for the two SNPs rs9939609 and rs1421085 have 
increased risk of obesity. 
In 1962, Neel proposed the thrifty gene hypothesis [163] suggesting that populations whose 
ancestral environments were characterized by periods of feast and famine, experienced positive 
selection for thrifty alleles that promote the storage of fat and energy. Thus, under modern 
conditions, populations with such thrifty alleles are expected to have high rates of obesity. Regarding 
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the ancestral alleles for polymorphisms rs9939609 and rs1421085 comparing sequence similarity 
with non-human primates, the ancestral rs9939609-A allele is associated with the obesity risk but not 
the ancestral rs1421085-T allele. This different genetic association pattern is not consistent with the 
thrifty gene hypothesis, as also suggested in a previous report [118], because under this hypothesis 
we should expect a similar pattern regarding ancestry of the risk alleles. 
This is the first study reporting allele and genotype frequencies of the FTO polymorphisms in the 
Portuguese population. We found evidence that the previously reported common polymorphisms 
rs9939609 and rs1421085 in FTO gene increase the risk of obesity in the Portuguese children. Further 
studies on other polymorphisms from FTO and other genes are needed, to establish the genetic basis 
contributing to the risk of obesity in the Portuguese population.  
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The lactase persistence -13910C>T 
polymorphism shows indication of 
association with abdominal obesity 
among Portuguese children 
  
 This chapter was mainly based on the following 
original paper: Albuquerque D, Nóbrega C, Manco L. 
The lactase persistence -13910C>T polymorphism 
shows indication of association with abdominal 
obesity among Portuguese children. Acta Paediatr 
2013, 102(4): e153-157. 
 
  
 
 
C h a p t e r  V  
 
91 
1. Abstract 
Aim: The -13910C>T (rs4988235) single nucleotide polymorphism located upstream of the lactase 
gene (LCT) was found tightly associated with lactase persistence in European populations. Recently, it 
was also associated with body mass index (BMI) and obesity in European adults. The aim of this study 
was to test the association of -13910C>T polymorphism, with obesity-related traits and risk of obesity 
in children.  
 
Methods: We genotyped 580 Portuguese children (6-12 years-old) for the -13910C>T polymorphism 
using Dual-labeled probes by real-time PCR. Anthropometric measurements were assessed in all 
children. Obesity was defined according to the IOTF cut-offs and abdominal obesity using the sex and 
age-specific ≥90th waist circumference percentile.  
 
Results: We found indication for association between the -13910*T allele and children abdominal 
obesity (OR=1.41; 95% CI: 1.03-1.94; p=0.030). Under the dominant model, the indicative association 
was observed between the LCT -13910 CT/TT genotypes and abdominal obesity, remaining significant 
after adjustment for age and gender (OR=1.65; 95% CI: 1.04-2.60; p=0.029). No association was 
detected with the risk of obesity (p=0.350). 
 
Conclusion: Our results suggest that the -13910C>T polymorphism may predispose to abdominal 
obesity in Portuguese children. The association with BMI or obesity risk, previously observed in 
adults, was not confirmed. 
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2. Introduction 
 
The lactase gene (LCT; MIM 603202, chromosome 2q21) was recently reported as a new 
candidate related with BMI and obesity in adults of European origin. Three independent studies 
reported a strong association of the -13910C>T (rs4988235) single nucleotide polymorphism, located 
~14kb upstream from the LCT coding region, with BMI and obesity: the -13910*T allele carriers (CT 
and TT genotypes) had higher weight, BMI and risk of obesity [102–104]. 
All newborns display an adequate expression of the lactase enzyme that decline significantly in 
quantity following weaning, and this condition is apparently the major reason for avoiding milk in 
diet [267]. However, substantial numbers of individuals maintain the ability to digest milk and other 
dairy products into adulthood. This lactase persistence (LP) phenotype is an autosomal dominant 
condition that reaches its highest values in north-western Europe (80-90%), declining to the south 
and east (~50%) [268, 269]. The lactase non-persistence (LNP) is considered the ancestral condition 
in humans and these individuals are unable to digest significant amounts of lactose, suffering from 
adverse unspecific abdominal symptoms, including bloating, abdominal pain and diarrhea, after 
ingestion of milk [270]. In European populations the -13910C>T polymorphism was found tightly 
associated with the persistence of the lactase enzyme in adulthood: TT or TC individuals possess 
sufficient enzyme activity in intestinal cells to be classified as LP, and individuals carrying the CC 
genotype are classified as LNP [169]. The prevalence of the -13910*T allele vary across Europe, 
reaching 70-80% in Northern European populations, and 5-10% in Southern European populations 
from Greece and Italy [271]. In Northern Portugal the -13910*T allele frequency was estimated 
37.0% [272]. 
Until now, the genetic background of LCT -13910C>T polymorphism in obesity has not yet been 
examined among children of European descent. Thus, the aim of this study was to test the 
association between LCT -13910C>T polymorphism and obesity or obesity-related traits in a sample 
of Portuguese children. 
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 3. Material and Methods 
 
3.1. Subjects and measures 
The study comprised 580 children with Portuguese ancestry (6-12 years old) randomly selected 
from several public schools in a Northern-Central region of Portugal located between Mondego and 
Douro rivers. Samples were collected from three geographic areas: municipalities of Coimbra 
(n=266), Vale de Cambra (n=147) and Guarda/Covilhã (n=167). 
Anthropometric measurements were assessed in all children. Children were distributed in three 
groups: 140 with obesity, 233 with overweight and 207 with normal weight. The definition of 
overweight and obesity was obtained using the International Obesity Task Force (IOTF) cut-offs [221], 
resulting from the BMI in adult’s cut-points of 25 kg/m2 and 30 kg/m2, respectively. Abdominal 
obesity was defined using the sex and age-specific ≥90th waist circumference percentile [259]. 
The study protocol was approved by Direção-Geral de Inovação e de Desenvolvimento Curricular, 
the ethical Committee of the Portuguese Ministry of Education (available at http://mime.gepe.min-
edu.pt/ with the identification number process: 0151100001), and was conducted in accordance with 
the institutional guidelines of the University of Coimbra. Written informed consent was previously 
obtained from all the children´s parents.  
 
3.2. Genotyping 
Genomic DNA was extracted from buccal swabs using the PureLink Pro 96 Genomic DNA Kit 
(Invitrogen Corporation, Carlsbad, CA, USA), according to the instructions of the manufacturer. 
The -13910C>T polymorphism (Chr.2: 135851076 position) was genotyped using dual-labeled 
probes for real-time polymerase chain reaction (PCR) on a MiniOpticon instrument (Bio-Rad, 
Hercules, CA, USA) using primers and labelled probes previously reported [225]. The PCR 
amplification was carried out in 20 μl of a total reaction volume containing 2 μl (~20 ng) of DNA, 0.4 
μM primers, 0.2 μM probes in 1x of SsoFast™ Probes Supermix (Bio-Rad, Hercules, CA, USA). PCR 
conditions were an initial denature step at 95°C for 10 minutes, followed by 40 cycles of 1 minute at 
60°C and 15 seconds at 95°C. To assess genotyping reproducibility, a random 10% selection of 
samples was re-genotyped with 100% concordance (see conditions in chapter II). 
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3.3. Statistical analysis 
Allelic and genotypic frequencies of the -13910C>T polymorphism were estimated by direct 
counting. Hardy-Weinberg equilibrium probability value, heterozygosity and exact p values for 
population differentiation [273] were achieved using the software package Arlequin, v3.11 
(http://cmpg.unibe.ch/software/arlequin3/) [233]. 
In statistical analyses we follow a dominant model, and subjects with CT and TT genotypes were 
grouped and compared with CC subjects. Normality of the data was examined using the 
Kolmogorov–Smirnov test. Due to lack of the normal distribution, non-parametric tests have been 
used in the statistical analyses. The Mann-Whitney test was used to compare means of obesity-
related traits between genotypes. Logistic regression was used to estimate p-values, odds ratio (OR), 
and 95% confidence intervals (CI), assessing the association of -13910C>T polymorphism with risk of 
obesity and abdominal obesity. Statistical analyses were performed using the SPSS software 
(Statistical Package for the Social Sciences for Windows, version. 18.0, SPSS inc., Chicago, IL, USA). A 
significant p-value was considered at <0.05 for all comparisons. 
 
4. Results 
The anthropometric characteristics of the study subjects distributed by phenotype are shown in 
Table 5.1. 
The LCT -13910C>T genotype distributions regarding whole sample (n=580) were: CC 42.8%, CT 
44.8% and TT 12.4%. Individual LP -13910*T allele frequency was 34.8% (Table 5.2). The similar allele 
frequencies across the three sampled subgroups (-13910*T allele frequency values of 34.6%, 32.3% 
and 37.4% in Coimbra, Vale de Cambra and Guarda/Covilhã municipalities, respectively) indicate 
absence of population stratification for the -13910C>T polymorphism (p=0.466 on the exact test of 
sample differentiation). No deviations from the Hardy-Weinberg equilibrium were observed in any 
population subgroup, neither in the whole sample (p>0.05). 
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Table 5.1. Body size and genetic characteristics of the children participants according to phenotype. 
Characteristics Overall 
Phenotype* 
Normal Overweight Obese 
N 580 207 233 140 
Age (years) 9.0 ± 1.7 8.6 ± 1.6 9.6 ± 1.6 9.0 ± 1.8  
Girls (%) 51.9 54.1 48.1 55.0 
Height (cm) 136.1 ± 11.8 130.8 ± 11.1 139.8 ± 11.3 137.8 ± 10.8 
Weight (kg) 37.4 ± 11.6 27.9 ± 6.6 40.5 ± 9.5 45.9 ± 11.2 
BMI (kg/m
2
) 19.7 ± 3.5 16.1 ± 1.4 20.4 ± 1.8 23.8 ± 2.6 
BMI Z-score 0.95 ± 0.9 -0.11 ± 0.8 1.28 ± 0.24 1.98 ± 0.2 
Waist circumference (cm) 67.4 ± 7.8 60.4 ± 4.4 69.1 ± 5.4 74.9 ± 6.6 
Hip circumference (cm) 79.2 ± 10.5 70.4 ± 6.3 82.3 ± 8.3 87.1 ± 9.5 
Waist-to-Height Ratio 0.86 ± 0.06 0.86 ± 0.06 0.84 ± 0.06 0.86 ± 0.05 
Abbreviations: n, total subjects; BMI, body mass index; BMI Z-score, body mass index standard deviation. 
*Phenotype was defined using the International Obesity Task Force (IOTF) cut-offs.  
Data are presented as mean ± standard deviation. 
 
Testing the association with anthropometric variables, we found no association between the -
13910C>T polymorphism and obesity-related traits, as BMI, weight or waist circumference (p>0.05 
for all traits) (Table 5.3). 
Logistic regression analysis was used to test the association of the -13910C>T polymorphism 
with the risk of obesity and abdominal obesity (Table 5.4). We observe indication of an association 
between the LP -13910*T allele and abdominal obesity (OR=1.41; 95% CI: 1.03-1.94; p=0.030). In a 
dominant model of genetic effect, the -13910 CT/TT genotypes show also indication of an association 
with abdominal obesity (unadjusted OR=1.64; 95% CI: 1.04-2.62; p=0.034), remaining significant after 
adjustment for age and gender (OR=1.65; 95% CI: 1.04-2.60; p=0.029). No association was found 
between the -13910 CT/TT genotypes and obesity (OR=1.24; 95% CI: 0.79-1.92; p=0.350) or 
overweight (OR=0.86; 95% CI: 0.59-1.28; p=0.769). 
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Table 5.2 The LCT -13910C>T polymorphism genotype and allelic distribution among municipalities. 
 
Municipalities 
 Genotype distribution, % (n)  Allele frequencies 
HWE He 
N CC CT TT  C T 
Coimbra 266 43.6 (116) 43.6 (116) 12.8 (34) 
 
0.654 0.346 0.589 0.453 
Vale de Cambra 147 45.6 (67) 44.2 (65) 10.2 (15) 
 
0.677 0.323 1.000 0.439 
Guarda/Covilhã 167 38.9 (65) 47.3 (79) 13.8 (23) 
 
0.626 0.374 1.000 0.469 
Total 580 42.8 (248) 44.8 (260) 12.4 (72) 
 
0.652 0.348 0.788 0.454 
 
Abbreviations: n, total subjects; HWE, exact p-value for the Hardy-Weinberg equilibrium (p significant <0.05); He, expected heterozygosity.  
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Table 5.3. Comparison of anthropometric parameters among different genotypes of LCT -13910C>T 
polymorphism. 
 
 LCT -13910C>T genotypes 
p-value CC 
 (n=248) 
CT/TT 
(n=332) 
Age (years) 9.0 ± 1.7 9.1 ± 1.7 0.706 
Height (cm) 135.3 ± 11.8 136.8 ± 11.7 0.328 
Weight (kg) 36.5 ± 11.4 37.9 ± 11.7 0.252 
BMI (kg/m2) 19.5 ± 3.4 19.8 ± 3.6 0.308 
BMI Z-score 0.91 ± 0.9 0.98 ± 0.9 0.316 
Waist circumference (cm) 67.0 ± 7.7 67.7 ± 8.0 0.350 
Hip circumference (cm) 78.6 ± 10.6 79.6 ± 10.4 0.393 
Waist-to-Height Ratio 0.85 ± 0.04 0.86 ± 0.05 0.977 
    
Data are presented as mean ± standard deviation. 
p-values were obtained using the Kruskal-Wallis test. 
p-values significant <0.05 in italic and bold. 
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Table 5.4. Associations of LCT -13910C>T polymorphism with risk of obesity and abdominal obesity [OR (95% CI)]. 
 
 
 
Genotype distribution, % (n)  OR (95% CI) 
 Normal 
n=207  
Overweight 
n=233 
Obese 
n=140 
Gluteofemoral 
n=483 
Ab obesity 
n=97 
 Normal vs. 
Obese 
Normal vs. 
Overweight 
Gluteofemoral 
vs. Ab obesity  
Dominant Model          
CC 43.0 (89) 45.5 (106) 37.9 (53) 44.7 (216) 33.0 (32)  1 1 1 
CT/TT 57.0 (118) 54.5 (127) 62.1 (87) 55.3 (267) 67.0 (65)  
1.24 (0.79-1.92) 
p=0.350 
0.86 (0.59-1.28) 
p=0.769 
1.65 (1.04-2.60) 
p=0.032 
Allelic Model          
C 65.6 (273) 65.7 (307) 61.7 (174) 66.4 (641) 58.2 (113)  1 1 1 
T 34.4 (141) 34.3 (159) 38.3 (106) 33.6 (325) 41.8 (81)  
1.17 (0.86-1.62) 
p=0.305 
1.00 (0.76-1.32) 
p= 1.00 
1.41 (1.03-1.94) 
p=0.029 
 
Abbreviations: Ab obesity; abdominal obesity defined using the sex and age-specific ≥90
th
 waist circumference percentile. Gluteofemoral, children under the <90
th
 waist 
circumference percentile. OR, odds ratio; CI, confidence interval. 
Overweight and obesity was defined using the International Obesity Task Force (IOTF) cut-offs. 
p-value under the dominant and allelic model was adjusted for age and gender (p-value significant <0.05 in bold).  
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5. Discussion 
 
Several genetic polymorphisms have been reported to be associated with obesity or obesity-
related phenotypes both in children and adults [274], which is a growing problem worldwide 
including Portugal [240, 258]. To better understand the genetic basis of obesity it is important to 
replicate these results in different populations across the world. Recently it was reported that LCT -
13910C>T polymorphism is strongly associated with BMI and obesity in European adults by three 
studies that found adult’s carriers of the -13910 CC genotype with lower weight and BMI [102–104]. 
There are some controversial data regarding effects of dairy products intake on body weight and 
fat [275]. Several studies in adults support for an increase in body weight associated with dairy 
products intake [276–278]. One possible explanation for this association could be that the extension 
of consumption of dairy products in daily diet, often high in energy content, potentially increase 
calorie intake in adulthood [278]. In children, relationship between dairy products consumption and 
weight/body composition indicate either a beneficial or a neutral effect [279, 280]. However, no 
studies were performed to see if individual LCT genetic profiles influence the relationship between 
dairy products consumption and body weight. 
We conducted a population study to test whether the -13910C>T polymorphism, tightly 
associated with LP in individuals of European descent, was associated with obesity and/or obesity-
related traits in Portuguese children. The exact test of sample differentiation based on allele 
frequencies showed no significant differences between the three study geographic areas of Coimbra, 
Vale de Cambra and Guarda/Covilhã, excluding population substructure and possible bias in 
association signals for the -13910C>T polymorphism, a locus that was shown to be prone to 
population stratification [281]. We found indication of an association between the LP -13910 CT/TT 
genotypes and abdominal obesity (OR=1.65; p=0.032), however, we did not find evidence for the 
association of the -13910C>T polymorphism with the children risk of obesity or other anthropometric 
measurements. 
Considering previous studies showing that obesity risk in adulthood is significantly higher in T-
allele carriers (TT and CT genotypes) than in CC subjects [102–104], our findings suggest that, by a 
continuous intake of rich fat dairy products, individuals with -13910 CT/TT genotypes could have a 
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more predisposition to develop obesity into adulthood than individuals with -13910 CC genotype, 
associated with adult hypolactasia. 
This study suggests that LP -13910 CT/TT genotypes may predispose to abdominal obesity in 
Portuguese children. Association of the -13910C>T polymorphism with BMI or risk of obesity, 
previously observed in adults, was not confirmed in children. Further studies are needed i) to 
replicate the present results in children from other populations; ii) to see whether individual LCT 
genetic profiles influence the relationship between dairy products consumption and obesity-related 
traits. 
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1. Abstract 
Background: At least 52 genetic loci were associated with obesity-related traits. However, little is 
known about the genetic basis of obesity among children. This study aims to test whether 10 
polymorphisms in obesity-related genes MSRA, TFAP2B, MC4R, NRXN3, PPARGC1A, TMEM18, 
SEC16B, HOXB5 and OLFM4 are associated with the risk of obesity in Portuguese children. 
 
Methods: A total of 730 children aging from 6 to 12 years-old, recruited randomly from public 
schools in Portugal, were analyzed. Anthropometric measurements were obtained and children were 
classified into three phenotypic groups, normal-weight (n=256), overweight (n=320), and obese 
(n=154), according to the IOTF cut-offs. Polymorphisms were genotyped by allelic discrimination 
TaqMan® assays. 
 
Results: The MC4R rs12970134 polymorphism was nominally associated with BMI (p=0.035), BMI Z-
score (p=0.043) and waist circumference (p=0.020), and borderline associated with weight (p=0.053). 
Near nominally associations were also found for the PPARGC1A rs8192678 polymorphism with 
weight (p=0.061), and for the MSRA rs545854 polymorphism with BMI (p=0.055) and BMI Z-score 
(p=0.056). Furthermore, logistic regression showed that MC4R rs12970134 and TFAP2B rs987237 
were nominally, respectively, associated (p=0.029) and borderline associated (p=0.056) with the 
obese phenotype. 
 
Conclusion: This study highlighted the possible association of MC4R, PPARGC1A, MSRA and TFAP2B 
polymorphisms with several obesity-related traits in a sample of Portuguese children. The two 
significant associated TFAP2B rs987237 and MC4R rs12970134 polymorphisms showed an opposite 
direction of effect to that in the original reports. 
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2. Introduction  
 
The obesity phenotype has been increasing in the last decades and the causes for this complex 
disorder are thought to be related with an imbalance between energy intake and energy expenditure 
due to changes in lifestyles including exposure to an obesogenic environment [282]. Furthermore, it 
is estimated that the heritable predisposition to obesity may range from 40 to 70% [5, 283, 284]. 
In less than seven years, genome wide association studies (GWAS) have successfully identified 
more than 52 genetic loci, which were unequivocally associated with obesity-related traits [63]. The 
first locus associated with obesity was the fat mass and obesity associated (FTO) gene by Frayling et 
al. [65] which is the most replicated gene across the world, both in adult and children samples [66, 
69, 73], including in the Portuguese population [285]. Subsequently, several other studies emerged 
associating single nucleotide polymorphisms in several genes across the genome, most of them in 
adults [214, 286], and a few in children [114]. Nevertheless, candidate and replication studies of 
obesity loci among different populations emerge as an important step to identify and clarify which 
variants are indeed associated with obesity. The frequency of obesity-susceptibility alleles varies 
between populations, and these allele distributions could be a consequence of population-specific 
obesogenic environments associated with specific demography and cultural histories. Replication 
studies are also relevant to determine which polymorphisms previously associated with obesity in 
adults are also linked in children, and, in a final instance, to better understand the complexity of 
obesity susceptibility. 
In this study, a sample of Portuguese children was tested for the association of obesity and 
obesity-related quantitative traits with ten polymorphisms in nine candidate genes including, 
methionine sulfoxide reductase A (MSRA), transcription factor AP-2 beta (TFAP2B), melanocortin 4 
receptor (MC4R), neurexin 3 (NRXN3), peroxisome proliferator-activated receptor gamma 
coactivator 1 alpha (PPARGC1A), transmembrane protein 18 (TMEM18), homolog of S. cerevisiae 
Sec16 (SEC16B), homeobox B5 (HOXB5) and olfactomedin 4 (OLFM4). 
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3. Material and Methods 
 
3.1. Study subjects 
The original sample consisted of 1433 Portuguese children of European descent, aging between 6-
12 years old, randomly selected from several public schools in the central region of Portugal [258]. 
From this original sample, three body mass index (BMI) groups, using age and sex specific BMI cut-
offs provided by the International Obesity Task Force (IOTF) [221], were attained in a total of 730 
children, including: i) 154 obese subjects (resulting from the BMI in adult’s cut-points ≥30 kg/m2); ii) 
320 overweight subjects (resulting from the BMI in adult’s cut-points between 25 kg/m2 and 29 
kg/m2); and iii) 256 lean controls randomly selected from the initial group of 928 children with 18.5≥ 
BMI <25 kg/m2 [31 children were classified as underweight (BMI<18.5) and excluded of this study]. 
 
The study protocol was approved by Direção-Geral de Inovação e de Desenvolvimento Curricular, 
the ethical Committee of the Portuguese Ministry of Education (available at http://mime.gepe.min-
edu.pt/ with the identification number process: 0151100001), and was conducted in accordance with 
the institutional and ethical guidelines of the University of Coimbra. Written informed consent was 
previously obtained from the children´s parents. 
 
3.2. Anthropometric measurements 
All children underwent anthropometric measurements of height, weight, waist and hip 
circumference using a standardized protocol. Body weight (kg) and height (cm) were taken with 
participants dressed in lightweight clothing without shoes to determine the BMI. Waist 
circumference (WC) (cm) was measured midway between the lowest rib and the iliac crest, to the 
nearest 0.1 cm after inhalation and exhalation. Hip circumference (cm) was measured at the point 
over the buttocks yielding the maximum circumference. The BMI was calculated by dividing weight 
(in kilograms) by height (in meters) squared (kg/m2). Abdominal obesity was defined using the sex 
and age-specific ≥90th waist circumference percentile [259]. 
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3.3. Selection and Genotyping of polymorphisms 
Ten single nucleotide polymorphisms identified from the literature significantly associated to 
obesity or obesity-related traits in children of European origin were selected: rs17782313 (Chr 
18:60183864 position) and rs12970134 (Chr 18:60217517 position) near MC4R, prominent in the 
literature; rs10146997 (Chr 14:79478819 position) in NRXN3, rs8192678 in (Chr 4:23814039 position) 
PPARGC1A, rs7561317 (Chr 2:644953 position) near TMEM18 and rs10913469 (1:177944384 
position) in SEC16B, poorly studied; rs545854 (Chr 8:10002570 position) in MSRA and rs987237 (Chr 
6:50835337 position) in TFAP2B, associated in adult’s populations [214] but never replicated in 
children; and rs9299 (Chr17:48592068 position) in HOXB5 and rs9568856 (Chr 13:53490846 position) 
in OLFM4, recently associated with childhood obesity [114] but never replicated. 
The genomic DNA was extracted from buccal cells using the PureLink® Pro 96 Genomic DNA Kit 
(Invitrogen Corporation, Carlsbad, CA, USA), according to the instructions of the manufacturer. 
Samples were genotyped for all SNPs by allelic discrimination assays using TaqMan® probes 
(Applied Biosystems, Foster City, CA, USA). All polymerase chain reactions (PCRs) were done in a total 
volume of 20 µl containing 1x SsoFast™ Probes Supermix (Bio-Rad, Hercules, CA, USA), 0.5 μl of 
specific TaqMan® SNP Genotyping Assays (20x) (Applied Biosystems, Foster City, CA, USA) and about 
20 ng of genomic DNA, according to the manufacturer´s instructions. Thermal cycling conditions 
were 10 minutes at 95°C, and 35 cycles each of 95°C for 15 seconds and 60°C for 1 minute. The 
fluorescence was observed through a MiniOpticon real time PCR system (Bio-Rad, Hercules, CA, 
USA). To assess genotyping reproducibility, a selection of 10% random samples was re-genotyped for 
all SNPs with 100% concordance by the Single Strand Conformation Polymorphism (SSCP) method or 
sequencing by the Sanger’s dideoxy chain termination reaction using Big-Dye Terminator v1.1 Cycle 
Sequencing kit (Applied Biosystems, Foster City, USA) and the ABI 310 sequencer (Applied 
Biosystems, Foster City, USA). 
 
3.4. Statistical analysis 
The allelic and genotypic frequencies of all polymorphisms were estimated by direct counting. 
Hardy-Weinberg equilibrium probability values were achieved using an exact test [287]. Logistic 
regression under an additive genetic model, allowing for analysis of a binary outcome (a case–control 
status), was used to test obesity and overweight phenotype polymorphism associations, adjusted for 
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age and sex, by calculating odds ratios (OR) with 95% of confidence intervals (CI) and p-values. For 
MC4R rs17782313 and rs12970134 polymorphisms, linkage disequilibrium (r2) values and a 
case/control (normal vs. obese) haplotype association were assessed. All these statistical analyses 
were done by using the set-based tests implemented on PLINK software v.1.07 
(http://pngu.mgh.harvard.edu/purcell/plink/) [234]. Normality of the data was assessed using the 
Kolmogorov-Smirnov test. For each obesity-related quantitative parameters (BMI, BMI Z-score, 
weight and waist circumference), the nonparametric Kruskal-Wallis test was used to evaluate 
differences among the three genotypes in all the polymorphisms. This statistical analysis was 
performed using the SPSS software (for windows, version 18.0, SPSS inc., Chicago, IL, USA). A 
significant p-value was considered below 0.005 (0.05/10) by applying a Bonferroni correction for 
multiple testing, and a p-value between 0.005 and 0.05 has been considered as nominally significant. 
QUANTO, v.1.1 power calculator (freely available http://hydra.usc.edu/gxe/) was used to 
estimate the power of association as a function of the frequency of the effect allele assuming an 
additive model [237]. 
 
4. Results 
The anthropometric characteristics of the study subjects distributed by phenotype are shown in 
Table 6.1. 
The genotyping success rate varied between 96.3% and 99.7%. The minor allele frequencies 
observed for all polymorphisms in the total sample were: 15% for rs7561317-A (TMEM18), 16% for 
rs10913469-C (SEC16B), 36% for rs8192678-A (PPARGC1A), 18% for rs987237-G (TFAP2B), 16% for 
rs545854-C (MSRA), 12% for rs9568856-A (OLFM4), 18% for rs10146997-G (NRXN3), 32% for rs9299-
C (HOXB5), 21% for 17782313-C (MC4R) and 22% for rs12970134-A (MC4R) (Table 6.2). These 
frequencies are in accordance with those found in the HapMap CEU population 
(http://www.ensembl.org/). Genotype distributions among the control group were in agreement 
with Hardy-Weinberg equilibrium for all the studied polymorphisms (p>0.05). 
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Table 6.1. General characteristics of the Portuguese children participants. 
 Total 
Phenotype distribution* 
Normal Overweight Obese 
Subjects  730 256  320 154 
Girls, % 50.7 55.9 45.3 53.2 
Age, years 9.1 ± 1.7 8.6 ± 1.6 9.5 ± 1.6 9.0 ± 1.7 
Height (cm) 136.2 ± 11.7 131.1 ± 11.1 139.5 ± 11.1 137.9 ± 10.6 
Weight (kg) 37.2 ± 11.3 28.1 ± 6.6 40.2 ± 9.3 46.1 ± 11.0 
BMI (kg/m2) 19.6 ± 3.4 16.1 ± 1.5 20.3 ± 1.8 23.8 ± 2.5 
BMI Z-score 0.93 ± 0.97 -0.15 ± 0.78 1.3 ± 0.23 1.99 ± 0.23 
WC (cm) 67.2 ± 7.8 60.3 ± 4.5 68.9 ± 5.4 75.1 ± 6.6 
HC (cm) 79.0 ± 10.3 70.4 ± 6.5 81.9 ± 8.0 87.1 ± 9.4 
WHR 0.85 ± 0.06 0.86 ± 0.06 0.85 ± 0.06 0.87 ± 0.05 
 
Data are presented as mean ± standard deviation. 
*Phenotype distribution was determined using age and sex specific BMI cut-offs provided by the International 
Obesity Task Force (IOTF). 
Abbreviations: BMI, body mass index; BMI Z-score, body mass index standard deviation score; WC, waist 
circumference; HC, hip circumference; WHR, waist-to-hip ratio. 
 
 
We analyzed the obesity-related quantitative traits BMI, BMI Z-score, weight and waist 
circumference among different genotypes for each of the studied polymorphisms. The mean values 
for the anthropometric traits among the three different genotypes are detailed in Table 6.2. The 
MC4R rs12970134 major G-allele was found nominally associated with increase in BMI (p=0.035), 
BMI Z-score (p=0.043) and waist circumference (p=0.020), and borderline associated with weight 
(p=0.053). Near nominal associations were also found for the PPARGC1A rs8192678 minor A-allele 
with weight (p=0.061) and waist circumference (p=0.093), and for the MSRA rs545854 major G-allele 
with BMI (p=0.055) and BMI Z-score (p=0.056). After correction for multiple testing no statistically 
significant associations were found. 
Genotype distributions of obesity-related parameters for the MC4R rs12970134 polymorphism, 
which showed the highest statistical significant associations with the obesity-related traits, are 
detailed in Figure 6.1. Homozygotes for the minor A-allele have the lowest value distributions for all 
the analyzed quantitative parameters (BMI, BMI Z-score, waist circumference and weight). 
 
  
Figure 6.1. Box plot demonstrating the distribution of untransformed BMI, BMI Z
waist circumference within each genotype group of 
represents the anthropometric traits values between the 25
within the boxes indicates the median values. 
 
 
MC4R rs12970134 polymorphism. Each box 
th and 75th quartiles, and the dark line 
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Table 6.2. Minor allele frequencies and Hardy-Weinberg equilibrium test of the 10 studied polymorphisms in the sampled Portuguese children and their 
associations with obesity-related quantitative traits. 
Polymorphism Chr. Gene Alleles* n MAF HWE 
No. 
11/12/22 
Genotype (mean ± SD) 
 
p-value 
11 12 22 
 
rs10913469 1q25 SEC16B C:T 728 0.16 0.479 20/186/522      
BMI (kg/m2)        19.6 ± 3.6  19.5 ± 3.5  19.6 ± 3.4   0.930 
BMI Z-score        0.99 ± 0.9  0.92 ± 1.0  0.93 ± 1.0   0.902 
Weight (kg)        37.5 ± 13.4  36.9 ± 11.9  37.0 ± 11.1   0.736 
Waist C (cm)        67.9 ± 8.6  66.9 ± 8.3  67.3 ± 7.5   0.709 
rs7561317 2p25 TMEM18 A:G 721 0.15 0.886 16/191/514      
BMI (kg/m2)        19.2 ± 3.6 19.2 ± 3.3  19.7 ± 3.5  0.141 
BMI Z-score        0.81 ± 1.1  0.84 ± 0.9  0.97 ± 1.0   0.120 
Weight (kg)        36.7 ± 13.1  36.3 ± 11.4  37.6 ± 11.2   0.306 
Waist C (cm)        66.1 ± 7.7 66.3 ± 7.5  67.6 ± 7.8  0.121 
rs8192678 4p15 PPARGC1A A:G 703 0.36 1.000 89/323/291      
BMI (kg/m2)        20.0 ± 3.6 19.8 ± 3.4 19.4 ± 3.4  0.198 
BMI Z-score        0.99 ± 1.0 0.97 ± 0.9 0.89 ± 1.0  0.359 
Weight (kg)        38.9 ± 12.3 38.0 ± 11.3 36.1 ± 10.9  0.061 
Waist C (cm)        68.9 ± 8.7 67.5 ± 7.6 66.6 ± 7.5  0.093 
rs987237 6p12 TFAP2B G:A 725 0.18 0.615 21/218/486      
BMI (kg/m2)        19.0 ± 2.9 19.3 ± 3.2 19.7 ± 3.5  0.392 
BMI Z-score        0.87 ± 1.0 0.89 ± 1.0 0.94 ± 1.0  0.536 
Weight (kg)        34.1 ± 9.4 36.8 ± 11.2 37.5 ± 11.5  0.353 
Waist C (cm)        64.9 ± 7.8 66.6 ± 7.3 67.6 ± 7.9  0.130 
rs545854 8p23 MSRA C:G 717 0.16 0.334 22/187/508      
BMI (kg/m2)        18.3 ± 3.7 19.8 ± 3.6 19.7 ± 3.4  0.055 
BMI Z-score        0.51 ± 1,1 0.96 ± 1.1 0.95 ± 1.0  0.056 
Weight (kg)        34.3 ± 10.6 38.0 ± 11.7 37.1 ± 11.4  0.240 
Waist C (cm)        65.1 ± 6.9 67.5 ± 8.3 67.3 ± 7.5  0.282 
rs9568856 13q14 OLFM4 A:G 725 0.12 0.059 17/141/567      
  
111 
BMI (kg/m2)        19.2 ± 3.6 19.9 ± 3.4 19.5 ± 3.4  0.374 
BMI Z-score        0.92 ± 0.8 0.97 ± 0.9 0.92 ± 1.0  0.719 
Weight (kg)        35.6 ± 12.2 38.1 ± 11.1 37.0 ± 11.4  0.286 
Waist C (cm)        65.7 ± 8.4 68.0 ± 7.5 67.1 ± 7.8  0.248 
rs10146997 14q31 NRXN3 G:A 716 0.18 0.798 21/212/483      
BMI (kg/m2)        19.1 ± 3.5 19.6 ± 3.3 19.7 ± 3.5  0.672 
BMI Z-score        0.91 ± 1.0 0.92 ± 1.0 0.95 ± 1.0  0.579 
Weight (kg)        34.3 ± 11.9 37.5 ± 11.3 37.4 ± 11.3  0.436 
Waist C (cm)        64.6 ± 7.6 67.3 ± 7.7 67.5 ± 7.8  0.260 
rs9299 17q21 HOXB5 C:T 727 0.32 0.672 78/313/336      
BMI (kg/m2)        19.5 ± 3.4 19.7 ± 3.6 19.5 ± 3.3  0.710 
BMI Z-score        0.87 ± 1.0 0.94 ± 1.0 0.92 ± 0.9  0.751 
Weight (kg)        37.3 ± 11.6 37.5 ± 11.3 37.0 ± 11.4  0.792 
Waist C (cm)        66.9 ± 7.0 67.4 ± 7.9 67.2 ± 7.8  0.896 
rs12970134 18q21 MC4R A:G 729 0.22 0.163 29/266/434      
BMI (kg/m2)        18.1 ± 3.3 19.5 ± 3.5 19.7 ± 3.9  0.035 
BMI Z-score        0.53 ± 1.0     0.89 ± 1.0 0.98 ± 0.9  0.043 
Weight (kg)        32.5 ± 9.1  37.1 ± 11.3 37.7 ± 11.5  0.053 
Waist C (cm)        63.6 ± 5.8 67.1 ± 7.6 67.6 ± 7.9  0.020 
rs17782313 18q22 MC4R C:T 716 0.21 0.432 28/247/441      
BMI (kg/m2)        18.6 ± 3.6 19.7 ± 3.4 19.6 ± 3.5  0.269 
BMI Z-score        0.61 ± 1.1 0.95 ± 1.0 0.94 ± 1.0  0.257 
Weight (kg)        34.4 ± 10.6 37.7 ± 11.0 37.2 ± 11.5  0.260 
Waist C (cm)        65.6 ± 7.5 67.4 ± 7.3 67.3 ± 8.0  0.430 
 
Abbreviations: Chr., chromosome; n, number of genotyped children; MAF, minor allele frequency; HWE, Hardy-Weinberg equilibrium; BMI, body mass  
Index; BMI Z-score, body mass index standard deviation; WC, waist circumference. 
*Alleles: Minor (1): Major (2).  
p-values were obtained using the Kruskal-Wallis test.  
p-value nominally significant (p<0.05) are in bold and italic.  
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Logistic regression analysis, in an additive model, revealed that MC4R rs12970134 major G-allele 
was nominally associated with the obesity risk (OR = 1.477; p=0.029) and that TFAP2B rs987237 
major A-allele and TMEM18 rs7561317 major G-allele are near nominally associated with the risk of 
obesity (OR = 1.455; p=0.056; and OR = 1.416; p=0.092, respectively) (Table 6.3). Only the PPARGC1A 
rs8192678 polymorphism was found nominally associated with the overweight phenotype (OR = 
1.297; p=0.041) (Table 6.3). 
We further investigated the difference in the genotype distribution between cases and controls 
for abdominal obesity by logistic regression analysis. In the total of 730 children, 111 revealed 
abdominal obesity (using sex and age-specific ≥90th waist circumference percentile). From the ten 
polymorphisms studied, only TMEM18 rs7561317 (major G allele), showed nominal association with 
increased abdominal obesity (OR = 1.589; 95% CI, 1.02-2.50; p=0.042). 
The haplotype analysis for the two MC4R rs17782313 and rs12970134 polymorphisms, located at 
a distance of 33.5 Kb and in high linkage disequilibrium (r2 = 0.74), revealed that the common TG 
haplotype was associated with the risk of obesity (p=0.043) (with frequency of 81.2% in the obese 
group versus 75.0% in the control group). 
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Table 6.3. Allele frequencies of the 10 studied polymorphisms in the Portuguese children, and their associations with risk of obesity among phenotypic 
groups. 
 
SNP ID/ 
Gene 
Allele 
  Obese vs. normal 
 
Overweight vs. normal 
Normal*  Obese* OR CI 95% p 
 
Overweight* OR CI 95% p 
rs10913469 
SEC16B T>C 
T 0.855  0.847 
1.058 (0.71-1.57) 0.780 
 0.825 
1.154 (0.83.1.59) 0.387 
C 0.145  0.153  0.175 
           
rs7561317 
TMEM18 G>A 
G 0.825  0.869 
0.706 (0.47-1.06) 0.092 
 0.850 
0.829 (0.60-1.13) 0.248 
A 0.175  0.131  0.150 
           
rs8192678 
PPARGC1A G>A 
G 0.678  0.642 
1.176 (0.86-1.59) 0.293 
 0.619 
1.297 (1.00-1.66) 0.041 
A 0.322  0.358  0.381 
           
rs987237 
TFAP2B A>G 
A 0.804  0.856 
0.687 (0.46-1.01) 0.056 
 0.817 
0.915 (0.67-1.23) 0.559 
G 0.196  0.144  0.183 
           
rs545854 
MSRA G>C 
G 0.820  0.836 
0.960 (0.65-1.41) 0.838 
 0.847 
0.878 (0.63-1.20) 0.425 
C 0.180  0.164  0.153 
           
rs9568856 
OLFM4 G>A 
G 0.882  0.866 
1.156 (0.75-1.77) 0.504 
 0.884 
0.985 (0.68-1.41) 0.935 
A 0.118  0.134  0.116 
           
rs10146997 
NRXN3 A>G 
A 0.818  0.860 
0.731 (0.49-1.08) 0.119 
 0.808 
1.07 (0.79-1.45) 0.645 
G 0.182  0.140  0.192 
           
rs9299 
HOXB5 T>C 
T 0.679  0.654 
1.122 (0.83-1.51) 0.453 
 0.687 
0.962 (0.74-1.23) 0.762 
C 0.321  0.346  0.312 
           
  
113 
rs12970134 
MC4R G>A 
G 0.749  0.815 
0.677 (0.47-0.96) 0.029 
 0.782 
0.829 (0.63-1.09) 0.183 
A 0.251  0.185  0.218 
           
rs17782313 
MC4R T>C 
T 0.781  0.817 
0.799 (0.55-1.14) 0.221 
 0.780 
1.005 (0.75-1.33) 0.972 C 0.212  0.183  0.220 
      
 
Abbreviations: SNP ID; single nucleotide polymorphism identification; OR, odds ratio; CI, confidence interval. 
*Phenotypic groups was determined using age and sex specific BMI cut-offs provided by the International Obesity Task Force (IOTF). 
Logistic regression was used to compare genotype distribution. p-values (asymptotic p-value for t-statistic) shown are for an additive model and are adjusted for age and 
sex. OR is shown for the minor allele.  
p-value significant (p<0.05) are in bold and italic.  
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5. Discussion  
 
Understanding the genetic basis of obesity in children could be used as a first step to develop 
possible preventive measures. Recent GWAS have identified many (more than 50) different genetic 
variants conferring susceptibility to obesity [57]. However, the modest association with the obesity 
risk observed for most variants implies that replication studies in different populations are required 
to detect and confirm such signals of association, eliminating false positives that may arise by chance 
or systematic bias. 
Focused on ten polymorphisms across the genome (located in or near the MSRA, TFAP2B, NRXN3, 
PPARGC1A, TMEM18, SEC16B, HOXB5, OLFM4 and MC4R genes), previously associated by GWAS 
with obesity-related outcomes in populations of European origin, we conducted a genetic association 
study to investigate their role in the susceptibility of obesity in a sample of Portuguese children. 
Using obesity-related quantitative traits to assess whether the genotypes predicts the trait value, we 
identified the MC4R rs12970134 loci nominally associated with several obesity-related traits, and two 
loci (PPARGC1A and MSRA) near nominally associated with at least one anthropometric parameter 
(Table 6.2). In addition, using logistic regression analyses, the MC4R rs12970134 polymorphism was 
found nominally associated (p=0.029) with the risk of obesity and the TFAP2B rs987237 
polymorphism showed borderline significant association (p=0.056) with the obese phenotype. Thus, 
this study highlights these four polymorphisms as potential genetic markers of the obesity phenotype 
in this Portuguese children sample. 
The MC4R gene is known to be the most common cause of monogenic obesity in extreme 
childhood obesity [63], but also its flanking genomic region has been the third strongest implicated in 
polygenic obesity. The expression of MC4R is restricted to the hypothalamus involved in food intake 
regulation [43]. Until now, several variations of this gene were established with BMI and/or waist 
circumference, showing an independent role in body variation. Polymorphisms rs12970134 and 
rs17782313, located 154 kb and 188 kb, respectively, downstream of the MC4R gene, were found 
associated with obesity and obesity-related traits in several studies in Asian and European 
populations, both in children and adults [95, 96, 128, 288, 289]. In the present study, nominal 
significant associations were found between MC4R rs12970134 and BMI, BMI Z-score and waist 
circumference (p<0.05), as also with the risk of obesity (p=0.029). However, our findings do not 
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replicate previous reports that show the minor A-allele associated with increased risk in BMI and 
waist circumference in children of European [95, 96, 128, 288, 290] or Asian [289] descent. Instead, 
in the present study, Portuguese children showed the minor rs12970134-A allele significantly 
associated with lower BMI (p=0.035), BMI Z-score (p=0.043), waist circumference (p=0.020), and also 
with a lower risk for the obesity phenotype (OR = 0.677; p=0.029). For this polymorphism, the minor 
A-allele frequency was 18.5% in the obese group versus 25.1% in the control group. For the second 
MC4R polymorphism, rs17782313, previous studies showed the C-allele associated with childhood 
obesity (increasing BMI in ±0.22kg/m2) [95], however, in the Portuguese children, no statistical 
association was found with any obesity-related trait. The haplotype analysis showed the MC4R 
rs17782313 / rs12970134 TG haplotype associated with the risk of obesity, confirming the potential 
role of rs12970134 major G-allele in the etiology of obesity in our sample of Portuguese children.  
A GWA scan meta-analysis conducted by Lindgren et al. [78] found that the G allele of the MSRA 
rs545854 polymorphism was associated with waist circumference (p=8.9x10-9) in adults. Bille et al. 
[214] also found significant association between this polymorphism and waist circumference (OR = 
1.08; p=0.02). In our study, nominal borderline significant associations with BMI (p=0.055) and BMI Z-
score (p=0.056) were observed. The biological function between MSRA locus and adiposity remain 
unclear [78]. 
PPARGC1A is a transcriptional co-activator that has been implicated in the regulation of genes 
involved in energy metabolism [291]. The Gly482Ser missense mutation (rs8192678), predicted by a 
G-to-A transition at position +1,564 in exon 8 of the PPARGC1A gene, was found associated with 
obesity indices in middle-aged women of a cross-sectional Austrian population [291] and with 
abdominal obesity in Chinese adults [292]. In our study, near nominal associations were obtained 
with weight (p=0.061) and waist circumference (p=0.093) for the 482Ser variant. 
The molecular function of the TMEM18 gene product is to bind DNA to suppress transcription; it 
could be differently expressed in the hypothalamus and is possibly involved in the regulation of 
feeding [293]. Polymorphism rs7561317, located about 22kb downstream of TMEM18, is the second 
best associated locus with BMI after FTO gene [63]. A GWA study conducted by Thorleifsson et al. 
[97] found that the rs7561317 GG genotype increases BMI in ±0.70kg/m2 and is associated with 
obesity. In the present study, significant associations were not found between any obesity-related 
trait and the TMEM18 rs7561317 polymorphism, however, our findings are directionally consistent 
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with previous studies conducted in children and adolescents, as the rs7561317 major G-allele was 
found marginally associated with the risk of obesity (OR = 0.706; p=0.092). 
 The TFAP2B gene is suggested to be involved in global adipocyte response to positive energy 
balance [78]. The minor G-allele of rs987237 polymorphism was previously found associated with 
increased waist circumference (p=1.9x10-11) and BMI (p=7.0x10-12) in a meta-analysis of 16 GWAS 
within adults of European ancestry [78]; and also in children it was found associated with increased 
waist circumference (p=3.5x10-2) and BMI (p=0.06) [290]. Our data in Portuguese children do not 
replicate previous findings while we observed a nominal borderline significant association of the 
major rs987237 A-allele with the risk of obesity (OR = 0.692; p=0.056). 
 In the present study, the major MC4R rs12970134-G and TFAP2B rs987237-A alleles showed, 
respectively, nominal and near-nominal significant associations with the risk of obesity, but the 
direction of effect was reverse when comparing to that in the original reports. Despite opposite 
direction on the effect of a risk allele is highly unlikely, this was observed in several studies including 
between different populations [294] but also inside a same population [295]. For the TFAP2B 
rs987237 polymorphism, the original significant association was found in adults [78], and to the 
authors knowledge, this study with Portuguese participants is the first replication report involving 
children. Therefore, the opposite direction of association for rs987237-A risk allele could be due to 
differences between children and adults regarding natural physiological differences. 
 All genes studied in this work are considered as candidates for the risk of developing obesity. 
Most of them are involved in homeostasis and energy metabolism, nevertheless the casual effect of 
these polymorphisms in the pathogenesis of obesity remains unclear. In the present study with 
Portuguese children, only the MC4R rs12970134 polymorphism showed nominal significant 
association (p<0.05) with obesity and most of obesity-related traits. In a previous study for the FTO 
gene using the same cohort of individuals [285], significant associations were also found between the 
rs9939609 minor A-allele and increased risk for several anthropometric traits, including weight 
(p=0.019), BMI (p=0.018), BMI Z-score (p=0.011) and waist circumference (p=0.016), in concordance 
with reports worldwide. Thus, both loci FTO and MC4R appear to play a key role in the obesity 
phenotype in Portuguese children. Most of the analyzed polymorphisms in this present study showed 
no nominal effects in obesity-related traits, but this difference with the previous findings may be due 
partly to the sample size, which may have been insufficient to replicate the original findings. The 
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estimated power of association observed ranges from 6% to 72%, but at least for MC4R rs12970134 
polymorphism, the variant most associated to obesity in our sample, the obtained power (72%) is 
close to values (≥80%) commonly considered sufficient to detect genetic variant interaction effects. 
 Among the 10 loci reported in this study, polymorphisms in or near MC4R, PPARGC1A, MSRA and 
TFAP2B genes could be assumed to play a role in the risk of obesity in this population sample of 
Portuguese children. While we could not replicate the original findings concerning the direction 
effect of the MC4R rs12970134 and TFAP2B rs987237 risk alleles our results deserve confirmatory 
studies in other populations. Moreover, our data may show that the polymorphisms provided here 
could play a modest role in the obesity etiology in children, at least when comparing with the FTO 
gene, suggesting the existence of others unknown loci involved in the obesity susceptibility. Our 
replication study could also have public health significance while genes playing an essential role in 
energy homeostasis, such as PPARGC1A or TFAP2B, suggested by our data as obesity-related genes, 
may be used as targets for obesity treatment. Further investigations in the near future regarding 
genetic associations and functional roles of these polymorphisms should be helpful to confirm its 
implication in the development of obesity and if they could be attractive targets for therapeutic 
agents. 
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 1. Abstract 
Background: The melanocortin-4 receptor (MC4R) gene is the most common cause of monogenic 
obesity and could be a first step to unravel genetic causes of obesity. The aim of this study was to 
screen for MC4R gene mutations in a sample of Portuguese children with severe obesity. 
 
Methods: A total of 32 severely obese children from Portugal, with a BMI ≥ 99th (ranging 6-10 years-
old), were studied. The MC4R gene promoter and the entire coding region were analyzed by direct 
bidirectional sequencing. 
 
Results: Two MC4R gene mutations were found at heterozygous state: the previously described 
5’UTR single nucleotide polymorphism -178A>C (rs34114122), identified in a girl with a BMI Z-score= 
2.51; and the common missense mutation 307G>A (Val103Ile) (rs2229616) in the MC4R gene coding 
region, identified in a boy with a BMI Z-score= 2.60. The carrier frequency of the Val103Ile mutation 
in the study sample was (3.1%), similar to other studies in European populations (ranging 1 to 5%). 
No other pathogenic MC4R gene mutations were detected in our study sample. 
 
Conclusion: These results suggest that mutations in the MC4R gene might not be a common cause of 
severe obesity in Portuguese children. 
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 2. Introduction 
 
The melanocortin-4 receptor (MC4R) gene (OMIM 155541), located in the chromosome 
18q21.3, is composed by a single exon encoding for the 332-amino acid seven-transmembrane G-
protein-linked receptor, critically involved in regulating energy balance [42]. The MC4R gene is 
expressed mainly in the central nervous system, including the hypothalamus, and has been 
implicated in the regulation of food intake and energy expenditure [42, 296]. 
Deficiency in the MC4R activity associated with MC4R gene mutations is the most common 
cause of monogenic obesity, representing about 6% of severe human obesity [47]. In 1998, two 
independent groups report for the first time a mutation in MC4R gene, which abolishes the receptor 
function, associated with severe obesity [44, 45]. Until now, more than 150 mutations of this gene 
were described decreasing MC4R activity associated with human obesity, and usually classified into 
different classes depending of their molecular effects [41]. 
Most of study screenings of MC4R gene were focused in the coding sequence. Nevertheless, a 
few studies included the MC4R promoter region, which could be helpful to provide further insight in 
the identification of transcriptional mutations affecting MC4R gene expression [297–299]. 
The main goal of this study was to screen for mutations in the promoter and entire coding 
regions of MC4R gene in a sample of severely obese Portuguese children to determine possible 
genetic causes.  
 
 
 3. Material and Methods 
 
3.1. Study subjects  
In a previous study, 1433 Portuguese children were randomly selected from public schools, and 
classified using age and sex specific body mass index (BMI) cut-offs provided by the International 
Obesity Task Force (IOTF) [258]. A total of 32 unrelated children, with a severely obese phenotype, 
which pass the 99 percentile, were identified and selected to screen for mutations at the MC4R 
promoter and entire coding region. 
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The study protocol was approved by Direção-Geral de Inovação e de Desenvolvimento Curricular, 
the ethical Committee of the Portuguese Ministry of Education (available at http://mime.gepe.min-
edu.pt/ with the identification number process: 0151100001), and was conducted in accordance with 
the institutional guidelines of the University of Coimbra. Written informed consent was previously 
obtained from the children´s parents. 
 
3.2. Anthropometric Measurements 
Height (cm) and weight (kg) were taken with participants dressed in lightweight clothing without 
shoes. Waist circumference (cm) was measured midway between the lowest rib and the iliac crest, to 
the nearest 0.1 cm after inhalation and exhalation. Hip circumference (cm) was measured at the 
point over the buttocks yielding the maximum circumference. The BMI was calculated with the 
weight in kilograms divided by the square of height in meters (kg/m2). 
 
3.3. Direct sequencing of the MC4R gene 
A buccal swab sample was collected from each sampled child for genetic studies. The genomic 
DNA was extracted from buccal swabs using the PureLink® Pro 96 Genomic DNA Kit (Invitrogen 
Corporation, Carlsbad, CA, USA), according to the instructions of the manufacturer. 
DNA was amplified by polymerase chain reaction (PCR), using primers and conditions previously 
published for the MC4R coding sequence [231], and primers 5’-CGCCTACAGCCCCTAACACT-3’ 
(forward) and 5-CCTCCTGGGTCAGGGAGT-3’ (reverse), for the promoter region. This primer pair was 
designed with the Primer3 software, v0.4.0 [228] (freely available in http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi). 
Bidirectional sequence analysis of genomic DNA was performed in 32 unrelated children. 
Sequencing was performed on an ABI 3130 DNA Analyzer (Applied Biosystems, Foster City, CA, USA) 
using BigDye® Terminator v3.1 Cycle Sequencing Chemistry (Applied Biosystems, Foster City, CA, 
USA), according to protocols recommended by the manufacturer. Base calling was performed with 
Sequencing Analysis v5.2 (Applied Biosystems, Foster City, CA, USA). 
The sequences were analyzed with the Staden package software [232] and the SeqScape 
software v2.5 (Applied Biosystems, Foster City, CA, USA). The obtained sequences were compared 
with the standard MC4R gene sequence (ENSG00000166603). 
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3.4. Bioinformatics analysis 
For potential transcription factor binding site analysis the TFSearch software 
(http://www.cbrc.jp/research/db/TFSEARCH.html), was used based on the TRANSFAC database [300]. 
DNA sequences encompassing approximately 20bp upstream and downstream the polymorphic site 
were provided as input sequence data. Taxonomy matrix was entered as “vertebrate” and the 
threshold score was set at 85.0 for the analysis. For the missense variant, PolyPhen2 (Polymorphism 
Phenotyping v2) software, available online at (http://genetics.bwh.harvard.edu/pph2/) was used to 
assess the phenotypic effect [301]. The amino acid substitution is predicted damaging when the score 
is >0.95. 
 
 
4. Results 
A total of 32 severely obese (BMI≥99th) children from Portuguese origin were screened for 
mutations in the MC4R gene, including the promoter region. The characteristics of the sampled 
children are summarized in Table 7.1. Genomic DNA sequencing revealed two MC4R gene variations 
in two different subjects: the nucleotide change -178A>C (rs34114122) in the promoter region, found 
at heterozygous state in a 8 years-old girl with a BMI Z-score= 2.51 (Height: 128.4 cm; weight: 48.6 
kg); and the missense mutation c.307G>A (Val103Ile) in the coding region, found at the heterozygous 
state in a 6 years-old boy with a BMI Z-score= 2.60 (Height: 134.4 cm; weight: 42.7 kg). The Val103Ile 
(rs2229616) was previously described as a common variant, and the obtained frequency for 
heterozygous subjects in our sample was 3.1% (1/32), similar to previous studies from other 
European countries (Table 7.2). 
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Table 7.1. Characteristics of the sampled Portuguese children screened for MC4R mutations. 
Characteristics Children 
N 32 
Girls/Boys 11 / 21 
Age, years 8.4 ± 1.6 
Height, cm 135.2 ± 9.9 
Weight, kg 47.3 ± 11.2 
BMI, kg/m2  25.5 ± 2.6 
BMI Z-score* 2.3 ± 0.2 
Waist circumference, cm 77.8 ± 5.8 
Hip circumference, cm 89.0 ± 8.8 
WHR 0.87 ± 0.0 
 
Data are presented as mean ± standard deviation. 
Abbreviations: n, number of subjects; BMI, body mass index; BMI Z-score, body mass index standard deviation 
score; WHR, waist-to-hip ratio. 
*BMI Z-score was determined using age and gender specific BMI cut-offs provided by the International Obesity 
Task Force (IOTF). 
 
 
Bioinformatics analysis was used to predict the possible effect of the two identified variants in 
molecular pathway. For the promoter nucleotide change -178A>C, the TFSearch software used to 
screen for putative transcription factor binding sites, indicated an AML-1a binding site with 88.7 
score at the (ACCTCA) sequence when the minor C allele is present. Regarding the Val103Ile missense 
variant, analysis with the PolyPhen2 software indicates a low score (0.021) predicting non 
pathogenicity for this variant. 
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Table 7.2. Frequencies of obese individuals carrying the common Val103Ile missense mutation at 
heterozygous state among several populations. 
Population Cohort characteristics 
n 
(carrier/total) 
Frequency* Reference 
Sweden Unrelated probands 13/284 4.6% [302] 
UK Extremely obese adults 8/190 4.2% [303] 
Malaysia Obese adults 5/118 4.2% [304] 
Sweden Extremely obese adults 9/217 4.1% [305] 
France  
Morbidly obese adults and 
adolescents 
8/209 3.8% [231] 
European/USA Extremely/obese adults 5/140 3.6% [306] 
Serbia Obese adults 2/62 3.2% [307] 
Portugal Severely obese children 1/32 3.1% [308] 
France Morbid Obese adults 23/875 2.6% [309] 
UK HERTS cohort 28/1089 2.6% [299] 
Denmark Men with juvenile-onset obesity 18/750 2.4% [310] 
France Obese children 18/746 2.4% [309] 
Switzerland Severely obese adults 11/469 2.3% [311] 
Belgium 
Morbidly obese adults and obese 
children/adolescents 
5/218 2.3% [47] 
Germany Obese children 6/291 2.1% [312] 
Japan Extremely obese adults 1/50 2.0% [313] 
UK 
Children with severe early-onset 
obesity 
10/500 2.0% [314] 
France Severely obese children 1/63 1.6% [315] 
Germany Extremely obese children/ adolescents 13/808 1.6% [316] 
Italy Obese children/adolescents 4/240 1.6% [317] 
Germany 
Overweight and obese 
children/adolescents 
8/510 1.6% [318] 
Germany Extremely obese children/adolescents 4/306 1.3% [319] 
UK Probands with early-onset obesity 3/284 1.2% [314] 
Italy Obese children and adults 4/120 0.8% [320] 
Finland  
Children with early-onset obesity and 
adults obese 
2/308 0.7% [321] 
USA/France Severely obese adults and children  3/431 0.7% [297] 
Spain Obese adults 1/159 0.6% [322] 
Italy Obese children/adolescents 1/208 0.5% [323] 
USA Severely obese adults 0/47 0% [305] 
*Frequency of individuals with Val103Ile mutation / total number screened (%). 
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5. Discussion 
To our knowledge, this is the first study screening for mutations in the MC4R gene in a 
population sample of severely obese Portuguese subjects. The melanocortin-4 receptor deficiency is 
widely accepted as the most prevalent form of monogenic obesity [41]. Hence, in children whit early-
onset obesity, screening for mutations in the MC4R gene could be a first step to determine genetic 
causes of obesity. We screened the promoter 5’ untranslated region (5’UTR) and coding region of 
MC4R gene to investigate possible genetic causes in severely obese Portuguese children. 
Only one MC4R coding region sequence variation was found at the heterozygous state in a 
Portuguese obese subject: a G to A nucleotide transition at position 307 resulting in the amino-acid 
substitution valine (Val) to isoleucine (Ile) at codon 103 (Val103Ile). This missense mutation was first 
described in two obese British adults at the heterozygous state [303]. In our study, the frequency of 
the rare allele (103Ile) was 1.56% (1/64) and is in line with those reported in previous studies (Table 
7.2). No other mutations were found in the MC4R coding region of our study sample. 
Across world populations, carrier frequencies for the 103Ile in obese individuals range from 0% 
(Black women, USA) to 4.6% (Sweden) (sample size between 40 to 1100 subjects; see Table 7.2). Our 
study sample has a lower population size comparing with previous studies; nevertheless the 
frequency obtained for the Val103Ile carrier individuals is consistent with the findings in other 
European countries. In Southern Europe, carrier frequencies ranged between 0.6% (Spain) to 1.6% 
(Italy), and in Northern European countries this frequency is higher ranging from 1.6% to 4.6% 
(France, Belgium, Germany, UK and Sweden). 
Regarding this polymorphism there are inconsistent findings and ambiguous association with 
obesity in population studies making the functional effect unresolved. Gotoba et al. [303] presumed 
that this mutation was not related to obesity. Moreover, Rosmond et al. [302] has explicitly reported 
that individuals with the 103Ile allele have lower BMI, lower waist-to-hip ratio, and lower abdominal 
obesity. Geller et al. [324], in a sample comprising extremely obese children or adolescents and both 
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parents revealed a reduced transmission of the Ile103 allele to obese offspring: carrier individuals of 
the Ile103 allele have an approximately reduction of 1.6 kg of body weight in a 1.8-m-tall individual. 
A Genome-wide association study (GWAS) conducted by Meyre et al. [265] in a sample on early-
onset extreme obesity adults, found a negative association of the 103Ile polymorphism with obesity. 
Moreover, several case-control studies found similar 103Ile frequencies between extreme obese and 
non-obese individuals, consistent with previous studies showing no association with obesity [46, 231, 
304, 306, 314, 319, 325]. The low score obtained using the PolyPhen2 software (0.021) corroborated 
a benign effect for this amino acid substitution. 
A second nucleotide substitution, the -178A>C transversion, in the 5’UTR region of MC4R gene, 
located 178 nucleotides upstream of the initiation methionine codon, was identified at heterozygous 
state in one severely obese subject. This polymorphism was first described by Jacobson et al. [305] in 
Swedish obese subjects. This single nucletotide change (rs34114122) was described with a minor 
allele frequency of 1% (C-allele) in the general European population and 4% in Iberian populations 
(ENST00000299766). A study conducted by Alharbi et al. [299] found a rs34114122-C allele frequency 
of 0.01% in a UK population and they don’t found any effect on BMI. Another study conducted by 
Cole et al. [326] found this polymorphism at a minor allele frequency of 0.018% in the Hispanic 
population (USA) and concluded that rs34114122 likely has a functional effect on the appetite 
hormone ghrelin. Bioinformatics analysis indicates that -178A>C substitution creates one putative 
transcription factor binding site for AML-1a which might suggest functional significance. Thus, the 
possibility that this nucleotide change in the promoter region of MC4R could be implicated on the 
etiology of obesity cannot be discarded. 
This study is the first to screen for MC4R gene mutations in a sample of Portuguese children 
with severe obesity. Only two severely obese subjects shown sequence variations in a heterozygous 
state: the –178A>C substitution, in the MC4R promoter region, and the missense mutation Val103Ile, 
in the MC4R coding region. Further investigation about the obesity association and the functional 
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function of these two polymorphisms is needed to confirm its implication in the role of obesity. We 
conclude that MC4R gene could not be assumed as an important genetic cause of severe obesity in 
the Portuguese population. 
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1. Conclusions  
 
General conclusions from results presented in this study are summarized below. 
 
 In 2011, the prevalence of overweight and obesity among 6-12 years-old children from 
central region of Portugal was 33.0%, from which 10.7% were obese.  
These values represent an increase in the prevalence of overweight/obesity in Portuguese 
children in the last years: 
o Comparing these results with a previous study using data from 2002, we found a 
slightly higher prevalence in overweight/obesity (~1.5%), however, the prevalence of 
obesity decrease (~0.6%). 
o Prevention and campaigns awareness seems to be insufficient, and Portugal remains 
on the list of European countries with higher prevalence in children obesity. 
 The rs9939609 and rs1421085 polymorphisms located in the FTO gene in high LD (r2=0.82) 
were found associated with the risk of obesity (p=0.02 and p=0.01, respectively), also with 
obesity-related traits, weight, BMI, BMI Z-score and waist circumference (p<0.05 for both 
and all traits) in the Portuguese children. Concerning the rs1861868 polymorphism we 
found association with BMI, weight and waist circumference (p<0.05 for all traits), 
however, no association was found with risk of obesity (p=0.31). 
o When performing a Haplotype analysis (rs1861868-rs1421085-rs9939609), two 
combinations (ACA and GCA) were found associated with a higher risk of obesity 
(p=0.02 and p=0.03, respectively). 
 The -13910C>T polymorphism, located ~14 kb upstream of the LCT gene and associated 
with lactase persistence in European populations, may predispose to abdominal obesity 
however the association with BMI was not confirmed in our sample. 
 The MC4R rs12970134 polymorphism was found associated with BMI, BMI Z-score and 
waist circumference, and nearly associated with weight (p=0.05). An association with the 
risk of obesity was also found (p=0.02). 
 Near nominal association was found between the PPARGC1A rs8192678 polymorphism 
and weight (p=0.06). 
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 The MSRA rs545854 polymorphism was also nearly associated with BMI (p=0.055) and 
BMI Z-score (p=0.05). 
 The TFAP2B rs987237 polymorphism was found nearly associated (p=0.05) with the obese 
phenotype. 
 Regarding the association of MC4R rs12970134 and TFAP2B rs987237 polymorphisms the 
signal detected with obesity showed an opposite direction of effect to that previously 
found in other populations. This result was uncommon, but similar findings were found in 
several studies regarding other conditions. 
  In our sample, 32 children were classified with morbid obesity (BMI ≥99th). We detected 
no mutations in the MC4R gene associated with this phenotype. However, we found a 
heterozygous individual with the Val103Ile common polymorphism, ranging similar 
frequency to that obtained in other European countries. We also found an heterozygous 
individual with the promoter substitution -178A>C previously described as a non-
pathogenic variant.  
 
Overall, the results gathered in the present study demonstrate the possible association of 
several genes with common obesity in a sample of Portuguese children. Our results also show that 
allele and genotype frequencies obtained were generally similar to those obtained in other European 
populations. 
This study is a significant contribution to the knowledge of the genetic susceptibility of obesity in 
Portuguese children, but could also to help in future meta-analysis studies clarifying which variants 
are truly associated with the predisposition to develop an obese phenotype. This study also helps to 
better understand the genetic diversity that could be associated with obesity in the Portuguese 
population and compare it with other populations. Further studies are needed with larger samples to 
elucidate the real association or not of polymorphisms found nearly associated with obesity. The 
polygenic obesity remains complex because it is determined by the interaction of multiple additional 
factors. Despite eight years of investigation in genetic association studies since the discovery of the 
FTO rs9939609 polymorphism, our knowledge about genetic predisposition to polygenic obesity 
remains unsolved. Today, several other mechanisms were identified as playing a role in obesity 
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predisposition. Epigenetics, nutrigenetics, microbiota, etc. are new promising research branches 
which may explain parts of the missing heritability. 
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